Socioeconomic status and vascular diseases in the INVADE study by Mentz, Hannah
Socioeconomic status and vascular
diseases in the INVADE study
Inaugural-Dissertation
zur Erlangung des Doktorgrades der Philosophie
an der Ludwig-Maximilians-Universität München
vorgelegt von
Hannah Mentz
aus Starnberg
2016
Erstgutachter: Prof. Dr. Manfred Grohnfeldt
Zweitgutachter: PD Dr. med. Holger Poppert
Drittprüfer: Prof. Dr. Frank Fischer
Tag der mündlichen Prüfung: 27. Januar 2016
II
Dedication
Dedication
For the non-scientific part of my thesis, I particularly want to thank my, for the first time
in writing, husband Michael for all the evenings listening to the progress of my work, his
motivational skills, and his endless and affectionate support.
A special thanks goes to my parents. Since primary school, they provided me with the
best and most suitable education available. I am truly honoured to be the first woman in
our family to get a doctoral degree. They taught me to live my dreams and complete
envisaged projects purposefully. As my father recently told me: “You got the thirst of
knowledge from your mother and the necessary determination from myself.”
I guess, both of you provided me with a great combination of the two of them.
III
Acknowledgement
Acknowledgement
Foremost, I would like to thank my university advisor Prof. Dr. Manfred Grohnfeldt
at the Ludwig-Maximilians-University Munich and my medical supervisor PD Dr. med.
Holger Poppert at the University Hospital Klinikum Rechts der Isar, Technical University
Munich, for providing me with the opportunity to complete this thesis and delve deeper
into socioeconomic facets of the INVADE study. Your support and guidance over the past
three years was of fundamental importance to me. The active interest you took in my
working process and your thoughts greatly inspired me. Thank you for your availability,
timely replies to all my questions, motivation as well as constructive inquires.
I especially want to thank Prof. Dr. Manfred Grohnfeldt for his continued and heartfelt
supervision- from my very first day at the Ludwig-Maximilians-University Munich during
my Bachelor’s period, through my master’s degree as my thesis supervisor, until today,
the day I am finally handing in my doctoral thesis.
Additionally, I would like to thank Prof. Dr. Helmut Küchenhoff and his team working in
the StaBLab, Ludwig-Maximilians-University Munich and Dr. Alexander Hapfelmeier at
the IMSE, University Hospital Klinikum Rechts der Isar, Technical University Munich, for
their professional statistical advice and inside knowledge.
Furthermore, I want to thank the INVADE e.V. board of management, Dr. med. Karl-
Heinz Ander, Dr. med. Hans Gnahn, Dr. med. Othmar Gotzler, and Dr. med. Klaus
Pürner for the chance to participate in this study. A warm thanks goes to Dr. med. Horst
Bickel for his positive contribution to my work and to the study coordinators, Mrs. Astrid
Biermeier and Mrs. Sigrid Stetter for the trial administration and support in the head
quarter in Baldham, Germany.
IV
Zusammenfassung
Zusammenfassung
Theoretischer Hintergrund
Unter den zehn häufigsten Todesursachen in Deutschland nimmt Schlaganfall Platz
sieben ein, Myokardinfarkt (MI) Rang zwei. Schlaganfall und MI verfügen über eine große
Anzahl gemeinsamer Risikofaktoren, so geht fortgeschrittenes Alter beispielsweise mit
einer signifikant erhöhten Inzidenzrate für Schlaganfall und MI einher. All das trägt zu
einer grundlegenden sozialen und ökonomischen Belastung durch diese Krankheiten in
einer überalterten Gesellschaft wie der deutschen bei. Überdies hat auch die individuelle
sozioökonomische Position großen Einfluss auf die Inzidenz von Schlaganfall und MI.
Ziel der Studie
Die Zielsetzung dieser Studie war es, die Assoziation von ausgewählten sozioökonomischen
Variablen, wie Bildungsniveau, Beschäftigung, Familienstand und Wohnform mit der Inzidenz
von ischämischem Schlaganfall einschließlich transitorische ischämischer Attacke (TIA)
sowie MI in der INVADE Kohorte (Interventionsprojekt zerebrovaskuläre Erkrankungen
und Demenz im Landkreis Ebersberg), nach dem Adjustieren von etablierten Risikofaktoren,
zu untersuchen.
Diese Ergebnisse ermöglichen einen gezielten, auf die gesundheitlichen Bedürfnisse der
Menschen ausgerichteten Ansatz in der betreffenden Region.
Methodik
Die multivariate Cox Regression wurde angewandt, um Hazard ratios zu berechnen
und die Assoziation von bekannten Risikofaktoren und selektierten sozioökonomischen
Variablen auf die Inzidenz von Schlaganfall inklusive TIA und MI zu analysieren.
Alle multivariaten Analysen wurden nach Stand aktueller Literatur auf traditionelle Kovariablen
kontrolliert. Diese umfassten Alter zu Studieneintritt, Geschlecht, Hypertonie, Diabetes
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mellitus, Body-Mass-Index, körperliche Aktivität, Alkoholkonsum und Rauchen, um eine
unabhängige Schätzung der Beziehung zwischen dem Status zu Baseline und inzidenten
Ereignissen zu erreichen. Je ein Modell wurde für ischämischen Schlaganfall inklusive
TIA, ischämischen Schlaganfall separat und MI berechnet.
Ergebnisse
3 908 Teilnehmer, darunter 1 600 (40,9%) Männer und 2 308 (59,1%) Frauen im Alter
von 53,74 bis 101,85 Jahren (Standardabweichung (SD)= 7,8) wurden eingeschlossen.
Während der Studienphase erlitten 230 (5,9%) Patienten einen ischämischen Schlaganfall
inklusive TIA, 161 (4,1%) einen ischämischen Schlaganfall und 92 (2,4%) Teilnehmer
einen MI.
Fortgeschrittenes Alter (B= 0,08, Standardfehler (SF)= 0,01, p= 4,76x10-19) und Rauchen
(B= 0,35, SF= 0,16, p= 0,03) waren mit einem erhöhten Risiko für ischämischen Schlaganfall
inklusive TIA assoziiert. Körperliche Aktivität (B= -0,39, SF= 0,16, p= 0,02) hatte einen
signifikanten positiven Effekt. Ein höherer Bildungsstatus wirkte signifikant protektiv (B= -
0,85, SF= 0,42, p= 0,05). Ehe, Wohnsituation und Beschäftigung hatten keine schützende
Auswirkung.
Höheres Alter (B= 0,09, SF= 0,01, p= 1,18x10-17), gesteigertes LDL-Level (B= 0,005,
SF= 0,002, p= 0,041) sowie Rauchen (B= 0,559, SF= 0,193, p= 0,004) erhöhten das
Risiko für ischämischen Schlaganfall signifikant, wohingegen körperliche Betätigung (B=
-0,39, SF= 0,19, p= 0,04) einen schützenden Effekt zeigte. Erneut war ein niedrigeres
Bildungslevel mit einem höheren Risiko für ischämischen Schlaganfall assoziiert (B= -
1,63, SF= 0,72, p= 0,03). Ehestatus, Zusammenleben und berufliche Tätigkeit zeigten
keine Assoziation mit der Inzidenz von ischämischem Schlaganfall.
Fortgeschrittenes Alter (B= 0,09, SF= 0,01, p= 0,76x10-9), Hypertonie (B= 0,45, SF=
0,26, p= 0,08) und Rauchen (B= 0,55, SF= 0,25, p= 0,03) waren signifikante Risikofaktoren
für MI. Das weibliche Geschlecht (B= -0,946, SF= 0,297, p= 0,001) und hohe HDL-
Konzentrationen waren signifikant protektiv (B= -0,025, SF= 0,009, p= 0,004). Bildungserfolg,
Ehe, Zusammenleben und gegenwärtige sowie frühere Beschäftigung zeigten keine
signifikante Assoziation mit dem Erleiden eines MI.
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Interpretation
Die Entwicklung präventiver Strategien auf kommunaler Ebene hat sich als höchst effizient
erwiesen. Ein Ausbau der gesundheitlichen Bildung, der sich auf die beschriebenen
sozioökonomischen Diskrepanzen in der INVADE Kohorte fokussiert, könnte Inzidenzraten
senken sowie die finanzielle und gesundheitliche Belastung durch vaskuläre Erkrankungen
im Landkreis Ebersberg mildern.
Da Forschung eine fundamentale Rolle bezüglich der Reduzierung der Last durch Schlaganfall
und MI einnimmt, können vereinte Bemühungen der Wissenschaft und Politik auf wohlgezielte
Präventionsprogramme in niedrigeren sozioökonomischen Schichten zu einem Rückgang
der Gesamtkosten im deutschen Gesundheitssystem beitragen.
Schlüsselwörter
INVADE Studie, ischämischer Schlaganfall, transitorische ischämische Attacke, Myokardinfarkt,
sozioökonomischer Einfluss, gesundheitliche Bildung
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Theoretical background
Among the major ten causes of death in Germany, stroke ranks on place seven, while
myocardial infarction (MI) is attributed to place two. Stroke and MI share a large number
of risk factors. For instance, advanced age is highly associated with increased incidence
rates of stroke and MI. This adds to the fundamental social and economic burden of
disease in an aging society like Germany. Furthermore, the socioeconomic position of
an individual has a great impact on the incidence of stroke and MI.
Aims of the study
Objective of this study was to investigate the association of selected socioeconomic
variables, namely educational attainment, occupation, marital status, and cohousing,
with the incidence of ischaemic stroke, ischaemic stroke including transient ischaemic
attack (TIA), and MI in the INVADE cohort (Intervention project on cerebrovascular diseases
and dementia in the district of Ebersberg), after having adjusted for well-established risk
factors.
These findings enable a specific and medical need-orientated approach for the area in
question.
Method
Multivariate Cox regression was used to calculate hazard ratios and analyse the association
between well-documented risk factors, selected socioeconomic variables, and the incidence
of ischaemic stroke including TIA and MI.
All multivariate analysis were adjusted for traditional covariates based on current literature.
These were age at baseline, sex, hypertension, high-density lipoprotein as well as low-
density lipoprotein, atrial fibrillation, diabetes mellitus, body mass index, physical activity,
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alcohol consumption, and cigarette smoking in order to give an unbiased estimate for
the relation between baseline status and incident events. For ischaemic stroke including
TIA, ischaemic stroke, and MI, one model was calculated, respectively.
Results
3,908 participants, 1,600 (40.9%) men and 2,308 (59.1%) women, aged 53.74 to 101.85
years (SD= 7.8) were included. During the trial period, 230 (5.9%) patients suffered
from ischaemic stroke including TIA, 161 (4.1%) from ischaemic stroke, and 92 (2.4%)
participants from myocardial infarction.
Advanced age (B= 0.08, SE= 0.01, p= 4.76x10-19) and smoking (B= 0.35, SE= 0.16,
p= 0.03) were associated with an increased hazard of ischaemic stroke including TIA.
Physical activity (B= -0.39, SE= 0.16, p= 0.02) had a significant protective effect. A higher
education status was significantly protective (B= -0.85, SE= 0.42, p= 0.05). However,
there was no protective effect of being married, living arrangements, and occupation.
Higher age (B= 0.09, SE= 0.01, p= 1.18x10-17), high LDL concentration (B= 0.005, SE=
0.002, p= 0.041), and smoking (B= 0.559, SE= 0.193, p= 0.004) significantly increased
the risk for ischaemic stroke, while physical activity (B= -0.39, SE= 0.19, p= 0.04) had a
significant protective effect. Again, lower educational level was associated with increased
risk of ischaemic stroke (B= -1.63, SE= 0.72, p= 0.03). Marital status, housing conditions,
and occupation did not show any association with incidence of ischaemic stroke.
Advanced age (B= 0.09, SE= 0.01, p= 0.76x10-9), hypertension (B= 0.45, SE= 0.26,
p= 0.08), and smoking (B= 0.55, SE= 0.25, p= 0.03) were significant risk factors for
MI. Being female (B= -0.946, SE= 0.297, p= 0.001) and high HDL level were significantly
protective (B= -0.025, SE= 0.009, p= 0.004). Educational attainment, marriage, cohousing
as well as former or current occupational level had no significant association with suffering
from MI.
Interpretation
Implementation of preventive strategies have proven highly effective at community level.
A deepened health care education focusing on the revealed socioeconomic discrepancies
in the INVADE cohort might lower incidence rates and the financial as well as health
burden of vascular diseases in the administrative district of Ebersberg.
As research plays a fundamental role in reducing the strain of stroke and MI, combined
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efforts of science and politics on target-orientated preventive programs in lower socioeconomic
classes can contribute to a decline of overall costs in the German health care system.
Keywords
INVADE study, ischaemic stroke, transient ischaemic attack, myocardial infarction, socioeconomic
impact, health care education
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1 Introduction
1.1 Context of this thesis
This study investigates the association of selected socioeconomic variables, namely
educational attainment, occupation, marital status, and cohousing, with the incidence
of ischaemic stroke, ischaemic stroke including transient ischaemic attack (TIA), and
myocardial infarction (MI) in the INVADE cohort (Intervention project on cerebrovascular
diseases and dementia in the district of Ebersberg), after having adjusted for well-
established risk factors. As ischaemic stroke and TIA are closely linked, the category of
ischaemic stroke including TIA was enclosed to analyse potential differences by comparing
the findings in both groups.
Consequently, chapter 1 defines ischaemic stroke, TIA as well as myocardial infarction
and reports recent incidence, prevalence, and mortality rates. Chapters 2 and 3 give an
overview of current literature regarding risk factors for ischaemic stroke including TIA,
and myocardial infarction, respectively. This will explain the collection of risk factors
applied in the present study. Furthermore, chapter 4 delves deeper into socioeconomic
position and health, focusing on the variables chosen in the present study. Specific
findings on socioeconomic circumstances in association with the risk of stroke or myocardial
infarction are described in chapter 5. Based on the results reported in the previous
chapters, chapter 6 underlines the importance and motivation of the study. This section
leads over to the methods described in chapter 7, followed by the results in chapter
8. To conclude, chapter 9 discusses the stated findings, strengths, and limitations of
this study. Finally, implications for prevention of ischaemic stroke including TIA and
myocardial infarction are described.
As the generalization of epidemiological results on other countries or geographical regions
has to be handled with care, the present study gives deeper insight into socioeconomic
position and vascular diseases in the administrative district of Ebersberg. These findings
enable a specific and medical need-orientated approach for the area in question.
1
Introduction
1.2 Definition ischaemic stroke, transient ischaemic
attack and myocardial infarction
The following section will provide a current definition of ischaemic stroke, transient ischaemic
attack and myocardial infarction.
Classically, stroke is characterized as a neurological deficit attributed to an acute focal
injury of the central nervous system by a vascular cause. This encompasses cerebral
infarction, intracerebral haemorrhage (ICH), and subarachnoid haemorrhage. Despite its
worldwide impact, there is no consistent definition of the term “stroke” in assessments of
the public health, in clinical practice, or in clinical research [1].
A recent definition of ischaemic stroke is an episode of neurological dysfunction caused
by focal cerebral, spinal, or retinal infarction [1].
Furthermore, a TIA can be described as a brief episode of neurologic dysfunction caused
by focal brain or retinal ischaemia [2]. It is not associated with lasting cerebral infarction
[3]. The term “transient” indicates a lack of permanence.
In 2002, a research group of cerebrovascular physicians suggested a tissue-based,
rather than time-based definition. They described a TIA as a brief episode of neurological
dysfunction due to focal brain or retinal ischaemia, with clinical symptoms typically lasting
less than one hour, and without evidence of acute infarction [2]. This proposed new
definition has been well received and numerous cerebrovascular experts endorsed this
further developed suggestion [3]. Defining TIA with a 24-hour maximum duration has
the potential to delay the initiation of effective stroke interventions. A 24-hour limit for
transiently symptomatic cerebral ischaemia is arbitrary. It is not representative for the
usual duration of these events [3].
Based on the considerations mentioned above, the American Heart Association (AHA)
writing committee found that the definition was well supported by the data in current
literature. Nevertheless, the reference to a one-hour time point in the new definition was
not supportive, as this point in time does not demarcate events with and without tissue
infarction.
Accordingly, the following revised definition for TIA was proposed as a transient episode
of neurological dysfunction caused by focal brain, spinal cord, or retinal ischaemia,
without acute infarction [3].
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In terms of MI, it can be stated that there was a continuous need for a better definition
of this type of disease for epidemiological, diagnostic, and research purposes since the
1971 publication of the first standardized definition by the World Health Organization
(WHO) [4].
The term myocardial infarction pathologically describes the death of cardiac myocytes,
also known as cardiac muscle cells or muscle fibre, due to extended ischaemia. This may
be caused by an increase in perfusion demand or a decrease in blood flow. An acute
myocardial infarction (AMI) is categorized in the spectrum of acute coronary syndromes
(ACS). Those include unstable angina (UA), non–ST-elevation myocardial infarction (NSTEMI)
as well as ST-elevation myocardial infarction (STEMI) [5].
A persistent elevation of the ST-segment on an electrocardiogram (ECG) signifies a
severe occlusion of a coronary artery, leading to a necrosis of the myocardial tissue. This
condition is called STEMI. ACS without ST-segment elevation may either be attributed to
NSTEMI or UA [5].
Atherosclerosis describes the buildup of fats, cholesterol and other substances in and
on the artery walls resulting in plaques that can restrict the blood flow. These plaques
can burst and launch a blood clot. The rupture of a high risk plaque in the coronary
arteries is generally speaking a primary causative factor in the development of an acute
myocardial infarction [5]. High-risk or vulnerable plaques are provided with a cover of a
thin fibrous cap, which predisposes these plaques to rupture. Consequently, the rupture
of the thin fibrous cap exposes blood to plaque constituents that add to the activation,
adhesion, and aggregation of platelets and the production of thrombin. This process is
causing subsequent thrombus formation, which occludes the vessels, impedes the blood
flow, and subsequently leads to the development of AMI. It can be stated that more than
90% of patients with STEMI and approximately 35% to 75% of patients with NSTEMI or
UA have been reported to have thrombus formation in their coronary arteries [5].
The detection of a rise and/or fall of cardiac biomarkers, along with at least one of the
values being elevated (>99th percentile upper reference limit), is central to the third
universal definition of MI suggested by the expert consensus of the American College of
Cardiology Foundation. The highly sensitive and specific cardiac troponin can be seen
as the preferred biomarker of myocardial necrosis. Additionally, one of the five following
predefined criteria should be present to justify a diagnosis of MI [6]:
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Table 1.1
Criteria for diagnosis of myocardial infarction
Signs for myocardial infarction
New or presumably new significant ST-segment/T-wave changes or left bundle
branch block (cardiac conduction abnormality in ECG)
Development of pathological Q-waves on ECG (sign of previous myocardial
infarction)
New loss of viable myocardium, which is the muscular tissue of the heart, or
regional wall motion abnormality by imaging
Identification of intracoronary thrombus by angiography or autopsy
1.3 Incidence, prevalence and death rates of stroke,
transient ischaemic attack and myocardial infarction
To understand the great significance and the fundamental need of current research in
stroke and myocardial infarction, the current rates for incidence, prevalence and death
will be discussed in the following chapter on a global, regional and Germany-specific
level. Due to the neurological scientific and academic background this thesis is built on,
this work will focus on cerebrovascular disease, namely stroke.
1.3.1 Stroke
Global overview
Currently, about 7.3 billion people populate the earth [7]. Over the past twenty years,
the age-standardised rates of stroke mortality have declined globally. Nevertheless,
the absolute number of people who have a stroke every year, stroke survivors, related
deaths, and the overall global burden of stroke are immense and raising [8].
Based on the results of the Global Burden of Diseases study, stroke was the second
most common cause of death [9] and globally the third most frequent source of disability-
adjusted life years (DALY) in the year 2010 [10].
By 2030 there will be nearly 12 million deaths due to stroke, 70 million stroke survivors
and above 200 million disability-adjusted life years lost worldwide, if these trends in
stroke incidence, mortality, and DALYs continue [8]. By this time, an additional 3.4 million
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adults will have had a stroke. This is an increase of 20.5% in prevalence compared to
2012 [11].
A systematic review on worldwide stroke incidence trends reported a decline in overall
age-adjusted stroke incidence rates over the last four decades in developed countries
[12].
In the same time, there is a huge trend in rejuvenation regarding the proportion of stroke
in people ≤ 65 years. This can particularly be observed in low-income and middle-
income countries.
The proportion of young people <20 years and young and middle-aged adults, which is
20 to 64 years, affected by stroke is raising [13]. In terms of even younger population
groups, more than 83,000 children and youths aged 20 years and younger are afflicted
with stroke per year [8]. Compared to older patients, young stroke patients show different
etiologic subtype patterns [14].
From a social and public health point of view, any decrease in stroke incidence is a great
achievement. Though, it has to be kept in mind that the reduced incidence in old age
goes along with increased numbers in younger patients as mentioned above. Obviously,
this leads to a crucial cut in quality and productivity of life corresponding with fundamental
costs in the public health care system [15]. Further details will be discussed in chapter 6
on the motivation of this study.
To get a comprehensive picture, the ten leading causes of death in the world in 2012 are
displayed in the figure 1.1, demonstrating affected individuals in millions. Stroke ranks
with 6.7 million deaths worldwide on second place, following ischaemic heart disease on
top rank leading to 7.4 million deceases [16].
In low-income and lower/upper-middle-income countries, stroke incidence seems to raise,
while decreasing in high-income countries of 42% over the last forty years [12]. In this
context, it clearly has to be stated that the main part of research and attention to stroke
prevention and intervention measures takes place in high-income countries, whereas
more than 85% of the cases of stroke occur in low-income and middle-income countries
[17].
In the following, figures 1.2-1.5 compare the major causes of death in low, lower-middle,
upper-middle and high-income countries per stroke deaths/100,000 residents. In low-
income-countries, stroke accounts for 52 deaths/100,000 inhabitants and in lower-middle-
countries for 78 deaths/100,000 inhabitants. Additionally, in upper-middle-countries, the
5
Introduction
Figure 1.1
The 10 leading causes of death in the world in 2012;
legend to this overview: place 4: lower respiratory infections; place 5: trachea bronchus,
lung cancers; place 10: hypertensive heart disease [16].
rate reaches 126 deaths/100,000 inhabitants, which is almost double compared to low-
income-countries. Finally, in high-income countries 95 deaths/100,000 inhabitants were
reported due to stroke [16], underlining the general trends described in the beginning of
this section worldwide.
6
Introduction
Figure 1.2
The 10 causes of death in low-income countries in 2012;
legend to this overview: place 7: preterm birth complications; place 9: birth asphyxia and
birth trauma; place 10: protein energy malnutrition [16].
Figure 1.3
The 10 causes of death in lower-middle income countries in 2012;
legend to this overview: place 4: COPD (Chronic obstructive pulmonary disease); place 6:
preterm birth complications [16].
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Figure 1.4
The 10 causes of death in upper-middle income countries in 2012;
legend to this overview: place 4: trachea bronchus, lung cancers [16].
Figure 1.5
The 10 causes of death in high-income countries in 2012;
legend to this overview: place 3: trachea bronchus, lung cancers; place 4: Alzheimer disease
and other dementias; place 7: colon rectum cancers [16].
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At the end of this paragraph, figure 1.6 shows the stroke mortality rate on a global level
[8].
Figure 1.6
Age-standardized stroke mortality per 100,000 people in 2010 [8].
Overview of the situation in the United States
Based on this global overview, there will be an outline of the current situation in the
United States of America.
As there is a huge data volume and a broad range of studies originated from the United
States (US), those findings will be disused as a reference throughout this thesis.
On average, every 40 seconds, a person in the US has a stroke. Every four minutes,
an individual dies of this condition [18]. In 2010, stroke accounted for approximately one
of every 19 deaths in the US [18] which currently states a population of 321.3 million
inhabitants [7].
When examined independently from other cardiovascular diseases (CVD), stroke reaches
number four among all causes of death, behind diseases of the heart, cancer, and
chronic lower respiratory disease. This is in contrast to data published by the WHO,
naming stroke as second cause of death in high-income countries, indicating variations
on country level. In the US, the number of deaths from stroke as an underlying cause
was reported as a total number of 129,476 affected persons in the year 2010 [18].
Every year, about 795,000 people experience an incident or recurrent stroke in the
US. Approximately 610,000 of these events are first attacks, and 185,000 are recurrent
attacks. Of all stroke subtypes, 87% are ischaemic and 10% are intracerebral haemorrhage
strokes, whereas only 3% can be attributed to subarachnoid haemorrhages.
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Differences in gender
Women have a lower age-adjusted stroke incidence in comparison to men. Nevertheless,
sex differences in stroke risk may be modified by age [19]. There have been gender
differences reported in the onset of stroke. Women tend to be older at onset than men,
with 75 years compared to 71 years respectively [20].
Data from the Framingham Heart Study (FHS), a long-term and ongoing trial on residents
of the town of Framingham, Massachusetts, which was launched in 1948 with 5,209
adults and has now reached its third generation of subjects [21], reported that white
women in the age of 45 to 84 had a lower risk of stroke compared to white men. However,
this relation is reversed in older ages in women >85 years, who showed an increased
risk [20]. The higher prevalence of stroke for females is probably linked with hormonal
changes during the menopause. Lifetime risk of stroke among those 55 to 75 years of
age was one in five for women (20%-21%) compared to approximately one in six for men
(14%-17%) [22].
Additionally, the major part of these strokes were documented in women older than 70
years, who were more likely socially isolated, live alone, have fiscal restraints as well as
higher rates of comorbid diseases. The increased rate of stroke deaths in females is
anticipated to raise in the future based on population projections. An excess of 32,000
stroke deaths in women in 2000 compared to nearly 68,000 deaths by 2050 is predicted
[19].
Results from the Austrian Stroke Unit Registry state that among patients submitted to
acute stroke unit care, women were significantly older (median age 77.9 for females
versus (vs.) 70.3 years for males), had higher pre-existing disability, and more severe
strokes. After correction for age, no significant sex-related differences in quality of care
were determined. Comparable onset-to-door times, times to and rates of neuroimaging
as well as door-to-needle times and rates of intravenous thrombolysis were identified
for both sexes. Nevertheless, despite the equal acute stroke care and a comparable
rate of neurorehabilitation, women showed a worse functional outcome at three-month
follow-up (modified Rankin scale 3–5: odds ratio (OR), 1.26; 95% confidence interval (CI)
[1.17–1.36]). The modified Rankin scale is frequently applied to estimate the degree of
disability or dependence in the daily activities of people who have suffered a stroke.
However, a lower mortality rate (OR, 0.70; 95% CI [0.78–0.88]) after correcting for
confounders was reported for women [23].
In the past 16 years, the German Erlanger Stroke Register reported that the total stroke
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incidence decreased in men (incidence rate ratio (IRR) 1995 to 1996 vs. 2009 to 2010
0.78; 95% CI [0.58–0.90]), but not in women [24].
Differences in race and ethnicity
Over the past decade, stroke incidence has been diminished in the US in whites but not
in blacks [25]. This indicates a worsening of the racial differences in stroke incidence
[15]. In summary, stroke became the fourth-leading cause of death in whites and the
fifth-leading cause of death in men while it persisted to be the second-leading cause of
death in women and blacks [26].
Overview of the situation in the European Union
In the European Union (EU), which currently encompasses 504.6 million inhabitants,
one million first ischaemic strokes are estimated each year [27], [28]. For the last ten
years, data on temporal trends of age- and sex-adjusted stroke incidence in European
communities is restricted [8]. Furthermore, the estimation of time-trends across different
population-based registers can be compounded as these studies cannot be considered
homogeneous in various aspects touching stroke incidence in the local population. Examples
for this are ethnic group diversity, geographical region or risk factor distribution in the
general population [24].
Current situation in Germany
Based on this, an overview of the situation in Germany will follow.
Derived from data published by the German Federal Statistical Office, 52.044 individuals,
which is 5.8%, died of acute myocardial infarction (ICD-10 classification I21) whereas
stroke (ICD-10 classification I64) attributed with 18.883 (2.1%) of deaths in 2013 [29].
Consequently, AMI ranked on place two, while stroke marked place seven on the list of
the major ten causes of death in Germany (see table 1.2).
The aging of the population in Germany and whole Europe will further raise the socioeconomic
burden of stroke and limit the medical and social resources accessible to support the
needs of individuals affected by stroke and their kin. Based on the current Robert-Koch-
Institut federal health report, the life expectancy in Germany is 81.6 years for women and
76.0 years for men [30].
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Table 1.2
Top 10 causes of death in Germany, based on ICD10-classification in 2013 [29]
ICD-10 code Causes for death n %
I25 chronic ischaemic heart disease 73,176 8.2
I21 acute myocardial infarction 52,044 5.8
I50 heart failure 45,815 5.1
C34 malignant neoplasm of bronchus and lung 44,813 5.0
J44 other chronic obstructive pulmonary disease 28,882 3.2
F03 unspecified dementia 24,738 2.8
I11 hypertensive heart disease 24,669 2.8
I64 stroke, not specified as haemorrhage or infarction 18,883 2.1
J18 pneumonia, unspecified organism 18,797 2.1
C50 malignant neoplasm of breast 18,009 2.1
To meet this challenge, the Helsingborg Declaration clearly stated the need for population-
based monitoring of particular core indicators like stroke incidence and case fatality [31].
Based on this demand, in 1994, a community-based stroke register was established in
Erlangen, Bavaria, Germany [32].
The Erlangen Stroke Project can be described as the first prospective community-based
stroke register including all age groups in Germany. It underlined incidence rates of
stroke similar to those reported from other population-based studies in western industrialized
countries [33], [34], [35], [36], [37], [38]. In 1998, the annual incidence rate for Germany
was 1.74 per 1,000, in detail 1.47 for men and 2.01 for women [32]. After having adjusted
for age compared to the European population, the incidence rate was 1.34 per 1,000,
which was 1.48 for men and 1.25 for women. Furthermore, the overall case fatality at
28 days was 19.4%, at three months 28.5%, and at one year 37.3%. Additionally, it
was stated that 51.0% of all first strokes were recorded in individuals aged 75 years or
older.
This rate was comparable to estimates also found in predominantly white populations in
the Framingham study in the United States [39], [40] or Australia [41].
However, those incidence rates were lower than those reported in former East Germany
and closer to the rates observed in other Eastern European countries [32]. As Germany
has been separated for 45 years, both politically and socioeconomically, it remains to
be seen to what extent and in which period of time reunification will diminish this gap in
stroke incidence and fatality rates predominantly.
In addition to this, it was reported that more than 94% of those patients with stroke were
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hospitalized. This is comparable with the proportion observed for the majority of other
industrialized countries, particularly in urban areas [32]. The stated case-fatality rates
at day 28 were also similar to those identified in other Western European countries [33],
[35], [38].
Differences in gender in Germany
Recent data from the Erlangen Stroke Project recorded 3,243 patients with first-ever
stroke over a period from January 1995 to December 2010 [24]. The median age was
75 years, 55% of all patients were females. In this context, it clearly has to be stated that
the total stroke incidence decreased in male population over the study period of 16 years
(IRR 1995–1996 vs. IRR 2009–2010 0.78; 95% CI [0.58–0.90]), but not in females. A
decrease in ischaemic stroke incidence (IRR 0.73; 95% CI [0.57–0.93]) was reported
in men and an increase of stroke due to small artery occlusion in women (IRR 2.33;
95% CI [1.39–3.90]). The discrepancies in time trends of pathological and etiological
stroke subtypes that became obvious might be connected to gender differences in the
development of major vascular risk factors [24].
Heuschmann et al. (2004) analysed predictors of in-hospital mortality and attributable
risks of death after ischaemic stroke based on data retrieved from the German Stroke
Registers [42]. An overall in-hospital mortality of 4.9% was stated. In women, higher
age (p<0.001), the severity of stroke accounted by number of neurological disabilities
(p<0.001) as well as atrial fibrillation (hazard ratio [HR], 1.3; 95% CI [1.0-1.6]) were
independent predictors for death in the hospital. Furthermore, in the male population,
diabetes (HR, 1.3; 95% CI [1.0-1.8]) and previous stroke (HR 1.4; 95% CI [1.0-1.9])
significantly influenced the early outcome in addition to the factors defined for females in
a negative way. More than half of all in-hospital deaths derived from serious medical or
neurological complications (54.4%; 95% CI [54.3-54.5]).
To visualize gender differences in the EU, figure 1.7 compares the age-standardized
mortality rates for cerebrovascular diseases per 100,000 inhabitants in Germany, France,
the Netherlands and the United Kingdom by sex [30].
1.3.2 Transient ischaemic attack
It clearly has to be stated that only few epidemiologic data are available in terms of
incidence and prevalence of TIA. In Europe, the incidence rate was 0.52 to 2.37 and
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Figure 1.7
Comparison of age-standardized mortality rates for cerebrovascular diseases per 100,000
inhabitants in four European countries by sex [30].
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0.05 to 1.14 in men and women aged 55 to 64, 0.94 to 3.39 and 0.71 to 1.47 in those
aged 65 to 74, and 3.04 to 7.20 and 2.18 to 6.06 in those aged 75 to 84, respectively. In
this context, it has to be mentioned that higher incidences were reported in men than in
women [43]. Those variations in incidence might be due to the vague definition of TIA.
The corresponding incidences were comparable in the US. A nationwide survey of US
adults showed that the estimated prevalence of self-reported physician-diagnosed TIA
was 2.3%. This number corresponds with approximately five million people. The true
prevalence of TIA is assumedly higher, as this medical information will not always reach
the healthcare provider [44]. About 15% of all strokes are announced by a TIA [45].
Meta-analyses reported the short-term risk of stroke after TIA to be about 3% to 10%
at two days and 9% to 17% at 90 days [46], [47]. Additionally, it can be stated that
individuals who had a TIA and survive the initial high-risk period, have a ten-year stroke
risk of approximately 19% and a combined ten-year risk of stroke, MI, or vascular death
of 43%. This is 4% per year [48]. Within one year after TIA, approximately 12% of
patients will perish [49]. Supposedly, one third of episodes registered as a TIA would be
considered infarctions on the basis of diffusion-weighted magnetic resonance imaging
results [50].
To facilitate health care planning and resource allocation, regular up-dating of stroke
prevalence data is fundamental [51]. Further research is needed to enhance understanding
of stroke and TIA determinants as well as the burden worldwide. Reasons behind
discrepancies and changes in trends in strain of stroke between countries of different
income levels need to be established [8].
1.3.3 Myocardial infarction
Current situation in the United States
In terms of incidence, about every 44 seconds, an US citizen will have a MI. The forecasted
annual incidence of MI is 515,000 new attacks followed by 205,000 recurrent attacks.
Around 600 in every 100,000 men and 200 in every 100,000 women have an AMI every
year [5].
On average, a patient is 64.9 years old in males and 72.3 years in females at their first
myocardial infarction [52]. An annual decline in the overall mortality rates among AMI
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patients in the US can be observed [5]. Since the mid-1990s, the rate of hospitalization
for MI and in-hospital case fatality rates have decreased continuously [53].
Current situation in Germany
Focusing on Germany, the lifetime prevalence of diagnosed myocardial infarction in those
aged 40 to 79 years is 4.7% [54]. An increase was documented with advancing age,
which is raising from 1.5% in 40 to 49 year olds to 10.2% in 70 to 79 year olds. In
females, the prevalence is 2.5%, which is about half of the percentage for men (7.0%).
People younger than 60 years show a prevalence of less than 1%.
For Germany, the incidence is approximately 300/100,000 inhabitants. Additionally, the
mortality from myocardial infarction continues to fall (see figure 1.8). According to official
statistics on causes of death, 29,550 women and 34,679 men died of acute myocardial
infarction in 2003. In this regard, 6.5% of all deaths were documented in the female
population and 8.7% in the male. Additionally, the age-adjusted mortality rate among
women decreased from 48.0 to 32.4 deaths from infarction per 100,000 inhabitants. In
the same period of time it declined from 127.6 to 71.4 per 100,000 male inhabitants
[29].
According to the mentioned data published by the German Federal Statistical Office
above, 52,044 individuals (5.8%) died of acute myocardial infarction in 2013 [29]. As a
result, MI holds place two on the list of the top ten causes of death in Germany (see table
1.2).
The only increase in mortality from myocardial infarction has been reported in women
over 90 years of age [30].
Data from the Augsburg myocardial infarction registry emphasizes that the proportion
of patients with infarction who die before reaching the hospital or during their first days
in hospital has fallen since 1985. This development is inseparably linked to improved
emergency care. As a consequence, better acute treatment and rehabilitation have
reduced the risk of men and women over 65 years experiencing another heart attack.
Notwithstanding that 90% of all deaths following a MI still occur before the patient has
reached the hospital or during the patient’s first day of active treatment [30].
Differences in gender
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Figure 1.8
Mortality rate for acute myocardial infarction in Germany by sex [30].
A decline of the incidence rate can also be reported in women between the ages of 55
and 75, while the incidence in women between the ages of 25 and 54 is increasing. This
raise is linked to higher cigarette consumption among the German female population and
with women starting to smoke at an earlier age [55]. In young women, the thromboembolic
events are mainly associated with the intake of hormones.
Nevertheless, males are primarily affected by heart attacks. In earlier years men are at
an eight-fold higher risk to suffer from a myocardial infarction and nine times more likely
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Table 1.3
Most frequent cause of death per 100,000 inhabitants in Germany by sex [30].
to die from it than women of the same age. After the age of 65, the risk for men is three
times higher than for the female population. From the age of 85, there is no longer any
difference perceivable. Taken together, the age-standardized incidence and mortality
rate is double for men compared to women (see figure 1.8) [30]. In females, oestrogen
shows a protective effect.
The Federal Health Report announced by the Robert-Koch-Institut displays gender differences
in table 1.3 [30]. For females, MI was on third rank, followed by stroke on fourth place. In
contrast to this, MI was already on second place and stoke only on sixth rank in men.
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2 Risk factors for stroke and transient
ischaemic attack
To get a deeper understanding of variables attributed to risk of stroke and TIA, the
following chapter will give an overview of established and upcoming risk factors. This
insight in current scientific literature will underline the composition of risk factors chosen
in the present study.
Risk factors that cannot be modified are composed of age, sex, low birth weight, race,
and ethnicity as well as genetic predisposition. Well-documented and modifiable risk
factors comprise of hypertension, dyslipidaemia, exposure to cigarette smoke, diabetes,
postmenopausal hormone therapy, carotid artery stenosis, atrial fibrillation, other specific
cardiac conditions, sickle cell disease, poor diet, physical inactivity, obesity as well as
body fat distribution. Less well-documented or potentially modifiable risk factors are
stated as the metabolic syndrome, drug abuse, excessive alcohol consumption, sleep-
disordered breathing, use of oral contraceptives, hyperhomocysteinaemia, migraine, inflammation,
hypercoagulability, and elevated lipoprotein(a) [56].
Extensive evidence allows determining a variety of specific variables that alter the risk of
a first stroke. Consequently, this approach enables to find strategies for decreasing risk
in stroke and TIA.
Generally non-modifiable risk factors are variables which cannot be modified. These risk
factors identify subjects who are at altered risk of stroke. This group may profit from
precise prevention or treatment of other modifiable risk factors [56].
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2.1 Generally non-modifiable risk factors
2.1.1 Sex
As stated before, stroke is globally more common in men than in women [57]. Additionally,
the male population generally has increased age-specific stroke incidence rates in terms
of ischaemic and haemorrhagic stroke [58], [25]. An exception for these findings represent
the age group 35 to 44 years and those aged >85 years [59]. Pregnancy and the intake
of oral contraceptives (OC) add to the elevated risk of stroke in young women [60], [61],
[62]. Stroke leads to death in one in six women [63]. General differences in gender are
described in chapter 1.3.1 on incidence and prevalence of stroke.
There are some risk factor issues specific to women that need to be considered carefully.
On average, women are older than men at stroke onset, which is approximately 75 years
for females compared with 71 years for males [64]. Combined with atrial fibrillation,
women have a significantly higher risk of stroke than men [65]. Results from the FHS
supported that women with natural menopause before the age of 42 had twice the risk
of ischaemic stroke compared to women with natural menopause [66].
A large body of studies has reported that hormone replacement therapy is associated
with a higher risk of stroke in post-menopausal women [67]. This increase might have
accounted to the unfavourable risk profile in female patients.
Additionally, low-oestrogen-dose oral contraceptives are linked to a 93% increased risk of
ischaemic stroke. However, the absolute increased risk is small, namely 4.1 ischaemic
strokes per 100,000 non-smoking, normotensive women [68]. Endogenous oestrogen
seems to act protective, while hormone replacement therapy increases the risk.
In this context, migraine with aura is associated with ischaemic stroke in younger women.
This is particularly true in combination with smoking or the use of oral contraceptives. If
all three factors merge, the risk raises approximately nine-fold compared with women
without any of these [69]. For further details see 2.2.11 on OCs.
Lastly, the risk of ischaemic stroke during pregnancy and the first six weeks after giving
birth was reported to be 2.4 times higher compared to non-pregnant women of similar
age and race [70].
The Framingham study investigated the gender differences in stroke incidence and post-
stroke disability [64]. In summary, a consistent body of international studies stated higher
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rates of dependency in women after stoke, including the China National Stroke Registry
[71].
Moreover, more and more research support that women may receive suboptimal treatment
of cardiovascular risk factors as the perception of risk by the treating physician might be
lower than for male patients [72]. As a result, sex-based adaptions in risk factor profiles
and stroke incidence rates are of special interest [73].
Furthermore, trends from the Rotterdam study have shown that although blood pressure
levels were increased in both, in men and women, grade 2 hypertension (160-179 / 100-
109) was much more frequent in women than men. This might also have had an impact
on stroke incidence rates in females [73].
2.1.2 Age
Stroke is considered as a disease of the elderly people. As stroke risk factors can
be described as variables which progress over life time, the risks of both, ischaemic
stroke and for intracerebral hemorrhage, alter over time. This fact is further promoted by
cumulative effects of age on the cardiovascular system [74].
Also in terms of people in their middle years, a decrease of mean age of stroke from 71.2
years to 69.2 years in only 13 years could be reported in some areas in the US. These
results are based on an increase of stroke rates in individuals between 20 to 54 years
[75]. Additionally, the North American Nationwide Inpatient Sample reported higher rates
of hospitalization because of stroke for individuals between 25 and 34 years of age to
a period of 35 and 44 years of age from 1998 to 2007 [76]. Recent findings from the
Framingham Heart Study predicted the lifetime risk of stroke to be one in six or more
in this target group [22]. This development of stroke onset in increasingly younger ages
implements greater lifetime impairment and a considerable burden of disability. Further
information is stated in chapter 1.3.1 on incidence and prevalence of stroke.
The risk to suffer an ischaemic stroke and ICH redoubles every ten years having passed
the mark of 55 years [25], [58].
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2.1.3 Others: low birth weight, race and ethnicity, genetic factors
Low birth weight
Numerous cohort studies underlined an association between low birth weight and risk
of stroke in later life. In a population-based trial conducted in England and Wales, it
could be confirmed that stroke mortality rates are higher among people with lower birth
weights [77]. This can be explained as followed. Low-birth-weight babies were usually
born in less wealthy families, given birth to by undernourished mothers with poor overall
health status in a socially disadvantaged area [77]. Lackland et al. (2003) compared
a group of South Carolina Medicaid beneficiaries who were 50 years or older and had
suffered stroke with population controls [78]. The odds for stroke were more than twice
in subjects, having had a birth weight of <2500 g in comparison to participants weighing
4000 g. For low-birthweight newborns compared to normal-birth-weight neonates an
OR of 2.16 (p<0.01) for heart disease, MI and the risk of stroke by the age of 50 was
emphasized in a nationally representative longitudinal investigation in the US [79].
It has to be kept in mind that there are regional differences in birth weight that could
partly be based on geographic disparities in stroke-related mortality. This is also linked
to a persons’ birthplace [78]. Until today, potential reasons for these relationships remain
unclear and statistical correlations alone do not prove causality [56].
Race and ethnicity
It is problematic to investigate race or ethnic effects on disease risk separately [80].
A vast number of epidemiological studies underline those differences in regards to the
risk of stroke [81]. Blacks [59], [82] and some Hispanic/Latino Americans [83] show an
increased occurrence of all types of stroke which also leads to an altered mortality rate.
The risk of first ischaemic stroke raises dramatically from 88 per 100,000 in whites to
149 per 100,000 in Hispanics/Latinos and to 191 per 100,000 in Blacks [52]. Blacks
and Hispanics/Latinos have two to four times the stroke rate, recurrence of stroke, and
deaths related to stroke than whites [15]. Despite the fact that discrepancies are more
pronounced in younger age groups, race and ethnicity differences remain within older
age groups [15].
The Atherosclerosis Risk In Communities study (ARIC) reported an increase of 38% in
terms of stroke incidence of all types in the white population (95% CI [1.01 to 1.89])
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compared to blacks [84]. Until today, further investigations are needed in order to clarify,
if these racial differences are based on genetic or environmental discrepancies, or if
there is an interaction between these influencing factors [74]. The higher incidence and
mortality rate of stroke in African Americans could be explained by increased prevalence
of obesity, hypertension, diabetes mellitus, and prehypertension [85], [86], [87], [88].
In the period of 45 to 65 years, approximately half of the racial disparity in stroke risk
derives from well-established risk factors, particularly high systolic blood pressure (see
2.2.1) [89]. These results in combination with socioeconomic variables mark a critical
need to understand the differences in the development of traditional risk factors.
However, altered occurrence of these variables does not clarify all of the excess risk [86],
[90]. Several studies have discussed that differences based on ethnicity and race could
find their roots in social deciding factors like nativity [91], geographical background [90],
linguistics, access to and make use of health care systems [81] as well as neighborhood
determinants [92], [93]. Such socioeconomic factors will further be discussed under
chapters 4 and 5 on socioeconomic position in life and regarding stroke, respectively.
Genetic Factors
Familial history of stroke has been hypothesized as a risk factor for stroke [94], [95].
Taking into account the process of the disease, it seems reasonable that a positive
parental history of stroke may especially lead to an increased risk of stroke events. This
process might be triggered through a number of aspects.
Firstly, through genetic heritability of stroke risk factors like higher blood pressure (see
2.2.1), elevated serum cholesterol (see 2.2.4) or diabetes (see 2.2.2). Secondly, the
inheritance of susceptibility to the effects of such risk factors or thirdly, familial sharing
of cultural/environmental and lifestyle factors might play a decisive role. Examples for
shared life style variables are higher sodium and fat diet, little physical activity as well as
lower socioeconomic status. The interaction between genetic and environmental factors
can be crucial [95].
In not less than 35% of patients, the origin of ischaemic stroke cannot be determined.
Lately, there have been encouraging findings from techniques using DNA sequence data
in combination with clinical information which might improve our knowledge of stroke
origin. In this context, it has to be clearly stated that no implementations for preventive
therapy could be made so far [74].
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Looking into recently operated clinical trials, Flossmann et al. (2004) conducted a meta-
analysis underlining that a positive family history of stroke alters risk of stroke by approximately
30% (OR, 1.3; 95% CI [1.2-1.5], p=0.00001) [96].
The FHS stated that parental stroke by the age of 65 was linked with a three-fold increase
in risk of offspring stroke. After adjusting for conventional stroke risk factors, this increased
risk persisted, hence parental stroke history could be used as a helpful risk marker of
the tendency to develop stroke over life time [97]. The assessment of stroke heritability
diverges with variables like the subtype of stroke, sex, and age [98], [99].
Cardioembolic stroke appears to be the least heritable type of stroke in comparison with
other ischaemic stroke subtypes [98]. A heritability for cardioembolic disease of 32.6%
was found based on genome-wide common variant single-nucleotide polymorphism analysis
[100]. A parental history of stroke is more present in women [99]. In addition to this,
Schulz et al. (2004) reported that younger stroke patients tend to have a first-degree
relative who suffered from stroke [98].
Frequent genetic variants for these risk factors have been investigated in genome-wide
association trials. There is a rising number of studies which focus on the influence of the
accumulative burden of risk alleles of risk factors for stroke [74]. It still has to be seen
if the development of a genetic risk score will contribute to clinically helpful information
beyond the knowledge that can be taken from clinical risk factors. So far, only a small
number of loci affecting stroke susceptibility or risk factors for stroke could have been
determined [74].
A great number of well-established and rising risk factors are discussed in the following
sections. Those variables show genetic as well as environmental and behavioural aspects.
Additionally, a number of uncommon genetic disorders can be linked to stroke, such as
cerebral autosomal dominant arteriopathy with subcortical infarcts, leukoencephalopathy,
Marfan syndrome, Fabry disease, and neurofibromatosis which go beyond the scope of
this thesis. Personalized medicine, applying genetic testing, is able to enhance the safety
in terms of primary prevention based on pharmacotherapies [56].
To conclude, it could be conceivable to classify genetic factors as potentially modifiable.
Currently, no gene specific therapeutic approaches are accessible for the main part of
medical conditions apart from treatments for some rare illness, such as Fabry disease
and sickle cell disease [74]. Consequently, genetic factors have been classified as non-
modifiable in this thesis.
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2.2 Well-documented modifiable risk factors
The following section shall delve deeper into the field of well-known risk factors that can
be influenced and handled to some degree.
2.2.1 Hypertension
Hypertension can be seen as a leading risk factor for cerebral infarction [74]. Following
the Seventh Joint National Committee, hypertension can be defined as systolic blood
pressure (SBP) >140 mmHg and diastolic blood pressure (DBP) >90 mmHg [101]. The
correlation between stroke risk and blood pressure (BP) is stable, predictive, continuous,
persistent, graded, autonomous, and etiologically significant [101]. As a fundamental
rule it can be stated that a higher BP, including the non-hypertensive range, leads to an
increased risk of stroke [102].
In Germany, hypertension is a wide spread illness. Approximately half of all adults show
clear evidence of hypertension and one in four individuals with diagnosed hypertension
is on medication. High blood pressure is more prevalent in Germany compared to most
other industrialized countries (see table 2.1 men and women aged 35 to 64) [103]. Only
half as many individuals suffer from high blood pressure in the US and Canada.
Table 2.1
International comparison of occurrence rate of hypertension and anti-hypertension therapy
[103].
A large number of clinical studies have analysed various risk factors and markers for
development of hypertension. Those included among others, family history of hypertension
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and genetic factors, age, ethnicity, greater weight, lower physical activity, consummation
of tobacco, psychosocial stressors, and dietary factors such as dietary fats, higher sodium
and lower potassium intake as well as excessive alcohol level. Furthermore, socioeconomic
variables also revealed their fundamental influence. A general lower socioeconomic
status and low education were significantly associated with hypertension [52]. The
influence of socioeconomic position in life will be reviewed under chapter 4.
Overwhelming evidence from studies conducted over the last 40 years depict the prevention
of stroke by pharmacological treatment of hypertension [101]. This statement was underlined
in a meta-analysis referring to 23 randomized trials with stroke outcomes. The risk of
stroke was decreased by 32% due to antihypertensive drug treatment in comparison
with no drug treatment. (95% CI [24-39]; p=0.004) [104].
This effect could be replicated for the European population as well. 4,695 patients with
isolated systolic hypertension were addressed in the Systolic Hypertension in Europe
study. Subjects were randomized to active treatment with a calcium channel blocker or
placebo. A 42% risk reduction (95% CI [18-60]; p=0.02) could be stated in the actively
treated group [105].
In accordance to recent US data, 72% of hypertensive patients were aware of their
diagnosis, 61% were treated due to this diagnosis, and 35% had their BP supervised.
Until today, in minority and elderly populations a lack of diagnosis and inadequate treatment
are present [101].
Another study stated that BP control can be accomplished for the larger part of individuals.
In this matter, the patients’ treatment usually consists of ≥2 drugs [106].
Hypertension prevails as the most important, well-documented modifiable stroke risk
factor. The treatment of this condition can be contributed to the most efficient approaches
to prevent ischaemic stroke [74]. However, to this day, hypertension remains still undertreated
and replenished projects to refine treatment compliance are needed to be developed,
evaluated, and implemented into clinical routine [56].
2.2.2 Diabetes mellitus
Diabetes is perceptibly linked to hypertension, an increased prevalence of atherosclerotic
risk factors as well as abnormal blood lipids (see 2.2.4) [56], [74].
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Globally, the prevalence of Diabetes mellitus (DM) for all age groups was estimated at
2.8% in 2000. By 2013, it is projected to be 4.4%. The total number of people with DM
worldwide is forecasted to rise from 171 million in 2000 to 366 million in 2030 [107]. In
2010, a total of 1.9 million new cases of type 1 or type 2 DM were diagnosed in US adults
≥20 years [108]. In the Multi-Ethnic Study of Atherosclerosis, the incidence of DM varies
considerably by race. The incidence is reported to be highest in Hispanics with 11.3%,
followed by black with 9.5%, then Chinese with 7.7%, and lastly, by white participants
with 6.3% [109].
In Germany, there are approximately four million people with diabetes. 80% to 90% of
them are suffering from type 2 diabetes. This type of diabetes becomes more frequent
with advancing age. Based on the growing proportion of elderly in the global including the
German population, the number of diabetics raised significantly in the last few decades.
Overweight, physical inactivity, and poor social conditions have an impact on development
of type 2 diabetes [30].
In terms of attributed conditions, DM increases the risk of Atrial fibrillation (AF). On the
basis of a meta-analysis including more than 1.6 million participants, DM was crudely
associated with a 40% increased risk for AF (RR, 1.39; 95% CI [1.10–1.75]) [110].
To control the risk factors mentioned above, an aggressive treatment of hypertension
and the decrease of glycated hemoglobin A1c (HbA1c) are recommended to prevent
cardiovascular complications [111], [112].
Diabetes mellitus can be considered as an independent risk factor for stroke. Each
year, the risk is raising by 3% and triples with present diabetes of over 10 years [113].
Approximately 20% of all patients suffering from diabetes mellitus will die due to stroke
[74].
2.2.3 Relation of diabetes mellitus and hypertension
Obviously, in some patients a number of adverse medical conditions come together. In
terms of type 2 diabetes mellitus, two current meta-analyses analysed the effect of BP
lowering in affected patients.
The first meta-analysis randomized a total number of 73,913 patients with diabetes
mellitus in 31 intervention trials. The group of investigators around Reboldi et al. (2011)
stated that an aggressive treatment decreased the incidence of stroke by 9% (p=0.006).
Additionally, a lower as opposed to a less aggressive BP control diminished the stroke
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risk by 31% (RR, 0.61; 95% CI [0.48–0.79]). Following the meta-regression analysis,
the risk of stroke was reduced by 13% (95% CI [0.05–0.20); p=0.002) for each 5-mmHg
reduction in SBP and by 11.5% (95% CI [0.05–0.17]; p<0.001) for each 2-mmHg reduction
in DBP respectively [114].
In the second meta-analyses, Bangalore et al. (2011) investigated 37,760 patients with
type 2 diabetes mellitus or impaired fasting glucose/impaired glucose tolerance with
achieved SBP of ≤135 mmHg versus ≤140 mmHg. It could be underlined that intensive
BP control was linked with a decrease of 17% in stroke and 10% in all-cause mortality
(OR, 0.90; 95% CI [0.83–0.98]). A constant risk reduction for stroke to a SBP of <120
mmHg was observed. Nonetheless, a rise of 40% regarding serious adverse events with
no benefit for other outcomes was visible at levels of <130 mmHg [115].
2.2.4 Dyslipidaemia
Total Cholesterol
Hypercholesterolaemia is defined as a total cholesterol level ≥240 mg/dL and a risk
factor for heart disease (see 3.2.3) as well as stroke [116].
One man in three and one women in three show clear evidence of hypercholesterolaemia
in Germany. The most frequently affected subjects are females aged 60 to 69 years.
Hypercholesterolaemia tends to manifest earlier in males, already affecting around 25%
in the age of 30 to 39 years [30].
An association between higher cholesterol levels and a raised risk of ischaemic stroke is
reported in the majority of epidemiological studies.
The Multiple Risk Factor Intervention Trial (MRFIT) in more than 350,000 men already
stated that the relative risk of death from non-haemorrhagic stroke raised linearly with
increasing level of cholesterol [117]. The Asia Pacific Cohort Studies Collaboration
(APCSC) (n=352,033 participants) reported an increase by 25% (95% CI [13-40]) in
ischaemic stroke rates for every 1 mmol/L rise in total cholesterol [118].
In both, the Women’s Pooling Project (n=24,343 US women <55 years, no previous
cardiovascular disease) and in the Women’s Health Study, a prospective cohort study
(n=27,937 US women ≥45 years) higher cholesterol levels were also linked to increased
risk of ischaemic stroke [119].
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In contrast to this, some investigations could not reveal a clear connection between
cholesterol and stroke risk [74].
In the ARIC study (n=14,175 middle-aged men and women, no previous CVD), the
association between lipid values and incident ischaemic stroke was not strong [120].
Additionally, no connection between cholesterol and cerebral infarction could be underlined
in the Eurostroke Project (n=22,183) [121].
All in all, epidemiological trials tend to emphasize a competing stroke risk associated
with total cholesterol levels in the general population [56]. Considering the complexity of
the association between total cholesterol and stroke, it should be underlined that there
seems to be no positive relation between stroke mortality and total cholesterol [122].
High-density lipoprotein
The main part of all epidemiological studies report an inverse association between high-
density lipoprotein (HDL) and stroke [123], [124], [125], [126]. Increased concentrations
of HDL are significantly associated with a decreased accumulation of atherosclerosis
(see also 3.2.3) within the arterial walls [127]. It removes fat molecules from macrophages,
white blood cells engulfing and digesting cellular debris, in the wall of arteries.
In the Copenhagen City Heart Study, the Oyabe Study as well as in the Israeli Ischaemic
Heart Disease Study, HDL cholesterol was also constistently inversely linked to ischaemic
stroke [128], [124], [126]. The Northern Manhattan Stroke Study (NOMASS) revealed
higher HDL cholesterol levels linked to decreased risk of ischaemic stroke [123]. In the
Cardiovascular Health Study (CHS), high HDL cholesterol was related to a reduced risk
of ischaemic stroke in males but not in females [129].
In contrast to this, the ARIC study reported no significant association between HDL
cholesterol and ischaemic stroke [120]. A decreased risk of stroke ranging from 11%
to 15% for each 10 mg/dL increase in HDL cholesterol was documented in a systematic
review [130].
Low-density lipoprotein
Low-density lipoprotein (LDL) particles transport their content of fat molecules into artery
walls and attract macrophages, thus increasing the risk of atherosclerosis [131].
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In a pooled cohort analysis of the ARIC study and the CHS, lower levels of LDL cholesterol
were inversely related to incident intracranial haemorrhage [58].
A meta-analysis of 22 trials including 134,537 patients analysed the association of LDL
cholesterol lowered with statin therapy and major cardiovascular events including stroke
[132]. The risk of major vascular events was decreased by 21% (95% CI [23–29]) for
each 39 mg/dL reduction in LDL cholesterol. In accordance with these findings, for every
39 mg/dL decrease in LDL, there was a 24% (95% CI [5–39]) reduction in the risk of
stroke.
Furthermore, another meta-analysis, including 14 trials reporting on stroke outcomes,
found that the relative risk (RR) of stroke was significantly lower among statin recipients
compared to the control group (RR, 0.83; 95% CI [0.74–0.94]) [133].
2.2.5 Atrial fibrillation
Atrial fibrillation is related to a four- to five-fold increased risk of ischaemic stroke due
to embolism of stasis-induced thrombi formed in the left atrial appendage of the heart
[134]. Treating AF is therefore a major major potential to prevent primary stroke [74].
On average, the absolute stroke rate ranges at 3.5% per year in 70 year-old subjects
diagnosed with AF but the risk differs 20-fold among patients based on age and other
clinical features [135], [136]. Additionally, AF can be seen as an independent predictor
of increased mortality [137].
Until today, a significant minority of stroke related to atrial fibrillation can be seen without
a prior diagnosis of the condition. There is a great number of studies concerning active
screening for AF in patients >65 years of age in primary care surroundings. Those
investigations state that pulse assessment by trained personnel helps to detect undiagnosed
atrial fibrillation [138]. In addition to this, systematic pulse measurement in the course
of routine clinic examinations combined with a 12-lead ECG in patients, who showed an
irregular pulse, lead to a 60% increase of diagnosis [138].
Stroke risk stratification in atrial fibrillation patients
As soon as there is a set diagnosis of AF, an estimation of an individual’s risk for
cardioembolic stroke and for haemorrhagic complications of antithrombotic therapy is
needed. In order to be able to estimate risk of AF-related cardioembolic stroke, more
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than a dozen risk stratification schemes have been published based on numerous combinations
of clinical and echocardiographic predictors [136]. Finding the balance between advantages
and risks of long-term antithrombotic therapy in primary stroke prevention is crucial
[74].
As the treatment of choice for patients at high risk of cardioembolic stroke and acceptably
low risk of haemorrhagic complications, dose-adjusted warfarin was commonly chosen.
It can be stated that treatment with dose-adjusted warfarin strongly protects against
stroke (RR reduction, 64%; 95% CI [49–74]). Essentially, this leads to an elimination
of the immense risk of ischaemic stroke linked with AF if the intensity of anticoagulation
is sufficient. Additionally, this approach resulted in a reduction of all-cause mortality by
26% (95% CI [3–23]) [139]. Furthermore, anticoagulation decreased stroke severity and
post-stroke mortality [140]. In comparison to aspirin, dose-adjusted warfarin reduced
stroke by 39% (95% CI [22–52]) [139].
2.2.6 Physical activity
For Germany, figure 2.1 shows the proportion of men and women who practise sport for
two and more hours a week. According to the 2003 Telephone Health Survey, 37.4% of
males and 38.4% of females above the age of 18 practised no sports at all. An additional
20.9% of men and 28.4% of women were active in some kind of sports for less than two
hours a week. The remaining 41.7% (male) and 33.2% (female) announced that they are
physically active for two or more hours a week. The proportion of such relatively highly
active persons was highest in early adulthood, whereas only little fluctuation could be
stated for middle-aged people. Participation rates fell quite rapidly after the age of 70 at
the latest [141].
In this connection, a recent study to inactivity among US adults stated that every hour
per day of increased television watching was associated with 0.15 kg of greater weight
gain every four years. This was also true the other way around. Every hour per day of
decreased television watching was linked with a similar amount of relative weight loss
[142].
An enormous amount of adverse health effects are linked to physical inactivity. In this
line, an increased risk of total as well as specific cardiovascular mortality and morbidity
due to stroke was published. A number of meta-analyses underline that physically active
people tended to show a 25% to 30% decreased risk of stroke or death compared to
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Figure 2.1
Proportion of men and women who practise sports for two and more hours a week in
Germany [30].
the least active men and women [143]. A meta-analysis of 23 studies on the association
of physical activity (PA) with stroke, for instance, reported that high (RR, 0.79; 95% CI
[0.69–0.91]) and moderate (RR, 0.91; 95% CI [0.80–1.05]) levels of activity compared
with low levels of movement were inversely associated with the likelihood of developing
stroke. This included both, ischaemic and haemorrhagic stroke [144].
The major gains seem to derive from diverse types of activity which include occupational
activity, leisure time physical activity as well as fast walking. Until today, studies are rare
regarding race and ethnicity [145].
It remains unclear, how the intensity as well as amount of physical activity affects stroke
risk. A gender interaction can be assumed. An increased gain in women following
greater intensity was reported in the Physical Activity Guidelines Advisory Committee
Report. The median RR was 0.82 for all stroke types for moderate-intensity activity
versus no or light activity. By comparison, the RR for high-intensity versus no or light
activity was 0.72. In the male population, no apparent benefit of greater intensity with
median RR 0.65 for moderate-intensity versus no or light activity and a RR 0.72 for high-
intensity versus no or light activity was stated [146].
It is assumed that the protective effect of physical activity is partially driven by its impact
on diminishing risk factors for CVD [147], including diabetes [148] and excessive body
weight. Additionally, anti-inflammatory elevations in plasma tissue plasminogen activator
activity and HDL cholesterol concentrations as well as decreased plasma fibrinogen and
platelet activity have also been discussed [149].
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In summary, overwhelming evidence from prospective observational studies underlined
that routine physical activity can prevent stroke. Regarding the Physical Activity Guidelines
for Americans, at least 150 minutes per week of moderate intensity or 75 minutes per
week of aerobic physical activity with vigorous intensity, or an equivalent combination
are recommended. In this context, it has to be emphasized that some physical activity is
better than none, as any extent of physical activity leads to health benefits [146].
2.2.7 Diet and nutrition
An individual’s energy balance, or consumption of total calories appropriate for needs,
is determined by the balance of average calories consumed versus expended. This
balance is driven by multiple factors. Those include the calories consumed, age (see
2.1.2), sex (see 2.1.1), physical activity (see 2.2.6), body size, and underlying basal
metabolic rate.
Table 2.2 summarizes the consumption of selected groups of food and beverages in
inhabitants aged 18 to 79 years in Germany [150].
Changes in intake of different foods and beverages were associated with weight gain on
the long-term in divergent ways. Refined grains, starches, and sugars as well as red
and processed meats are most positively associated with weight gain. By contrast to
this, increased consumption of whole grains, fruits, vegetables, nuts, and yogurt, was
linked to relative weight loss over time. Those findings suggested to focus on dietary
quality, not simply counting total calories, as crucial for a healthy energy balance [142].
Additional weight gain involved greater television watching including greater snacking in
front of the television due to the influence of advertising on poor food choices and the
lack of physical activity [142]. Additionally, lower average sleep duration had a significant
negative impact on an individual’s energy balance [142], [151].
A US national survey from 2008 stated that energy-dense snack foods and beverages
were present in 96% of pharmacies, 94% of gas stations, 22% of furniture stores, 16%
of apparel stores, and 29% to 65% of other types of investigated stores [152].
In the context of energy balance, the size of a meal played an important role. Preferences
for portion size were associated with the socioeconomic status, body mass index (BMI),
eating in fast food restaurants, and television watching [153]. In Germany, the turnover
per year in fast food rose from e2 billion to almost e6 billion during the 1990s. In
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Table 2.2
Consumption of selected groups of foods in grams per day in Germany [150].
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comparison, the amount spent on meals in restaurants remained constant at e50 billion
[154].
In industrialized countries, dietary supplements gain more and more popularity. In 2010,
approximately half of US adults used≥1 dietary supplement. The most common supplements
were multivitamin-multimineral products. The intake of supplements was linked to older
age, higher education, greater physical activity, lower BMI, moderate alcohol consumption,
and restraint from smoking [155].
In a pooled analysis of 25 randomized trials in a study population with and without
hypercholesterolaemia, nut consumption led to significantly improved blood lipid levels
[156]. A mean consumption of 67 g of nuts per day reduced the total cholesterol by 10.9
mg/dL (5.1%), LDL cholesterol by 10.2 mg/dL (7.4%), and the ratio of total cholesterol to
HDL cholesterol by 0.24 (5.6% change; p<0.001 for each). Interestingly, different types
of nuts showed comparable effects.
The following section shall delve deeper into the association of diet and risk of stroke.
A high BP can be seen as one of the most dominant modifiable risk factor for ischaemic
stroke as discussed above (see 2.2.1). A large body of studies underlined the association
between aspects of diet and the pathogenesis of high BP [56].
A scientific statement issued by the AHA showed an increased BP following high alcohol
consumption, excess salt intake, low potassium intake, suboptimal dietary pattern as
well as excess weight [157]. It was emphasized that blacks are especially sensitive
to elevated BP effects resulting from low potassium and high salt intake as well as
suboptimal diet. A major decrease of these racial disparities in BP and stroke can be
achieved by dietary modifications [157].
Fruits and vegetables
Figure 2.2 illustrates the consumption of fruit and vegetables by 18 to 79 year olds
in Germany. The proportion of persons consuming more than 400 grams of fruit and
vegetables per day, excluding juices, are displayed below [150].
Observational studies reported multiple relationships between diet and the risk of stroke.
A strong inverse association between servings of vegetables, fruits, and consecutive
stroke were stated [158]. Servings of fruits and vegetables less than three times per day
were compared to people who consumed three to five servings. It could be shown that
the relative risk of ischaemic stroke was less in the second group (RR, 0.88; 95% CI
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Figure 2.2
Consumption of >400 grams fruit and vegetables in Germany [150].
[0.79 to 0.98]) and even more pregnant in those consuming more than five servings per
day (RR, 0.72; 95% CI [0.66-0.79]) [159].
The relative risk of incident stroke was 0.69 (95% CI [0.52-0.92]) for participants in the
highest versus lowest quintile of vegetable and fruit intake published in analyses of the
Nurses’ Health Study and the Health Professionals’ Follow-Up Study [159].
In this context, it has to be kept in mind that the recommended daily consumption of fruits
and vegetables is at an average intake of >5 servings per day [160].
Sodium and potassium intake
As mentioned above, the level of sodium intake should be considered as well. Following
the Dietary Guidelines for Americans report, a sodium intake of <100 mmol/d for the
general population is indicated.
Epidemiological [161] and prospective studies [162] underlined the association between
a raised sodium intake and an elevated risk of stroke.
Additionally, a potassium intake of at least 120 mmol/d is recommended. An increased
level of potassium intake led to a reduced risk of stroke in prospective studies [163].
Regarding those results, the context of the mentioned studies has to be kept in mind. A
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large number of methodological limitations, followed by difficulties in estimating dietary
electrolyte intake as well as inhibited risk assessment could result in false-negative or
even paradoxical findings in observational studies. It can be assumed that the impact of
potassium and sodium on stroke elevation may be influenced by both, direct effects on
BP and independent aspects of BP [164].
Especially in dose-response clinical trials, the association between sodium intake and BP
was described as a direct and progressive relation without an apparent threshold [165]. A
higher sensitivity of BP-decreasing effects by less sodium consumption were apparent in
middle- and older-aged adults, blacks, and people diagnosed with hypertension [166].
Dairy products
Having had a closer look at milk products, a higher consumption of this kind of merchandise
is associated with lower incidence of diabetes mellitus and trends toward lower risk of
stroke [156], [167]. Some evidence suggests that these associations are stronger for
low-fat dairy or milk than for other dairy products but these results have to be considered
as still limited [52].
It is evident that low-fat dairy products, a diet rich in fruits and vegetables, and decreased
in saturated as well as total fat diminishes the BP [168].
2.2.8 Overweight and obesity
In Germany, approximately 50% of all men and 33% of women adults are overweight. In
addition to this, a further 17% of men and 20% of women suffer from obesity [30]. The
total number of overweight and obese inhabitants is increasing since the mid-1980s.
Forecasts for 2030 suggest that 51% of the Northern American population will be obese,
with 11% of severe obesity, marking an increase of 33% for obesity and 130% for severe
obesity [169].
The traditional but also more and more criticized classification of weight status can be
defined by the body mass index. It is calculated by weight in kilograms divided by the
square of an individual’s height in meters. Following the general classification, a BMI of
25 to 29.9 kg/m2 indicates overweight, people revealing a BMI ≥30 kg/m2 are registered
as obese [170]. Specifications include the measurement of abdominal obesity by either
waist circumference or the waist-to-hip ratio.
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A waist circumference >102 cm in men and >88 cm in women is clinically defined as
abdominal obesity. Until today, the prevalence rates of obesity and overweight are raising
alarmingly in developed countries, affecting children as well as adults [171].
In a collaborative analysis of data from 57 prospective studies which mainly refer to
Western Europe and North America, overall mortality was lowest at a BMI of approximately
22.5 to 25 kg/m2 in both sexes and at all ages, after having adjusted for smoking status.
Above this range, each higher BMI by 5 kg/m2 was associated with a 30% higher all-
cause mortality [172].
In a meta-analysis of 1.46 million white adults, all-cause mortality was stated to be lowest
at BMI levels of 20.0 to 24.9 kg/m2 over a mean follow-up period of ten years [173].
Obesity was correlated with significantly increased mortality caused by CVD and DM.
An association of 13% of CVD deaths could be revealed in 2004 [174].
Recent estimates suggest that reductions in smoking, cholesterol, BP, and physical
inactivity levels resulted in a gain of 2,770,500 life-years. In contrast to this, these gains
were diminished by a loss of 715,000 life-years caused by the increased prevalence of
obesity and DM [175].
Focusing on the association between weight and incident stroke, a meta-analysis published
a nonlinear relation between BMI and mortality [172]. In the BMI range of 25 to 50 kg/m2,
each 5 kg/m2 increase in BMI was linked to a 40% heightened risk of stroke mortality.
No relationship between BMI and stroke mortality in the lower BMI range (15-25 kg/m2)
could be detected.
Studies that investigated the effects of BMI and abdominal body fat showed that abdominal
body fat predicted stroke risk more efficiently than the BMI [176], [177].
Usually, the direct relationship of BMI and stroke has been endured in multivariable
analyses, controlling other cardiovascular risk factors as blood lipids, BP, and diabetes/insulin
resistance. It has to be mentioned that the strength of the association is decreased
in general. This leads to the conclusion that the effect of BMI on stroke risk is partly
mediated by the impact of adiposity on other stroke risk factors [56].
A great number of studies have investigated the mechanisms of weight reduction on BP
in non-hypertensive as well as hypertensive subjects. A mean decrease of 4.4 mmHg
in SBP and 3.6 mmHg in DBP could be stated due to an average weight loss of 5.1 kg
[178].
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2.2.9 Cigarette smoking
In Germany, approximately 33% of all inhabitants aged≥18 years do smoke, with 25.4%
smoking daily and 7.1% occasionally. A further 26.9% reported to be former smokers.
Taken together, nearly 60 percent of the German population smoke or used to smoke
[179]. Table 2.3 gives an overview by gender and age.
Table 2.3
Percentage of regular smokers, occasional smokers, former smokers, and persons who have
never smoked in Germany [179].
Short exposures to second-hand smoke can lead to blood platelets becoming stickier, a
decrease of coronary flow velocity reserves, and a damage of the lining of blood vessels.
All those factors can potentially increase the risk of an acute myocardial infarction.
In this context, it has to be emphasized that pooled data from 17 studies in Europe,
North America, and Australasia suggested that a smoke-free legislation can diminish the
incidence of acute coronary events by 10% [180].
Virtually every multivariable investigation of stroke risk factors, e.g. the Framingham
heart study [20], the Cardiovascular Health Study [181], and the Honolulu Heart Study
[182], stated smoking as a major risk factor for ischaemic stroke. Worldwide, tobacco
smoking, including secondhand smoke, was one of the top three leading risk factors for
disease in 2010 [183], doubling the risk for ischaemic stroke. Smoking was estimated
to contribute to 6.2 million deaths [183], causing approximately 467,000 adult deaths
(19.1%) in the United States. It is assumed that one third of these deaths were related
to CVD [184].
Stroke risk is altered through acute impact on the risk of thrombus generation in atherosclerotic
arteries and chronic effects associated with increased atherosclerosis [185].
Overall, the risk for smokers to suffer from stroke during their life span is twice as high
compared to individuals who never smoked [186], [187]. Recent estimates indicate that
approximately 19% of the burden of stroke is based on current smoking [188].
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A meta-analysis composed of 32 studies estimated the relative risk for ischaemic stroke
to be 1.9 (95% CI [1.7-2.2]), for ICH 0.74 (95% CI [0.56-0.98]), and for SAH 2.9 (95% CI
[2.5-3.5]) for smokers versus non-smokers [189].
A reliable association between cigarette smoking and ischaemic or haemorrhagic stroke
respectively was observed in the younger population. In the United States, smoking
seemed to contribute to 12% to 14% of all stroke deaths [190].
Furthermore, smoking can potentiate the influence of other stroke risk factors, such as
SBP [191], oral contraceptives [192], and vital exhaustion [191].
Apart from active smoking, the exposure to environmental tobacco smoke can be seen
as an established risk factor for heart disease [193]. The major extend of risk related
to environmental tobacco smoke seems unexpected, as this dose is considerably lower
than for active smoking. Physiological studies assume that there is a tobacco smoke
exposure threshold rather than a linear dose-effect association [194].
The most effective prevention is evidently to never smoke and to minimize exposure.
Being a smoker, risk is decreased with smoking cessation. This measure is associated
with a rapid reduction in risk of stroke and other cardiovascular events. Although, the risk
is diminished, it does not reach the level of those who never touched a cigarette [185].
Generally, smokers quitting smoking at 25 to 34 years of age gained ten years of life
compared with those who continued to smoke. Additionally, those aged 35 to 44 years
aquired on average nine years and those aged 45 to 54 years attained six years of life
[186].
A large number of efficient programs aiming at smoking cessation are available. To date,
studies documenting the relation between the participation in these projects and a long-
term reduction in stroke are still pending [56].
Tobacco control policies that aim at smoking cessation should be a key feature of stroke
primary prevention programs. This is especially fundamental in low- and middle-income
countries, as those regions carry the greatest dual burden of tobacco exposure and
increasing stroke rates [195].
2.2.10 Acute myocardial infarction
A meta-analysis reviewing population-based studies issued between 1970 and 2004
reported that the risk of ischaemic stroke after AMI was 11.1 per 1,000 (95% CI [10.7–11.5])
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during the index hospitalization, 12.2 per 1,000 (95% CI [10.4–14.0]) at 30 days, and 21.4
(95% CI [14.1–28.7]) at one year after AMI [196]. The following risk factors were found
to be associated with an increased stroke risk: advanced age (see 2.1.2), hypertension
(see 2.2.1), diabetes mellitus (see 2.2.2), AF (see 2.2.5), and congestive heart failure.
The Warfarin, Aspirin Reinfarction Study (WARIS) showed that warfarin in combination
with aspirin or given alone, compared with aspirin alone, led to a reduction of the risk of
thromboembolic stroke. However, at the same time, it was associated with a greater risk
of bleeding [197].
A meta-analysis analysing data of ten randomised trials that focused on the efficacy of
warfarin after AMI evaluated a stroke incidence over five years of 2.4%. Furthermore,
warfarin decreased the risk of stroke (OR, 0.75; 95% CI [0.63–0.89]) but again increased
the risk of bleeding [198]. Clinically, the CHA2DS2-VASc score (Congestive heart failure,
Hypertension, Age, Diabetes, prior Stroke or TIA or thromboembolism - Vascular disease,
Age, Sex Category) will enable a decision on a therapy with warfarin.
2.2.11 Others: oral contraceptives
The association of risk of stroke, particularly ischaemic stroke, with the use of OCs
continues to be controversial. The current guidelines for the primary prevention of stroke
issued by the American Heart Association/American Stroke Association (ASA) do not
go into detail any more [74]. The previous version summarizes that the risk of stroke
in association with use of OCs is low [56]. The combination of certain factors, like older
age, smoking cigarettes, obesity, hypertension, diabetes, and hypercholesterolaemia are
supposed to lead to higher relative and absolute risk. The controversial nature bases on
estimates that primarily derive from case-control and a smaller number of cohort studies.
Consequently, those trials are limited by a small numbers of females with stroke events.
In women without additional risk factors, the incremental risk of stroke related to the use
of low-dose OCs, if one exists, appears to be low [199].
Other risk factors like the sickle cell disease or asymptomatic carotid artery stenosis
will not be further discussed, as those variables are not relevant in the context of this
thesis.
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2.3 Less well-documented or potentially modifiable risk
factor
The last text section gives an overview of less well-documented or potentially modifiable
risk factors such as alcohol intake. This variable is also included in the present study.
2.3.1 Alcohol consumption
In 2003, the general alcohol consumption rate in Germany was 147 l, or in other words
10.2 l of pure alcohol, more than 50% of which was consumed in beer. Wine and
spirits each made up a fifth of total consumption [200]. Per capita consumption, which
is estimated in terms of pure alcohol consumption, nearly quadrupled over the period
of the 1950s to the early 1990s. In comparison to many other EU countries, like the
United Kingdom or the Netherlands, Germany has ranked as one of the countries with
the highest alcohol consumption for years [30].
It is evident that excessive alcohol consumption can result in various medical complications.
Obviously, this also includes the occurrence of stroke [56]. A conclusive body of literature
documents the association of intensive alcohol consumption and an increase in blood
pressure [201].
A great number of studies underlined that heavy consumption of alcohol can be seen
as a risk factor for all subtypes of stroke [202]. In this context, a J-shaped relationship
between alcohol and the risk of total as well as ischaemic stroke is reported. This pattern
attributes that light to moderate drinkers have less risk than abstainers, while heavy
drinkers are at the highest risk. Few or moderate drinks, particularly in the form of wine,
showed a protective effect whereas the risk was fundamentally raised by heavy alcohol
consumption [203]. Contrarily, a linear connection between alcohol consumption and
risk of haemorrhagic stroke was stated [204].
An effect of light to moderate consumption of alcohol was linked to lower fibrinogen
concentrations [205], increased insulin sensitivity, and glucose metabolism [206], greater
levels of HDL cholesterol [207] as well as reduced platelet aggregation [208]. Hypercoagulability,
reduced cerebral blood flow, hypertension, and increased risk of atrial fibrillation can be
the consequence of heavy alcohol consumption [205].
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A meta-analysis including 35 observational studies [204] stated that a consumption of
60 g of alcohol per day led to a 64% rise of stroke risk (RR, 1.64; 95% CI [1.39-1.93]),
a 69% increase in ischaemic stroke (RR, 1.69; 95% CI [1.34-2.15]), and a risk twice as
high of haemorrhagic stroke (RR, 2.18; 95% CI [1.48-3.20]). In contrast to this, drinking
<12 g of alcohol per day showed a reduced risk of total stroke (RR, 0.83; 95% CI [0.75-
0.91]) and ischaemic stroke (RR, 0.80; 95% CI [0.67-0.96]), with consumption of 12 g to
24 g per day associated with a decreased risk of ischaemic stroke (RR, 0.72; 95% CI
[0.57-0.91]).
A Finnish study described a strong association between the frequency of alcohol consumption
and stroke mortality. This finding was independent of total amount of alcohol consumption.
The risk of stroke death was the most pronounced in males who consumed alcohol >2.5
times per week [209].
The performance of prospective clinical studies investigating the diminished risk by reduction
of heavy alcohol consumption or the benefits by light alcohol consumption are not feasible
as it is well established that alcohol dependence can be considered as a major health
problem [74].
In this context, it clearly had to be mentioned that data on alcohol consumption are
generally based on questionnaire information. This approach, which is also applied
in the present study, may lead to misclassification of exposure status, which should
not be neglected. This incorrect classification may have induced biased estimates of
the association between alcohol consumption and risk of stroke. Bots et al. (2002)
therefore consider an underestimation of the true magnitude of the association [201].
An alternative approach to questionnaires could be the measure of the serum level of
gamma-glutamyl transferase as an unbiased although not perfect marker [210].
2.3.2 Others: drug abuse, migraine
Drug abuse
Social and health-related problems often occur in the context of drug addiction as a
chronic, relapsing condition [211].
An association between cocaine, heroin, amphetamines, and elevated stroke risk was
reported [212]. These drugs can lead to a great number of threatening conditions
including acute and severe BP elevation, vasculitis, cerebral vasospasm, haematologic,
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and haemostatic abnormalities. They contribute to raised blood viscosity and platelet
aggregation, embolization caused by infective endocarditis as well as ICH [213], [214].
Insights regarding stroke-related drug abuse are based on epidemiological studies in
urban populations. An elevation in the risk of both ischaemic and haemorrhagic stroke
was reported [215]. A cross-sectional study of hospitalized patients showed that amphetamine
abuse was linked to haemorrhagic stroke (adjusted OR, 4.95; 95% CI [3.24-7.55]) but
not to ischaemic stroke. Additionally, cocaine abuse was found to be associated with
haemorrhagic stroke (OR, 2.33; 95% CI [1.74-3.11]) and ischaemic stroke (OR, 2.03;
95% CI [1.48-2.79]). Only amphetamine abuse could be linked to an increased risk of
death after haemorrhagic stroke (OR, 2.63; 95% CI [1.07-6.50]) [215].
The evaluation of the clinical utility of screening tests for drug abuse in primary care
settings, like toxicology tests of blood or urine, the application of standardized questionnaires
to screen for drug use or misuse are still unsatisfactory. Until today, studies are needed
to address the independent risk of stroke in association with specific drugs of abuse. No
controlled trials exist revealing a decrease in risk of stroke following abstinence [56].
Migraine
Most consistently, migraine headache has been associated with stroke in young women.
This was particularly observed in those female patients suffering from migraine with
aura [216]. A meta-analysis of 13 case-control and eight cohort studies stated an
overall pooled RR of 2.04 (95% CI [1.72–2.43]) [217]. Additionally, an increased risk
of ischaemic stroke was reported in migraine with aura (pooled adjusted OR for seven
studies, 2.51; 95% CI [1.52–4.14]) compared with migraine without aura (pooled adjusted
OR for six studies, 1.29; 95% CI [0.81–2.06]). Furthermore, another meta-analysis of
nine studies, including six case-control and three cohort studies, stated a pooled RR
of 1.73 (95% CI [1.31–2.29]) between any migraine and ischaemic stroke [69]. Again,
the researchers reported a significantly increased risk of stroke among individuals with
migraine with aura (RR, 2.16; 95% CI [1.53–3.03]) compared with no aura (RR, 1.23;
95% CI [0.90–1.69]; meta-regression for aura status, p=0.02).
It has to be clearly underlined that the significant risk affecting women (RR, 2.08, 95%
CI [1.13–3.84]) but not men (RR, 1.37; 95% CI [0.89–2.11]) was reported. Females
younger than 45 years (RR, 3.65; 95% CI [2.21–6.04]), who smoked (RR, 9.03; 95% CI
[4.22–19.34]) and used OC (RR, 7.02; 95% CI [1.51–32.68]) showed a further increased
44
Risk factors for stroke and transient ischaemic attack
risk [69]. The two mentioned meta-analyses are in general agreement with studies
published earlier [218].
A huge amount of research has been conducted over the last decade to enlighten the
association between ischaemic stroke subtypes and the numerous risk factors described
above. Nevertheless, further studies are required to clarify the interaction of modifiable
variables alone and in combination with non-modifiable risk factors, and the discrepancies
in ischaemic stroke incidence. More and more concise research indicates that approximately
80% of stroke events could be reduced by making simple lifestyle modifications [219].
A more in-depth understanding of these distinctions will enable and bring forward more
effective stroke prevention programs in high-risk groups.
The population-based cohort Rotterdam study found that in the investigated cohort about
half of all strokes are attributable to established causal and modifiable factors. This
finding reassures not only to conduct intervention on established etiological factors but
also to carry out further study on less well-established factors [220].
2.4 Early risk assessment in stroke by the Framingham
Stroke Risk Profile
A major contribution of the Framingham study involves the application of a number of
statistical developments to support and facilitate risk prediction in creating a quantitative
scale. This scale helps to calculate the probability of developing a stroke during a specific
time period. The so-called Framingham Stroke Risk Profile has been widely implicated
as a clinical tool for estimating stroke likelihood by applying patient data available to an
office-based health care professional. Recent trends in the prevalence and impact of risk
factors as well as current findings such as familial occurrence of stroke are incorporated
into an updated modification of the Framingham Stroke Risk Profile on an ongoing basis
[221]. In Europe, the CHA2DS2-VASc Score is mainly used for clinical assessment.
2.5 Risk factors for transient ischaemic attack
Until today, the evidence of risk factors for TIA excluding ischaemic strokes is very
limited [43]. The ABCD2 score (Age, Blood pressure, Clinical features, Duration of TIA,
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and presents of Diabetes) was developed to estimate individual risk and to determine
potential patients on the first presentation (see figure 2.3 [222]). The US National Stroke
Association indicates that the score is optimized to predict the risk of stroke within two
and 90 days after TIA. The score is calculated by summing up points for five independent
factors, namely age, blood pressure, clinical features, duration of TIA, and presence of
diabetes [223].
Figure 2.3
ABCD2 score [222].
In a current review on prognostic TIA, the crude rate of stroke risk for the general
population was 1.7% at day two, 4.8% at week one, 6.6% at one month, 8.5% at three
month, and 11.4% at six months. By comparison, for hospital patients was 13.7% at one
month and 12.4% at three months, respectively [43].
There is very limited evidence regarding an association between family history of stroke
and the incidence of stroke after TIA. This leads to the assumption that a positive family
anamnesis of stroke does not conclusively predict the risk of ischaemic stroke after TIA
[43].
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3 Risk factors for coronary heart
disease focusing on myocardial
infarction
Following the chapter on risk factors for stroke, the upcoming section will provide an
overview of distinct differences and similarities regarding an increased risk for MI. This
review of current literature enables a deeper understanding of the selection of risk factors
for myocardial infarction in the INVADE study (see chapter 7).
As also seen in the outline of stroke risk factors, there are numerous well-established risk
factors leading to atherosclerosis and plaque formation resulting in MI. These include
male gender (see 3.1.1), age (see 3.1.2), family history (see 3.1.3), hypertension (see
3.2.1), diabetes (see 3.2.2), dyslipidaemia (see 3.2.3), and smoking (see 3.2.4). Furthermore,
the list of less well-established factors contains obesity (see 3.3.2), metabolic syndrome,
and chronic kidney disease.
In addition to this, potential triggers for AMI comprise of extreme physical inactivity (see
3.3.3), excessive alcohol intake (see 3.3.4), psychosocial conditions, the use of illicit
drugs such as cocaine, amphethamines, and nonsteroidal drugs [5].
The percentage of patients with a first MI, who will experience stroke within five years is
2% of men and 6% of women at 45 to 64 years of age and 5% of men and 8% of women
at ≥65 years of age [224]. In the following, crucial disparities and connections in risk
factors for MI regarding stroke will be stated, where applicable.
The term coronary heart disease (CHD) encompasses the following conditions: stable
angina, unstable angina, myocardial infarction, and sudden coronary death. As those
conditions are commonly discussed together in literature and not always clearly separated,
a general overview of CHD focusing on MI will be given in the following section.
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Based on pooled data from 1986 to 2007 reported in the FHS, ARIC, and CHS, 19% of
men and 26% of women at ≥45 years of age were reported to die within one year after
they had their first MI [224]. Additionally, within five years after a first MI, 36% of males
and 47% of females were documented to die aged ≥45.
The Behavioural Risk Factor Surveillance System (BRFSS) analysed data from 14 US
states regarding the alertness of warning signs for heart attack. Only 27% of all participants
(n= 71,994) were aware of five warning signs and symptoms. Addressed was firstly, pain
in jaw, neck, or back, secondly, weakness, light-headedness, or faint, thirdly, chest pain
or discomfort, fourthly, pain or discomfort in arms or shoulder and lastly, shortness of
breath. Significant variation in the percentage of subjects being aware of all five heart
attack warning signs and symptoms, and calling the ambulance as their initial action
varied by educational status [225].
The following chapter will delve deeper into the field of risk factors which are protective
determinants for cardiovascular health. The well supported concept of ideal cardiovascular
health is defined by the presence of firstly, ideal health behaviours, namely not smoking,
body mass index <25 kg/m2, physical activity at goal levels described below (see 3.3.3),
and following a diet consistent with current guideline recommendations (see 3.3.1). Secondly,
ideal health factors, which are untreated total cholesterol <200 mg/dL (see 3.2.3), untreated
blood pressure <120/<80 mmHg (see 3.2.1), and fasting blood glucose <100 mg/dL (see
3.2.2) [226] should be focussed.
3.1 Generally non-modifiable risk factors
3.1.1 Sex
Coronary heart disease was stated to be the leading cause of death among women in
both developed and developing countries [227]. The incidence of CHD is significantly
lower among women than men prior to the age of 50 years. After this time the risk for
CHD among women raises and approaches the risk reported among men by the age
of 80 [228]. Women have their first acute MI approximately nine years later than men.
Despite the fact that the Framingham study described risk factors for CHD in women, the
study population was limited to white Caucasians living in the US. The authors could not
thoroughly explain the observed later age of first occurrence of MI among women [229].
The measurement of only a limited number of risk factor can have led to this restraint. It
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is widely believed that the advanced age in female MI incidence is based on protective
effects of female sex hormones. Additionally, different habits in diet and smoking may
also play a fundamental role [230].
The INTERHEART study, a global case–control study including 52 countries, found
nine modifiable risk factors that explained more than 90% of acute MI across all major
ethnic groups in both young and older individuals. This was reported for both, men
and women [231]. Smoking (OR 2.87 for current vs. never having smoked), history
of hypertension (OR 1.91), diabetes (OR 2.37), abdominal obesity (OR 1.12 for top vs.
lowest tertile and OR 1.62 for middle vs. lowest tertile), psychosocial factors (OR 2.67),
daily consumption of fruits and vegetables (OR 0.70), regular alcohol intake (OR 0.91),
and routine physical activity (OR 0.86) were all significantly related to acute myocardial
infarction with p<0.0001 for all risk factors and p=0.03 for alcohol. The authors concluded
that abnormal lipids, smoking, hypertension, diabetes, abdominal obesity, psychosocial
factors, low consumption of fruits and vegetables, high alcohol intake, and rare physical
activity explain most of the worldwide risk of myocardial infarction in both sexes and at all
ages in all regions. As a result, methods of prevention can be based on similar principles
globally. This has a huge potential in preventing a large number of premature cases of
myocardial infarction [231].
A sub-sequent analysis of those nine risk factors, which were more strongly associated
with MI in women, were comprised of diabetes, hypertension, alcohol consumption, and
physical activity. In contrast to this, only former smoking was more strongly associated
with MI in the male population. On the other hand, the association of current smoking,
psychosocial factors, consumption of a high-risk diet, and abdominal obesity with MI did
not reveal any significant gender difference. Generally speaking, the listed risk factors
were more strongly associated with acute MI in subjects <60 years by comparison to
older individuals, aged ≥60 years. Delving deeper into the specifics among women,
hypertension, current smoking as well as diabetes were more strongly associated with
MI in younger compared to older ages. In the male population, abdominal obesity,
current and former smoking, hypertension but not diabetes were more strongly linked
to MI in younger compared to older men. In this connection, Anand et al. (2008) found
that the beneficial and protective effects of physical activity as well as regular alcohol
consumption and MI were stronger among older versus younger men [232].
These findings are consistent with previous investigations stating that the determinants
of CHD among women are relatively similar to those among men [233], [234]. Specifics
regarding the listed potential risk factors will be stated below.
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3.1.2 Age
Increasing age is regarded as the most significant risk factor for CHD. Individuals aged
older than 45 years have a greater risk for AMI, which is considered to be eight times
higher compared to younger individuals. In this context, it has to be kept in mind that
less than 10% of patients who have AMI are aged younger than 45 years [235].
As women have MIs at older ages than men, they are more likely to die of MI within a
few weeks [224], as described in the section regarding gender differences above (see
3.1.1).
3.1.3 Genetic factors and family history
It can be stated that individuals with a family history of ischaemic heart disease in a first-
degree relative have a higher risk for AMI [5]. Familial accumulation of CVD may be allied
with the aggregation of specific behaviours such as smoking and consumption of alcohol
or specific risk factors like hypertension, DM, and obesity. Those factors themselves may
have genetic and environmental contributors [236]. The presence of paternal history of
a heart attack has been reported to almost double the risk of a heart attack in men and
raise the risk in women by approximately 70% [237].
Family history of CVD plays an important role in the understanding of the disease complex
as well. Among a huge number of large-scale prospective epidemiology trials, the
Framingham Heart Study emphasized a strong and significant relation of a reported
family history of premature parental CHD with incident MI or CHD in its descendants
[237]. Additionally, family history of premature MI is also an independent risk factor
in other multivariable risk models that contain traditional risk factors. This has been
reported in large female [238] and male cohorts [239].
Apart from family history, genetics are more and more explored. In the European-derived
populations, the most consistently reported genetic marker for heart disease is located
at 9p21.3. It can be stated, that at this single-nucleotide polymorphism, approximately
27% of the white population is estimated to have zero risk alleles. Furthermore, 50% are
supposed to have one risk allele and the remaining 23% are predicted to have two risk
alleles [240].
The same 9p21.3 region has also been associated with ischaemic stroke (see 2.1.3)
[241].
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3.2 Well-documented modifiable risk factors
The following passage will describe well-known risk factors for MI, which can be modified.
3.2.1 Hypertension
Recent results from the Harvard Alumni Health Study stated that higher BP in early
adulthood was associated several decades later with higher risk for all-cause mortality,
CHD, and CVD mortality [242].
Focusing on myocardial infarction, about 69% of people who experienced a first heart
attack had a BP >140/90 mmHg. The same condition was observed for 77% of those
who had a first stroke [52].
Several trials addressed the awareness of a patient’s hypertensive condition, which is an
essential part in the prevention of AMI. Data from NHANES (2007 to 2010) revealed that
81.5% of all subjects were aware of their condition, 74.9% were under current treatment,
52.5% had their hypertension under control, and 47.5% did not have it controlled. Awareness
of hypertension was lower in the age group 18 to 39 years than among those aged 40 to
59 years or ≥60 years of age [243].
Finally, to get a better understanding of the future impact, it may be advisable to check
on upcoming expenses. For 2010, the estimated direct and indirect expenses of HBP
were $46.4 billion. By 2030, the total cost of HBP could increase to an estimated $274
billion based on methodology stated in Heidenreich et al., 2011 [244].
3.2.2 Diabetes mellitus
Diabetes mellitus is another major risk factor for CVD and stroke [245]. Consequently,
it is also associated with a higher risk of AMI [5]. Following AHA guidelines, identified
untreated fasting blood glucose levels of <100 mg/dL for adults can be attributed to one
of the seven components of ideal cardiovascular health [226].
Diabetic subjects are at higher risk of suffering from myocardial infarction and have worse
outcomes compared to individuals without diabetes. The underlying pathophysiology of
the atherosclerotic process is comparable to non-diabetic subjects. Nevertheless, the
prothrombotic and procoagulant state with which diabetes is accompanied is assumed
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to add to the increased incidence of and worse prognosis after MI [246]. Type 2 diabetes
is present in 10% to 30% of patients presenting with MI [247].
Finally, a look at the resulting cost is appropriate. The expenditures of DM were estimated
up from $174 billion in 2007 at $245 billion in the year 2012. Of these costs, $176
billion were direct medical costs, while $69 billion resulted from individual’s diminished
productivity. Inpatient care attributed to 43% of these expenses [248]. In general, the
medical costs for patients with DM were 2.3 times higher than for those without DM after
having adjusted for age and sex [108].
3.2.3 Dyslipidaemia
Dyslipidaemia can clearly be attributed to one of the most important risk factors of AMI.
This is based on the fact that elevated serum levels of LDL cholesterol and non–HDL
cholesterol significantly raise the risk of AMI. HDL value of less than 40 mg/dL is a risk
factor for atherosclerosis, too [235].
High cholesterol is consistently repeated as a major risk factor for CVD and stroke [116].
The AHA has identified untreated total cholesterol <200 mg/dL as one of the seven
components of ideal cardiovascular health for adults (see also 2.2.4) [226]. More detailed
information on dietary cholesterol and other factors that affect blood cholesterol levels
can be found in the chapter on diet and nutrition regarding MI (see 3.3.1).
It can be stated that treatments aiming at lowering LDL levels in dyslipidaemic patients
are effective in preventing AMI. Beneficial LDL levels are 80 mg/dL or less in patients with
atherosclerosis and 100 mg/dL or less in asymptomatic patients with high risk for CHD.
According to the 2007 American College of Cardiology/American Heart Association guideline
for management of patients with STEMI, the recommended LDL cholesterol level should
be substantially less than 70 mg/dL [249].
3.2.4 Cigarette smoking
Cigarette smoking can be seen as a major risk factor for atherosclerosis and therefore
for AMI. The resulting risk is directly proportional to the number of cigarettes smoked per
day [235].
52
Risk factors for coronary heart disease focusing on myocardial infarction
There are several preventive measures supported by the American College of Cardiology
and the American Heart Association. Lifestyle modifications such as smoking cessation
are stated as one of the most essential preventive measures of AMI. To quit smoking for
six months has already been found to reduce the dysfunction of coronary endothelium
in AMI patients. Two years after cessation, the risk of AMI drops by remarkable 50%
[235].
There is a sex differential in the burden of smoke which may further expand as the
detrimental effects of smoking are stronger for women in some diseases. This encompasses
lung cancer and CHD [250]. A recent overview underlined the excess risk of smoking-
related CHD to be 25% higher in women than in men [251].
It stands to reason that some of the pathways mediating the relation between smoking
and coronary risk are more sensitive to the anti-oestrogenic effect of smoking than those
controlling the connection between smoking and stroke risk. For instance, decreased
oestrogen levels in smokers are considered to have a negative impact on components
of the lipid profile, which is a major risk factor for CHD and, to a lesser extent, for stroke.
This results in elevations in total cholesterol and triglycerides while lowering levels of
HDL cholesterol [252].
In this line, atherosclerosis and plaque formation shall be only mentioned, as these risk
factors are not actively considered in the present study.
3.3 Less well-documented or potentially modifiable risk
factors
The following section leads to less well-documented or potentially modifiable risk factors
like for example obesity (see 3.3.2), the amount and type of physical activity (see 3.3.3),
or alcohol consumption (see 3.3.4). Additional variables such as metabolic syndrome,
psychosocial conditions, and chronic kidney disease shall just be mentioned here.
3.3.1 Diet and nutrition
As dietary habits affect a broad range of established and recently discovered risk factors
[52], they shall be described in the following.
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A large number of meta-analyses underlined that each daily serving of fruits or vegetables
was associated with a 4% lower risk of CHD (RR, 0.96; 95% CI [0.93–0.99]) and a 5%
lower risk of stroke (RR, 0.95; 95% CI [0.92–0.97]) [253]. Additionally, greater whole
grain intake (2.5 compared with 0.2 servings per day) was linked with a 21% lower risk of
CVD events (RR, 0.79; 95% CI [0.73–0.85]). Similar estimates in men and women were
reported for various outcomes including CHD and stroke [254].
Furthermore, regularly consumption of nuts was associated with significantly lower incidence
of CHD (comparing higher to low intake: RR, 0.70; 95% CI [0.57–0.82]) [255].
In addition to these findings, refined grain intake was not associated with lower risk of
CVD (RR, 1.07; 95% CI [0.94–1.22]) [256]. In a meta-analysis analysing data of 16
prospective cohort studies including 326,572 generally healthy individuals in Europe, the
United States, Japan, and China, fish consumption led to a significantly lower risk of CHD
mortality [254]. Contrasted with no consumption, an estimated 250 mg of long-chain
omega-3 fatty acids per day was linked with 35% lower risk of CHD death (p<0.001).
In regards of the consumption of meat, unprocessed red meat was not significantly
associated with incidence of CHD. By contrast, each 50 g serving per day of processed
meat, which is sausage, bacon or deli meats, correlated with a higher incidence of CHD
(RR, 1.42; 95% CI [1.07–1.89]) [257]. In a meta-analysis including 442,101 participants
and 28,228 DM cases, unprocessed red meat consumption was linked with a higher risk
of DM (RR, 1.19; 95% CI [1.04–1.37], per 100 g/d) [258]. For associations between DM
and MI see 3.2.2.
Having had a closer look at dairy products, no significant higher or lower risk of CHD was
reported [255]. There was an independent association between the regular consumption
of sugar-sweetened beverages and higher incidence of CHD, with 23% and 35% increased
risk with 1 and ≥2 servings per day, respectively, compared with an intake of <1 per
month [259].
As already stated in the section about nutrition and stroke (see 2.2.7), a meta-analysis
of 15 prospective cohort samples revealed that each 1.64 g/day higher potassium intake
was linked with a 21% lower risk of stroke (RR, 0.79; 95% CI [0.68–0.90]) and trends
toward lower risk of CHD and total CVD [260].
In summary, societal and environmental factors are independently associated with energy
imbalance in terms of weight gain. This is driven through either increased intake of
calories or decreased expenditure. Education, income, race/ethnicity, and local conditions
in the environment like the availability and types of grocery stores, types of restaurants,
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safety, parks and open spaces, and walking or biking paths are closely linked with this
aspect [261].
Taken together, most of those findings combined in one dietary pattern, namely the
Mediterranean diet, characterized by higher intakes of vegetables, legumes, nuts, fruits,
whole grains, fish, and unsaturated fat as well as lower intakes of red and processed
meat, was associated with a 22% lower cardiovascular mortality (RR, 0.78; 95% CI
[0.69–0.87]) [262], risk of weight gain, continued CHD, and stroke [263].
How fundamentally important the focus on nutrition in relation to vascular health is,
becomes obvious when underlining the impact on mortality. In the year of 2010, a total
of 678,000 deaths of all causes were attributable to suboptimal diet [52].
An overview of the costs of miscellaneous strategies for primary prevention of CVD
emphasized that the estimated costs per year of life gained were between $20 to $900
for population-based healthy eating and approximately $1,500 for lifestyle advice [264].
More than $33 billion in medical costs and $9 billion in lost productivity resulting from
heart disease, stroke (see 6.1.5), cancer, and diabetes mellitus were assigned to poor
nutrition [265].
3.3.2 Overweight and obesity
Overweight and obesity attribute to the major risk factors for CVD and stroke (see 2.2.8)
[266], [267], [268]. Patients with a BMI of ≥30 have a higher risk of AMI [235]. The AHA
has identified <25 kg/m2 for adults aged ≥20 years as one of the seven components of
ideal cardiovascular health as mentioned above [226].
Those observations have a crucial impact on future generation’s morbidity. Overweight
children and adolescents are at increased risk for developing adverse health effects over
their life span. Those include a higher prevalence of traditional cardiovascular risk factors
such as hypertension (see 3.2.1), DM (see 3.2.2), and hyperlipidaemia (see 3.2.3) and
result in associated health conditions like AMI and stroke [269]. Additionally, this could
lead to poorer school performance, tobacco smoking (see 3.2.4), alcohol use (see 3.3.4),
poor diet (see 3.3.1), as well as premature sexual behaviour.
If this current trend in weight gain continues, total healthcare costs attributable to obesity
could reach up to $957 billion by 2030. This would account for 16% to 18% of all US
health expenses [270]. The total excess expenditures due to the current prevalence
55
Risk factors for coronary heart disease focusing on myocardial infarction
of adolescent overweight and obesity are approximately $254 billion. This estimated
amount is composed of $208 billion in lost productivity secondary to premature morbidity
and mortality as well as $46 billion in direct medical costs [271].
3.3.3 Physical activity
Another of the major risk factors for CVD is physical inactivity [272]. Leisure-time physical
activity has been associated with a lower risk of AMI among lean, normal-weight, and
overweight patients (BMI 25-25.9), respectively [235]. Light to moderate leisure time
activities performed regularly, like working in the garden and intensive walking, are
recommended.
Physical activity has been stated to decrease the risk of CHD by lowering haemostatic
and inflammatory biomarkers such as C-reactive protein. Additionally, decreasing blood
pressure, lipid levels as well as increasing insulin sensitivity are essential [5].
In terms of morbidity and mortality, physical inactivity is responsible for 12.2% of the
global burden of MI after accounting for other CVD risk factors such as abdominal obesity
(see 3.3.2), cigarette smoking (see 3.2.4), diabetes mellitus (see 3.2.2), hypertension
(see 3.2.1), psychosocial factors, lipid profile (see 3.2.3), and no alcohol intake (see
3.3.4) [231].
In summary, a large number of longitudinal studies stated a graded and inverse association
of PA amount and duration with incident CHD and stroke [273]. The economic consequences
of physical inactivity are fundamental. Concise WHO data sources concluded that the
expenses of physical inactivity account for 1.5% to 3.0% of total direct healthcare expenditures
in developed countries [274].
3.3.4 Alcohol consumption
Alcohol moderation and prevention of illicit drug use are important in the prevention
of cardiac conditions [235]. Currently issued European guidelines on cardiovascular
disease prevention in clinical practice recommend to limit the consumption of alcoholic
beverages to two glasses per day (20 g/day of alcohol) for men and one glass per day
(10 g/day of alcohol) for women [275].
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Considerable epidemiologic evidence linked moderate alcohol consumption to a reduced
risk of CHD and stroke. Especially red wine seems to be protective for cardiovascular
diseases [276].
It has to be kept in mind that alcohol consumption is associated with many potentially
confounding factors [277]. As a result, it is difficult to address the causal effect of alcohol
consumption on CVD risk in observational studies. Long-term randomized controlled
trials assessing the impact of regular alcohol consumption on hard cardiovascular endpoints
are unlikely to be ever conducted.
3.4 Early risk assessment in myocardial infarction
A person’s overall risk for CHD can be evaluated for example by administering his or her
cardiac risk factors in specific equations based on large cohort series as reported in the
Framingham study.
The US Preventive Services Task Force does not recommend routine screenings for
CHD in patients with low or even moderately increased risk. This recommendation
includes the routine use of methods like resting ECG or exercise treadmill test to screen
for evidence of coronary atherosclerosis or prediction of CHD events in persons without
significantly increased risk [278].
There are additional methods to detect CVD. Carotid intima-media thickness is considered
to be one of the most widely used and well-validated subclinical CVD measures. This
approach has also been implemented in the present study. Ultrasound is applied to
quantify the thickness of the intimal and medial layers of the carotid artery and quantify
plaque in the carotid artery, as applied in the present study. Both, plaque ultrasound
and carotid intima-media thickness measures are highly reproducible and significantly
associated with later CVD events. This connection was even observed among low-risk
populations [279].
3.4.1 Framingham scoring
The Framingham Risk Scoring (FRS) is based on the patient’s age, sex, smoking history,
blood pressure, and total and HDL cholesterol [280] (see figure 3.1).
57
Risk factors for coronary heart disease focusing on myocardial infarction
Figure 3.1
Framingham Risk Scoring [281].
Until today, it has been validated in various samples [282], [283]. The scoring serves
an estimate of the ten-year risk for CHD [284], [283]. Additionally, it is incorporated
into current cholesterol treatment guidelines [280]. In this context, it clearly has to be
considered to involve an individual’s socioeconomic status (SES) in the risk assessment.
Omission of socioeconomic position (SEP) involvement might bias CHD risk assessment
of patients with lower SES [285]. Based on FRS alone, individuals of higher and lower
SES had a predicted CHD risk of 3.7% and 3.9%, respectively. The observed risks for
each group were 3.2% and 5.6%. After having added SES to the model, the predicted
risk estimates became 3.1% for those with higher and 5.2% with lower SES. As a
result, inclusion of SES in the model resulted in upgrading of the risk classification for
15.1% of low-SES participants (95% CI [13.9-29.4]). This integration would consequently
contribute to reduce the bias.
3.4.2 Prevention of myocardial infarction
Measures for preventing AMI can be compared with those generally recommended for
preventing the development of CHD. Consequently, they embrace lifestyle modifications
such as quitting smoking, being engaged in regular exercise, and making dietary adjustments.
As described above, the control of comorbidities like hypertension, diabetes mellitus,
and hypercholesterolemia are crucial in addition to this. Lastly, an appropriate patient
education is fundamental (see 9).
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3.4.3 Population at risk
Physicians can by instance identify the population at risk based on the ten-year risk of
CHD occurrence related to the FRS. The risk should be calculated in all patients with
two or more revealed risk factors. Individuals showing ≥2 risk factors, who are found
to have high ten-year risk, would benefit the most from primary prevention [235]. In this
context, it is decisive to determine patients with CHD and those with risk equivalents
to launch secondary prevention schemes [235]. Patients, their relatives, and the public
should be educated properly, especially on how to detect and respond to an episode of
AMI [235].
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4 Influence of socioeconomic position
in life
This chapter presents a broad list of indicators of a person’s socioeconomic position
included in this study and discusses their origins. The present overview will give a
description of what the factors intend to measure as well as how data are commonly
elicited in health research. This will help to better understand and adequately categorizes
the reported results in chapter 5 on the specific impact of a person’s SES on stroke and
MI.
Additionally, strengths, limitations, and a life course approach of these variables will be
discussed.
4.1 Preliminary considerations
The term socioeconomic position is a frequently used concept in epidemiological and
health research. Even though researchers have an intuitive sense of what factors SEP
involve, the various ways of measurement reveal the complexity of the construct. A huge
variety of other terms, such as social or socioeconomic status, social class, and social
stratification are commonly used interchangeably [286]. Nevertheless, it has to be kept in
mind that their theoretical bases and, therefore, interpretations might defer significantly
[287].
A person’s socioeconomic position describes the social and economic factors that have
an influence on the kind of positions an individual or groups hold within the structure of a
society [287], [288]. These concepts enclose divergent historical and disciplinary origins,
which will briefly be discussed here. SEP is linked to various resources, exposures, and
susceptibilities that may have an effect on health [286].
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It has to be clearly stated that there is no single best indicator of SEP applicable for all
study aims and appropriate at every time point in all clinical trials. Each indicator is based
on particular measures and may be more or less relevant to diverse health outcomes.
Additionally, it might vary at different stages in a person’s life course.
Ideally, the choice of SEP measure should therefore be based on consideration of the
specific research question and the proposed mechanisms associating SEP with the
outcome. This is the case, when SEP is assumed to be a confounding or mediating
variable and the exposure of interest. On the other hand, if the aim of the study is to
investigate the existence of a socioeconomic gradient in a specific health outcome then
the choice of indicator may not be decisive [286]. If an isolated measure of SEP shows
an association with an addressed health outcome, it will not encompass by default the
completeness of the effect of SEP on health. It clearly has to be kept in mind that this
aspect is of particular importance in case SEP is considered a potential confounding
factor. To address this issue, multiple SEP indicators, by preference collected across the
course of life, could attribute to avoid residual confounding by unmeasured socioeconomic
circumstances [289].
The following chapter delves deeper into the theoretical basis, measurement, and interpretation.
Additionally, strengths and limitations of each indicator considered in this study will be
discussed. Figure 4.1 displays examples of indicators measuring life course socioeconomic
position [290].
Figure 4.1
Examples of indicators measuring life course socioeconomic position [290].
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4.2 Theoretical origins
A large number of the concepts underlying the use of SEP in epidemiological research
are based on the understanding of two formative social theorists, namely Karl Marx and
Max Weber. In Marx’s work, SEP was exclusively determined by “social class”, in which
individuals were defined by their relation to the “means of production” (e.g. land and
factories). The social class and class relations were typified by the inherent conflict
between exploited workers and the exploiting capitalists, who controlled the means of
production. Regardless of the fundamental political weight of Marxist ideology in the
20th century, there are only two classifications employed in epidemiological research
that are based on Marx’s theory of social class [291]. The first is the Erik Olin Wright’s
classification [292]. The second refers to categorizations developed in South America
[293].
As opposed to Marx, who was convinced that social stratification in capitalist societies
were both, source and outcome of the conflict between two necessarily opposed social
groups, Weber’s theory followed the approach that society is hierarchically stratified
along numerous dimensions. This assumption led to the creation of groups whose
members share a common market position, resulting in shared “life chances”. In Weber’s
concept, market position is not inevitably singularly defined by Marx’s class relations
[291].
In summary, theories about the association between health and socioeconomic status
substantially focus on three mechanisms [294]. The first approach is a materialist one,
basically stating that those with higher incomes are able to purchase higher quality of
nutrition, better housing, live in safer environments, and also have better access to health
care. The second underlines behavioural or so called lifestyle factors. In this category
alcohol consumption, smoking, dietary habits, and appropriate use of and admission to
health care can be stated. Those factors may vary with cognitive skill and access to
information. The third approach supports the idea of impact of psychosocial factors such
as empowerment as well as relative social integration and social status. Those aspects
subsume the exposure to stresses that may derive from low status and little autonomy
in important areas of life, such as work or housing environment [295]. Behavioural
concepts generally relate more closely to education, while occupational characteristics
or measures of relative deprivation might be applied to reveal psychosocial links between
socioeconomic status and health [295].
In this connection, it clearly has to be kept in mind that all these indicators are interrelated.
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None of them gathers completely the domains identified as fundamental in the theoretical
literature. In other words, such an approach may be over simplistic. In practical application,
all three approaches, taken together with others discussed below, are commonly utilized
in analyses of health inequalities [296]. In a large number of studies, these highly
correlated measures are practically applied interchangeably, despite the fact that this
may hamper efforts to comprehend how social position influences health [297]. One
aspect the majority of the studies have in common, is the fact that their use for analyzing
older populations is troublesome [295].
4.3 Education
4.3.1 Theoretical basics
Education is a commonly used marker in epidemiologic studies. The employment of
education as an SEP indicator historically goes back to the status domain of the Weberian
theory [298] and its endeavor to capture the knowledge related to the property of an
individual [288]. In this context, it has to be kept in mind that formal education is usually
completed in young adulthood and can be conceptualized within a life course framework
as an index that partly measures early life SEP [299], [294]. Additionally, it is strongly
influenced by parental characteristics.
Education and therefore the ability to make an informed choice has been used as a
reliable measurement of socioeconomic status based on the following advantages. Firstly,
it is stable and becomes established in early adulthood as mentioned above. Secondly,
it is not modified by chronic illness in later adulthood and lastly, it is easy to measure
[300].
4.3.2 Measurement
There are several possible approaches how to measure a person’s educational level. It
can be addressed as a continuous variable, in terms of years of completed education,
or as a categorical factor by assessing educational achievements such as completion
of primary or high school, higher education diplomas or degrees, as in this study. The
continuous measure is based on the assumption that every year of education contributes
similarly to a person’s attained SEP and that time spent in education has greater importance
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than educational landmarks. In contrast to this, the categorical approach understands
that specific achievements are crucial in identifying the individual SEP [298].
4.3.3 Interpretation
Although education is commonly involved as a generic measure of SEP, there are particular
interpretations to clarify its association with health outcomes [301], [298], [302].
Firstly, education captures the transition from parents’ received SEP to the own adulthood
SEP. It can also be seen as a significant predictor of future employment and income
[294],[288], [303]. Consequently, educational level displays intellectual, material, and
other resources derived from the family of origin.
Secondly, the knowledge and skills developed through educational procedures and experiences
may affect a person’s cognitive functioning. It could make an individual increasingly
receptive to health related education messages or enable a facilitated communication
with and access to adequate health care services as well as a better compliance.
Measuring of knowledge in terms of “cultural literacy” and assessing its role in the
association between education and health might result in substantial difficulties in analysing
specific effects of education and knowledge on health [304], [305].
Thirdly, poor health in childhood can lead to reduced educational attendance and/or
achievement and predispose to adult disease. This might provoke a health selection
impact on health inequalities [306].
4.3.4 Strengths and limitations
Comparatively, education can be straightforward captured in self-administered questionnaires
and usually leads to a high response rate. Additionally, it is pertinent to people disregarding
their age or working conditions, unlike many other SEP indicators [298]. Moreover,
the age leaving full-time education is unaffected by poor health in adulthood [290].
Educational attainment can be reliably recalled and is easily quantified.
The meaning of educational position differs for different birth cohorts. Along with secular
trends in improving educational attainment, there have been substantial changes in
educational opportunities for women, as in this study, and some minority groups over
the last decades. Such cohort effects can be crucial but are often not taken into account
in epidemiological trials. Consequently, the findings from studies that include years of
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education or educational qualifications that incorporate participants from numerous birth
cohorts may be biased if cohort effects are not considered. Older cohorts will therefore
be over-represented among those classified with lower education [307].
Additionally, education must be seen in a culturally specific context. A further limitation of
educational levels exists if individuals have obtained their education outside the country
of residence [286]. This circumstance has no relevance in the present study, as the
addressed cohort has mainly attained its education in the area of Ebersberg.
Lastly, measuring the number of years of education or levels of attainment does not
always contain information about the quality of the educational experience. This is
decisive if conceptualizing the role of education in health outcomes particularly related to
cognitive skills, knowledge, and analytical capacities. It may be of less importance when
considering education as a broad indicator of SEP [286].
4.4 Marital status
A wealth of evidence underlined a protective effect of marital status and/or cohabitation
on long-term mortality and other health outcomes in a large body of trials in general
populations [308]. In general, mortality rates were increased among unmarried individuals
even after adjusting for registered socioeconomic and health variables which are assumedly
selecting people into and out of marriage [309].
4.4.1 Theoretical basics
Marriage has been hypothesised to have protective effects for longevity through a variety
of interconnected variables, with a greater overall marriage advantage for men compared
to women [308].
Influencing pathways might be financial resources, social integration, support and control,
as well as social role attainment [308]. Social integration into the family, community,
educational facilities like schools, and religious institutions through marriage has contributed
and continues to create a sense of meaning, obligations regarding others, purpose, and
belonging [310]. A stable relationship adds to socioemotional support, establishing a
greater resilience to stress and physiological strain [311]. In addition to this, a solid
partner may assist in the monitoring of health, adherence to treatment, health-related
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behaviours, and lifestyle adaptions [312].
In the financial point of view, marriage might contribute to a greater family income and
general wealth, allowing advances in medical care and higher quality of diet [310].
4.4.2 Measurement
Data usually derives from official sources, such as a country’s census bureau, survey
interviews or self-administered questionnaires. These investigations usually apply data
in which marital status and other covariates are documented in cross-sectional surveys
up to a decade before mortality exposure. Another option is the usage of data from panel
surveys with much smaller sample sizes [308].
4.4.3 Interpretation
A tendency to a decreasing influence of marital status has been suggested as the
institution of marriage becomes less prevalent in more and more societies. In some
areas it has been superseded by unmarried cohabitation [313]. In contrast to this, a
recent review stated, persistent with cross-national comparative findings, a widening
mortality difference between married and unmarried individuals in high-income countries
over recent decades [308]. The replacement of marital status with cohabitation bears a
comparable strata-specific beneficial effect [314].
4.4.4 Strengths and limitations
In such a complex system as marriage, involving and influencing that many facets of
life, additional impact of unobserved characteristics cannot be precluded as at least
a partial explanation. Future efforts to model such selection are warranted. Another
limitation is the fact that prospective studies of mortality tend to use household survey
data. This might lead to biased findings by the omission of older individuals in institutions
such as nursing homes [308]. To summarise, effects of marital status on health may
not only be specific to time, culture, and region, but may also depend on the disease.
Generalizability of previous findings must therefore be considered with caution. To get a
deeper understanding, disease- and region-specific investigations are needed [314], as
in the present study.
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4.5 Housing conditions and social environment
4.5.1 Theoretical basics
Housing characteristics measure material features of socioeconomic circumstances. Generally
speaking, housing based indicators are applied in industrialized and non- industrialized
countries. The characteristics assessed might diverge significantly based on the addressed
setting and be exceedingly specific to the area where they were developed. Howden-
Chapman et al. (2004) investigated housing standards and their association with health
[315]. Houses and neighborhood can be seen as an exceedingly practical setting for
public health action. By their nature, they integrate both, private and public interests
[315]. The following aspects are more directly linked with SEP.
4.5.2 Measurement
The most widely collected characteristic is housing tenure. This factor describes if the
house is owner occupied, in terms of owned outright, being bought with a mortgage,
rented from a private or social landlord. Ownership might be more present in rural areas
[316].
Additionally, household amenities can be taken into account as well. Those commonly
include owning a telephone, refrigerator or washing machine, access to hot and cold
water and central heating, sole use of bathrooms and toilets and whether the toilet is
inside or outside the home. These amenities serve as markers of material circumstances
in different cohorts and geographical areas. They may also go along with specific
mechanisms of disease. An example for this would be that the lack of running water
and no toilet might be related to an increased risk of infection indicating low standards of
hygiene [316].
In this study, the focus was on the number of people living together in one household.
4.5.3 Interpretation
Housing related factors are primarily markers of material conditions. Housing characteristics
are commonly the key component of most people’s wealth. They mainly attribute to
expenses issued from a person’s income. Generally, this factor is an essential, multidimensional
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indicator of SEP, and is in some cases difficult to interpret. As mentioned above, some
housing circumstances may be direct exposures or markers of exposures for specific
diseases.
4.5.4 Strengths and limitations
Defined characteristics of a cohort’s housing and amenities are extensively used as
measures of SEP. Those factors are relatively easy to collect and may also lead to
indications of special mechanisms relating SEP to specific health outcome. Their main
restraint is that, although addressing the same basic concept, these indicators may be
specific to the temporal and geographical background where they have been created. As
a consequence, it is challenging to compare them across trials [286].
4.6 Occupation based measures
4.6.1 Theoretical basics
Occupation based indicators of SEP are also widely used in epidemiological research.
Occupation can be seen in accordance with Weber’s notion of SEP as a reflection of a
person’s place in society, related to their social standing, capability of mind, and earnings
(see 4.2) [291]. In this study, the former occupation as well as current employment status
were addressed.
Furthermore, it describes working relations between an employer and his employees.
There is also the possibility of a characterization of an individual as exploiters or exploited
in class relations [286].
4.6.2 Measurement
The majority of studies consider the current or longest held occupation of a person to
characterize their adult SEP. This study approaches the occupational level in the same
way.
Nevertheless, with increasing interest in the role of SEP across the life course, some
trials encompass parental occupation as an indicator of childhood SEP in conjunction
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with individuals’ occupations at different stages in the person’s adult life [317]. In some
cases, the occupational measures can be expanded and transferred. The measures from
one person or the combinations of several individuals can be used to describe the SEP
of others connected to them. For instance, “highest status occupation in the household”
or the occupation of the “head of the household” can serve as an indicator of the SEP of
dependents, as children, spouse or the household as a unit [286].
4.6.3 Interpretation
Specific aspects of SEP measure different occupational classification schemes. Admittedly,
it might be demanding to detach those specific effects of individual indicators. In the
following, a number of more general mechanisms that may explain the association between
occupation and health related outcomes are addressed.
First, the occupation, may it be parental or own adult, is strongly associated with income.
Consequently, a relation with health might be one of a direct relation between material
resources, meaning the monetary and other tangible compensations for work that influences
material living standards, and an individual’s health condition. Next, the occupational
status represents social standing and may be linked with health outcomes due to certain
benefits and privileges that are provided by higher standing. Examples for this could
be an easier admission to better health care, access to education as well as more
beneficial residential facilities. In this line, a higher educational level enables a wider
range of career opportunities going along with a greater understanding of health related
behaviour.
Thirdly, occupation can reflect social networks, work based stress levels, work-related
control, and autonomy. Through this, health outcomes may also be influenced by psychosocial
processes [286].
Finally, occupation may also involve specific toxic environmental or work task exposures
such as physical demands (e.g. laborer or transport driver), benefits, or disadvantages
going along with particular occupational groups [286].
4.6.4 Strengths and limitations
A substantial strength of these measures is their availability in many routine data sources.
This includes census data and death certificates. Occupation can be used as an indicator
of social status, power, education, and income [290]. In this study, it was also addressed
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using a self-administered questionnaire.
The potential subjectivity and inconsistency of these ranking systems has always to be
kept in mind. Occupation may be affected and determined by poor health in adulthood
[290].
One major limitation of occupational indicators is that they cannot readily be assigned to
individuals who are momentarily unemployed. If used as the only source of information
on SEP, socioeconomic differentials may be underestimated through the exclusion of a
number of participants [318]. Overgeneralization can easily lead to a rejection of retired
people, people whose work is at home, which is mainly affecting women/housewives,
students, unemployed people as well as individuals working in informal, unpaid or illegal
jobs [286]. In the present study, there is a large group of housewives, whose occupational
level has to be considered accordingly.
Furthermore, there are groups that might be less readily defined or willing to disclose
their occupation [286].
4.7 Life course socioeconomic position
As described above, there is strong and further increasing evidence that unfavourable
SEP in early years, independently of adult SEP, is a strong predictor of adult illness [299],
[317]. A large number of prospective trials suggest a higher mortality among those who
undergo adverse socioeconomic position at different periods of life. A huge variety of
mechanisms have been discussed to explain these associations [319]. Coronary heart
disease and ischaemic stroke seem to be affected by components acting across the
entire life span, resulting in a rather cumulative risk model [294], [320].
In summary, figure 4.2 shows a model of the causal paths through which the socioeconomic
level could influence risk and outcomes.
4.8 Concluding remarks
An individual’s SEP can be seen as the key to delve deeper into and to better understand
inequalities in health. It is best considered as an umbrella term for a range of indicators
and co-dependent approaches. Across the life course, time and place, based on an
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Figure 4.2
Model of the causal pathways of socioeconomic status affecting risk and outcomes [290].
individual and on the whole, numerous studies have shown how socioeconomic disadvantage
is related to poorer health outcome [321].
Most work on inequalities in health related context has been conducted in developed
countries, leading to indicators appropriate in this environment. Further research is
necessary to develop indexes that might be more applicable in clinical settings in developing
countries [286].
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The starting point for a more complete etiological insight of socioeconomic health differentials
should consequently be based on mechanistic specificity of relations between particular
SEP indicators, as discussed above, and diverse health outcomes. As a result, this
approach enables us to get a deeper understanding of the mechanisms of educational
background, marital status, housing conditions, and occupational group that generate
socioeconomic inequalities in the incidence of ischaemic stroke, ischaemic stroke including
TIA as well as myocardial infarction in the community-based cohort in Ebersberg, Germany.
After having discussed the extensive impact of SES on an individual’s health and wellbeing
in general, the following chapter will focus on the specific influence of a person’s socioeconomic
position on stroke and MI, describing active mechanisms. This overview of current
literature will provide a basis for discussion in chapter 9.
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5 Socioeconomic position in stroke
and myocardial infarction
The following chapter will describe current findings regarding the association of socioeconomic
status, stroke, and myocardial infarction. As little is known about the impact of SEP on
transient ischaemic attack specifically, this shall be subsumed under stroke itself.
5.1 Association of stroke and socioeconomic position
5.1.1 General socioeconomic position
People in low socioeconomic groups have an elevated risk of stroke [290], even in
egalitarian European countries [322]. For Germany, Helmert et al. (1993) found increased
numbers of cardio-cerebrovascular diseases in lower social classes [323]. It can clearly
be stated that the social disparity in stroke has persisted over time, regardless of the
overall decline in the stroke mortality rate [324] (see 1.3).
The majority of clinical studies attempting to explain the basis for the socioeconomic
gradient in stroke state that risk of stroke is reduced after taking account of conventional
stroke risk factors [325], [326], [327], [328]. Even though, a significant excess risk in the
lower socioeconomic classes frequently endures [329], [328].
Studies focusing on incidence of stroke and socioeconomic status can be described
as heterogeneous in design and outcome measures applied [330], [326], [328], [331],
[332]. Some studies did not meet the criteria for the gold standard for comparable
stroke-incidence studies. Notwithstanding that all studies support an inverse association
between socioeconomic status and stroke incidence [290], [333]. A person’s socioeconomic
status measured in middle or old age may mirror influencing factors on later stages of
pre-clinical stroke and stroke triggers [334].
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A current updated review conducted by Addo et al. (2012) brings large evidence related
to associations between SES and stroke [335] as well as underlining a generally increased
impact of stroke among lower socioeconomic groups in different populations with 30%
higher incidence rates [336]. Both, men and women from low socioeconomic groups
experienced higher rates of stroke than individuals from high socioeconomic levels. The
strength of this association was more pronounced for ischaemic stroke [337].
There is a strong and independent association between living in a socioeconomically
disadvantaged neighborhood and risk of ischaemic stroke [338], [339], [340], [341] as
well as coronary heart disease [334], [342]. This association was globally stable even
after adjustment for individual socioeconomic position [343].
A follow-up study on neighborhood environment and stroke in Sweden stated that specific
potentially health-damaging neighborhood resources involve higher odds on stroke [344].
There was a statistically significant increased risk for those subjects with residence in
neighborhoods with greater availability of fast food restaurants [344].
Meta-analysis conducted overseas, namely in Australia and New Zealand, also confirmed
that people living in socioeconomically more deprived areas experience higher incidence
rates of stroke. Again, this may be explained by a increased prevalence of risk factors,
such as diabetes, hypertension, and cigarette smoking among those individuals [345].
5.1.2 Socioeconomic influences in early life
A large body of studies suggested that socioeconomic deprivation in early years is
associated with increased risk of stroke in adulthood [77], [346], [347], [348]. Low
socioeconomic status, educational attainment, and cognitive performance seem to be
powerful predictors of stroke early in life [337], [336], [328].
The so called “fetal origins hypothesis" assumes that stroke in later years is related to
responses to malnutrition in utero and infancy. Studies have shown that people with low
birth weight (for further details see 2.1.3), smaller length at birth, and short adult stature
are at higher risk of suffering from stroke in adulthood [77], [346]. This can be explained,
as the mentioned factors are known indicators of insufficient maternal nutrition and poor
growth in utero. As a result, they are associated with increased plasma fibrinogen
concentrations and the development of hypertension in later life. The mechanism of
these variables are still debatable but might include a permanent change in vascular
structure based on malnutrition [77], [346].
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In a review of childhood socioeconomic circumstances and adult mortality, the majority
of studies stated a high overall risk of stroke in participants with poor socioeconomic
circumstances in their early life [347]. A prospective cohort study in Scotland identified
paternal social class as the most stable association with risk of stroke [349]. In this
context, it has to be underlined that the revealed risk persisted after adjusting for risk
factors and did not improve with beneficial changes in socioeconomic status in later
life.
Liu and colleagues (2013) reported a combined effect of socioeconomic position and
chronic conditions, like diabetes mellitus, hypertension, and heart problems in regards
to stroke risk. Moreover, a potential cumulative effect of childhood and adulthood social
circumstances as well as adult chronic conditions on risk of stroke was proposed [350].
As both, the prevalence and the effect of smoking and hypertension are socially biased,
a decrease in smoking in lower socioeconomic groups and in those with hypertension
might lead to a decline in social inequality regarding the risk of stroke [333].
Furthermore, a 33-year follow-up study assessed the risk factors in adolescence in
relation to the later risk of stroke in Swedish men. Strong independent risk factors (all
p<1.0x10-6) for ischaemic stroke involved low aerobic fitness (HR 0.84 per SD increase),
high BMI (HR, 1.15 per SD increase), diabetes (HR 2.85), alcohol intoxication (HR 1.93),
and low annual income (HR 0.85 per SD decrease) [351]. All those risk factors for stroke
have been discussed in chapter 2.
5.1.3 Risk factors for stroke
Studies of general populations conducted in developed countries also underline a higher
prevalence of various traditional stroke risk factors in the low socioeconomic groups
[352], [337], [353], [327]. A study of patients with stroke and transient ischaemic attack
reported a higher proportion of smokers in the lowest SES quartile for instance [354].
As people belonging to lower socioeconomic groups are repeatedly exposed to various
risk factors, it can be assumed that the effect of one of these factors on risk of stroke
is supposedly stronger. Individuals from lower SEP can be considered more vulnerable
[355]. The mechanisms driving social disparity in stroke have been described as partially
resulting from differential exposure to well-established risk factors, such as smoking and
hypertension, over the course of a life time [325], [345], [336], [327].
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There are overall consistent findings regarding inverse associations for smoking, diabetes,
blood pressure, physical inactivity as well as obesity. The latter would specifically apply
for women [356], [357].
In the European Rotterdam study, older women with stroke were reported to show
inconsistent patterns of risk-factor prevalence [331]. In this trial, a relation was stated
between lower socioeconomic status and higher blood pressure. Nonetheless, smoking
and diabetes were more frequent in lower socioeconomic classes. Furthermore, alcohol
consumption and BMI were significantly associated with lower socioeconomic status.
In a pooled cohort study of 68,643 participants in Denmark, the combined effect of low
education and current smoking was more than expected by the sum of their separate
effects on ischaemic stroke incidence. This was especially observed in males, suggesting
that men in lower socioeconomic groups could be more vulnerable to the effect of smoking.
Furthermore, the combined effect of current smoking and hypertension was more than
expected by the sum of their separate effects on ischaemic stroke incidence as well. This
impact was most pronounced among women [333].
Assumptions differ as to how much of the observed dissimilarities in incidence and
outcome of stroke can be assigned to disparities in risk factor prevalence. As much
as risk factor profiles for different countries have altered over the last years, this is not
necessarily matched with a corresponding change in mortality rates [358].
The US National Health and Nutrition Examination Surveys were conducted at different
time points over a period of time from 1971 to 2002. The results revealed a decline in
the prevalence of high blood pressure and cholesterol in all socioeconomic groups going
along with widening socioeconomic disparities in smoking [359]. A broadening of the
discrepancies in the prevalence of risk factors for stroke among different socioeconomic
groups might to some extend be based on any widening in the socioeconomic disparities
in mortality from cerebro-cardiovascular diseases [360]. Although, effective interventions
and strategies for preventing stroke have been established, a substantially low uptake
remains in some populations on a global level [361], [362].
These associations have also been found in Germany. Table 5.1 gives an overview of
the prevalence of behaviour-related risk factors categorized by lower, middle, and upper
social class among 18 to 79 year olds [30].
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Table 5.1
Prevalence of behaviour-related risk factors according to social class in Germany [30].
5.2 Risk of stroke and selected socioeconomic variables
As this study will investigate the association of stroke and educational attainment, occupation,
marital status, and cohousing in an elderly cohort, a topical overview is given in the next
section.
5.2.1 Educational influences
A large body of studies agree that low compared to high educational levels are associated
with greater ischaemic but not with haemorrhagic stroke incidence and that stroke risk
factors are more prevalent in low educational groups [335], [203], [327], [363]. Furthermore,
behaviours and conditions, such as smoking and frequent consumption of alcohol, which
increase the risk of stroke, are more common among groups with low SES and educational
level, as mentioned above [201], [333]. Additionally, hypertension was more prevalent
among those with low education [333]. A 33-year follow-up study assessing risk factors
in adolescence compared to stroke risk in later life stated that systolic blood pressure and
alcohol intoxication showed a stronger association with haemorrhagic strokes, whereas
low education and diabetes indicated a stronger link to ischaemic strokes [351].
This is also described in section 5.1.1 on the general risk factors for stroke in the context
of an individual’s socioeconomic position.
The Women’s Lifestyle and Health Cohort Study including 49,259 women from Sweden
showed that the risk of stroke was significantly and inversely related to completed years
of education. The hazard ratio comparing lowest with highest education group was
2.1 (95% CI [1.4-2.9], p<0.001). This association was diminished after adjustment for
established risk factors, although remaining significant (HR 1.5; 95% CI [1.0-2.2], p=
0.04).
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As stroke risk increased with decreasing education level, school-leaving age was linearly
associated with stroke risk. Women who left at a younger age had higher levels of stroke
risk [364].
Avendano et al. (2004) addressed stroke mortality by educational level in ten European
countries, namely England/Wales, Switzerland, Austria, Italy (Turin), Spain (Barcelona
and Madrid), Belgium, Finland, Norway and Denmark [365]. For all age groups in all
investigated countries, higher mortality rates were stated in groups with an education
below upper secondary level or country-specific equivalent. This was consistent for both,
men (RR 1.27; 95% CI [1.24–1.30]) and women (RR 1.29; 95% CI [1.27–1.32]) [365].
In the EU based Rotterdam Study, risk was reduced in women from households in which
the head was classified professional. This effect was not mediated by traditional risk
factors. Nevertheless, the number of cases was small and the follow-up period was
short [331]. In a larger Danish cohort followed-up over 12 years, low education and
small income were associated with increased risk of stroke [366]. In European cohorts
of men, the majority of studies [94], [346] but not all trials [331] underlined an inverse
association between education or income and stroke.
Observations in the Swedish Stroke Register underlined a social stratification in reperfusion
therapy. This was partly explained by individual patient characteristics and the specialization
level of the respective local hospital [367]. Patients with university-level education were
more likely to receive perfusion therapy (5.5%) than patients with secondary (4.6%) or
primary education (3.6%; p<0.001). This discrepancy linked with education was still
perceivable after controlling for patient characteristics.
Educational impact on obesity
Based on data from the Centers for Disease and Prevention, the overall obesity prevalence
in the US was inversely associated with education level. College graduates showed a
20.8% rate of obesity, whereas those who attained less than a high school education
were attributed with an obesity prevalence of 32.9% [368]. Childhood sociodemographic
factors might have added to sex disparities in obesity prevalence. The sex gap was
largest in those with low parental education (16.7% of men compared with 45.4% of
women were obese). By contrast, it was smallest in those with high parental education
(28.5% of men compared with 31.4% of women were obese) [369]. Obesity rates were
disproportionally more excessive in children living in low-education, low-income, and
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higher-unemployment households [370]. In 2006, 39% of rural versus 32% of urban
children were obese [371].
Educational impact on physical activity
For Germany, figure 5.1 illustrates the extent of sporting activity by socioeconomic status.
The picture emerges that a larger proportion of people from the lower classes, both
men and women, do not practise any sports. Consecutively, individuals belonging to
middle class do less sports than those in higher classes [30]. Those discrepancies might
be partly explained by the fact that individuals in the higher social classes spend their
working day in a predominantly sitting position. Those subjects do specifically sports to
compensate for the lack of movement during the day. Additionally, some kinds of sports
involve a considerable amount of money to practice.
Figure 5.1
Extent of sporting activity by socioeconomic status in Germany [30].
In the US, an inverse association of adults ≥25 years not meeting the full aerobic and
muscle-strengthening federal PA guidelines with educational level was stated. In detail,
66.4% of all participants with no high school diploma, 57.6% of those with a high school
diploma or a high school equivalency credential, 46.8% of those with some college, and
33.2% of those with a bachelor’s degree or higher did not comply with the full federal PA
guidelines [372].
For Germany, data from the 2003 Telephone Health Survey revealed that overweight
and obesity occurred significantly more often among men and women with a lower
secondary-school leaving qualification compared to those with the higher education
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entrance qualification (“Abitur”). The educational factor had a slightly higher impact on
females [373]. Figure 5.2 displays the prevalence of overweight in light blue and obesity
in darker blue by school education and sex.
Figure 5.2
Prevalence of overweight and obesity by school education and sex in Germany [30].
5.2.2 Underlying mechanism for the association between
educational attainment and cardiovascular diseases
Until today, the underlying mechanism of the relation of lower educational attainment
and higher risk for cardiovascular diseases is not completely understood. As discussed
above, low educational level is a crucial risk factor for cigarette smoking and the development
of adverse factors, like obesity, hypertension, or high levels of serum cholesterol [328].
Several studies reported an increased risk of CVD, subsuming CHD and stroke, independent
of other cardiovascular risk factors [328]. Furthermore, there is evidence that cardiovascular
disease risk might also be independent of socioeconomic status, as already stated.
There are a number of aspects that help to understand basic mechanisms. Firstly,
individuals of lower SES are substantially less likely to have access to health care
[374]. This might also have an impact on the risk of cardiovascular diseases. Next, the
frequency of physician visit can be decisive. Hinkle et al. (1968) suggested that reported
discrepancies in cardiovascular disease risks were not a result of the educational process
itself but rather a consequence of biological diversities in acquired habits. Those differences
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can become obvious in diet patterns as well as the level and kind of activity, which
are formed during childhood and youth and continue into adulthood [375]. It has been
reported that the effect of educational attainment on myocardial infarction and stroke was
more prominent in persons ≤50 years. Consequently, it can be assumed that adverse
influences of low educational attainment tend to manifest in younger age groups. In
contrast to this, in older people, the classical risk factors might have a bigger influence
in determining an individual’s risk for cardiovascular diseases [328].
Finally, in another European multicenter study, a higher level of education had a positive
impact on motor and functional recovery during the inpatient rehabilitation period after
stroke [376]. The rate of compliance might be decisive. Low socioeconomic status and
educational attainment can also be related to less access to preventive and therapeutic
health care and health information [330].
5.2.3 Occupation
Globally, differentials between occupational groups increased over time [290].
In the US and northern Europe, high stroke mortality in people among manual occupations
was reported. This overview of socioeconomic discrepancies in stroke mortality found
a lower mortality in the non-manual class in comparisons to national mortality rates
[377].
Additionally, in an international review for the European Union Working Group on Socioeconomic
Inequalities in Health, manual classes had higher stroke mortality rates compared with
non-manual working conditions. This difference was reported to be relatively large in
England and Wales, Ireland, and Finland. In contrast to this, it was observed to be
rather small in Italy, Spain, Sweden, Norway and Denmark. Intermediate discrepancies
were found in the United States, France, and Switzerland. In the majority of countries,
diversities were much larger for stroke mortality than for ischaemic heart disease mortality
[377].
Furthermore, manual occupation of an individual’s father, which falls under indicator of
childhood socioeconomic status, predicted adult stroke mortality in a cohort of employed
men independent of their adult socioeconomic status [378]. Langagergaard et al. (2011)
reported a higher risk of death after stroke in unemployed subjects compared with employed
patients in Denmark [379].
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5.2.4 Marital status
Among persons with acute stroke symptoms, earlier medical-seeking behaviour was
reported in married patients compared to singles. This was especially true for married
men [380]. Additionally, the incidence of stroke seems to be increased in divorced and
widowed individuals [381].
The US Health and Retirement Study included 22,818 subjects born between 1900 and
1947, aged 50 and older, without stroke at baseline [382]. Based on possessions,
behavioural risk factors, and cardiovascular conditions, stroke incident was estimated.
This status was diversified as follows: married, widowed, divorced or separated, or never
married. It could be stated that women were less likely to be married compared to men.
Additionally, the distribution of risk factors differed according to sex and marital status,
meaning that males had higher incident stroke rates after having controlled for risk factors
(HR, 1.22; 95% CI [1.11-1.34]). In both sexes, never having experienced marriage or
widowhood predicted greater risk. It has to be mentioned in this context that associations
were diminished after adjustment for financial possessions. Additionally, widowed men
had the highest risk compared to married women (HR, 1.40, 95% CI [1.12-1.74]). Lower
income and wealth were linked to comparable high risk across subgroups, even though
this risk factor particularly affected unmarried women, as in this group the lowest income
and wealth levels were documented.
The authors concluded that the incidence of stroke and stroke risk factors differ largely in
terms of sex and marital status. It can be assumed that social experiences differentiated
according to gender, such as marriage and socioeconomic deprivation, mediating pathways,
which interconnect sex and stroke.
5.2.5 Cohousing
Japan and German both face growing issues of an aging society, which are comparable.
A recent Japanese study investigated the influence of life and family background on
delayed presentation to hospital in acute stroke [383]. A classification into three categories,
namely one- or two-person households, and patients living with three or more persons
was conducted, as present in this study. It was stated that one-person (OR, 2.980, 95%
CI [1.108-8.011]) and two-person households with individuals ≥65 years (OR, 3.059,
95% CI [1.297-7.217]) were significant independent factors for delayed presentation, in
addition to stroke subtype, time of stroke onset, and route of admission. Significant delay
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was demonstrated in two-person households with two individuals 65 years and older in
comparison to individuals living with three or more persons (p=0.038). In conclusion,
these results underlined that delayed hospitalisation was more likely in elderly couples,
particularly in those patients who experienced an evening onset of stroke.
Additionally, data from 11 Ontario hospitals including 10,048 patients with acute stroke
(87% ischaemic, 13% haemorrhagic) living at home were analysed [384]. Overall, 22.8%
of all subjects were living alone at home before stroke. It was found that participants
living on their own were more likely to be women (61.5% versus 41.4%), widowed (53.7%
versus 12.3%), or single (21.5% versus 3.8%) and significantly older (mean, 74.6 versus
71.5 years). Individuals living alone were less likely to arrive within a time frame of
2.5 hours (28.3% versus 40.0%; OR 0.54; 95% CI [0.48-0.60]), to receive thrombolysis
(8.0% versus 14.0%; OR 0.52; 95% CI [0.43-0.63]), or to be released home (46.0%
versus 54.7%; OR 0.65; 95% CI [0.58-0.73]).
5.3 Outcomes of stroke and socioeconomic position
Socioeconomic status was reported to be associated with an increased risk of death,
both, at 30 days and one year post-stroke [385], [386]. Additionally, poor survival in those
with less than eight years of education and those in the lowest quartiles of the poverty
index was stated [330]. A recent nationwide hospital-based study in Denmark showed
that the survival of patients with low income was reduced by 30% compared to those with
high earnings [387]. A recent trial analyzing data from hospitals in Luxembourg found
that approximately 50% of survivors had low education and lower income [388].
In the Swedish stroke register, high income, university level education, and being cohabitant
were independently associated with improved survival after first stroke [389]. It can be
assumed that an explanation for this association is multifactorial. Previous research
underlined that individuals with lower SEP suffer from a greater burden of vascular risk
factors and comorbidities as already mentioned above [353], [336], [354] and experience
more severe strokes [354], [390]. Low socioeconomic status is closely related with a
lower likelihood of receiving optimal acute care after stroke [391].
In contrast to this, there have also been publications revealing either no or a weak
association between socioeconomic status and survival [338], [392].
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5.3.1 Stroke severity
Globally, there is some evidence for a connection between low socioeconomic status
and more severe stroke [393], [354], [392]. This was specifically observed in those aged
65 years or older [338]. There were also associations of low socioeconomic status and
the dependency of activities of everyday living at 28 days post-stroke [386], higher levels
of longer term handicap as well as disability [394], [393]. In this context, it has to be
considered that some of these studies were hospital based or had limited recruitment
criteria and restricted potential for adjusting for confounding variables.
On a country level, the Berlin Stroke Register showed that older individuals or female
patients were more likely to have socioeconomic deprivation (SED) and functional impairment
after stroke compared to their male control groups [395]. Additionally, the results revealed
that patients with lower education level had lower rates of functional recovery three
months after stroke.
In this line, the South London Stroke Register emphasized that the effect of SED on
poor functional recovery was predominant among individuals, who were older, female,
and had suffered from an ischaemic stroke. The comprehensive impact on functional
impairment was stronger than that on mortality after stroke [396].
The Swedish stroke register reported an independent association of living alone, low
income, primary school education, and higher case fatality after the acute phase [389].
In addition to this, findings from the Adherence eValuation After Ischaemic stroke Longitudinal
(AVAIL) registry focused on the disability stage after stroke. The results indicated, after
controlling for demographic and clinical factors, that stroke survivors, who were unemployed
or housewives, less educated, disabled, and currently not working, retired or reported to
have inadequate income prior to their stroke, had significantly higher odds of post-stroke
disability [397].
Furthermore, a number of studies underlined an inverse relation between low socioeconomic
status and institutional care after stroke [386], [385], [393], affecting rehabilitation and
general recovery. Structures in residential outcome could display cultural as well as local
differences or material disadvantage in the domestic environment [398].
In summary, patients with lower socioeconomic status seem to have significantly worse
health outcomes in terms of disability and handicap after stroke [399], [290], [354].
The higher disease burden led to a phenomenon called “double suffering”. This term
describes that lower socioeconomic groups have not only a higher incidence of stroke
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and a worse risk profile but are also more sensitive towards functional impairments
[393].
5.3.2 Quality of life after stroke
Following the ten leading causes of death in the world in 2012, stroke ranked on place
two [400], as described in chapter 1.3. As a result, increasing alertness should focus on
improving the quality of life (QOL) for stroke survivors as a rising group in our society.
Several studies stated that specific patient factors, including socioeconomic status, stroke
severity, age, mood, and sex in terms of particularly societal roles, may have an influence
on QOL after stroke [401], [394]. Various trials, but not all, reported worse QOL after
stroke for women than men [402], [403]. This was specifically stated regarding mental
and physical function [403].
The AVAIL registry, a US national, multicenter, longitudinal registry of ischaemic stroke
and TIA patients aimed to determine the incremental impact of demographic, socioeconomic,
clinical, and stroke-specific effects on longitudinal QOL. The results reinforce that women
had worse QOL than men up to 12 months after stroke. This remained stable even
after adjusting for important sociodemographic variables, stroke severity, and disability
[404].
5.3.3 Stroke mortality
Generally speaking, stroke mortality rates are related to survivorship after acute events
and incidence rates. Both influencing factors may be affected by socioeconomic status
[330].
There are alterations in patterns of all-cause mortality regarding the socioeconomic
status. In terms of disease-specific mortality rates, stroke shows one of the strongest
inverse relations with socioeconomic status in Western Europe, the US, and Japan,
increasing with age [405], [406], [407].
A large number of studies confirmed this association between low socioeconomic position
and higher mortality after stroke [408], [389]. In contrast to this, other trials found no
[337], [345] or only a partial association [409], [379]. These discrepancies can originate
from demography, stroke severity, measures of socioeconomic position, study design,
healthcare system organization, and comorbidity [387].
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In a study using World Health Organization data from 35 countries in Europe and Central
Asia, there was an overall decrease of stroke mortality rates between 1990 and 2006 in
countries with the highest economic standard of living. Stroke mortality was considerably
increasing in countries with lower economic standards of living over the same period of
time [410].
The WHO MONICA, which is the Multinational Monitoring of Determinants and Trends
in Cardiovascular Disease Project, can be considered as one of the world’s largest
prospective studies on cardiovascular disorders. In the stroke component, 34,715 stroke
events were registered in 14 populations in Europe, China, and Siberia. The results
suggested that up to 68% of the variation in mortality rates in European countries could
be interpreted by diversities in nations’ gross domestic product. Based on this assumption,
stroke mortality in low income countries such as Russia and Latvia were more than twice
as that of more prosperous countries like Switzerland and France [411].
Trends in stroke mortality rates have been published over the last decades. Mortality
distinctions between socioeconomic groups broadened in the US between 1984 and
1997, despite this overall decrease in mortality. In this regard, the highest socioeconomic
quartile showed the lowest rates [407]. Comparable schemes were reported in Australia,
where the mortality rate declined by 66% to 69% among professional and administrative
workers but only by 38% to 42% among manual workers and farmers between 1969 and
1996 [412]. Further findings on occupational level are stated in 5.2.3.
Cesaroni et al. (2009) found that in both stroke subtypes, ischaemic and haemorrhagic,
deaths out of hospital occurred more frequently in women [337]. This is consistent with
other studies reporting gender differences in recognizing symptoms of both myocardial
infarction and stroke. This often leads to a late referral to the hospital among women
[413] and a higher probability of dying prior to hospitalization [337].
Globally, higher incidence of stroke, stroke risk factors, and rates of stroke mortality
are observed in low compared with high socioeconomic groups within and between
populations [335]. For further details see chapter 1.3 on incidence and mortality rates in
stroke.
In the following, the association of SEP and CHD will be discussed. The focus will be on
MI.
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5.4 General socioeconomic position in coronary heart
disease focusing on myocardial infarction
Cumulative exposure to socioeconomic disadvantage across the life course seems to be
inversely associated with coronary heart disease. Until today, these mechanisms are
not fully understood [414]. Low socio-economic status, lack of social support, stress
at work and in family life along with depression, anxiety, and hostility add to the risk of
developing a CHD. Additionally, the worsening of clinical course and prognosis of CHD
are affected.
In the Framingham Offspring study, cumulative SEP was also associated with incident
CHD after adjustment for age and sex [414]. Overall, low SES is associated with risk for
coronary heart disease independent of traditional CHD risk factors [415].
Socioeconomic influences in early life
As chronic diseases have long induction times, the period between exposure to risk
factors and CHD mortality can extend over decades [416]. The following section will give
an overview on how socioeconomic circumstances are crucial determinants of coronary
heart disease, partly because of their associations with risk factors in adult life. Thus, it
is a logical conclusion that the socioeconomic environment a child grows up in, may also
be decisive to clinically recognized disease in later life [317].
In this line, the majority of prospective studies showed that indicators of less favorable
socioeconomic conditions during childhood were associated with a greater risk for developing
or dying of CHD.
5.5 Risk of coronary heart disease and selected
socioeconomic variables
In this study, the association of MI and education, occupational level, marital status, and
cohousing is investigated. Therefore, the following section will provide deeper insights
into recent findings from international trials.
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5.5.1 Educational and occupational influences
A study by Avendano and colleagues (2005) analyzed longitudinal data from six European
countries from 1981 to 1995 to calculate stroke mortality rates. The status was obtained
for England/Wales, Turin (Italy), Finland, Norway, Denmark and Sweden. The researchers
compared these rates with rate ratios for ischaemic heart disease mortality [324]. Socioeconomic
status was described based on occupational class as well as educational level. A
comparable drop in age-standardized stroke mortality was reported for both, low and
high socioeconomic groups in most countries. This was evident in relative and also
absolute terms. Socioeconomic discrepancies in ischaemic heart disease mortality expanded
in the majority of countries during the observational period.
Additionally, a higher risk of myocardial infarction associated with less than 12 years
of education was reported [328]. The increased risk was independent of age, sex,
race and ethnicity, cigarette smoking, systolic blood pressure, diabetes mellitus, serum
cholesterol level, BMI, and socioeconomic status. Furthermore, the effect of education
on myocardial infarction and stroke seemed to be more striking in persons who were 50
years of age or younger [328].
In a randomized case control study conducted in Greece, in both, patients and controls,
education status was related to economic and occupation status, smoking habits, physical
inactivity, alcohol consumption, and non-compliance to treatment. After controlling for
these and other traditional risk factors as well as for age and sex, an increased coronary
risk of 82% (OR, 1.82, p<0.05) for individuals with a lower level of education was reported.
The risk was enhanced by 65% (OR, 1.65, p<0.05) for participants with an average
education, compared to those with an academic career. Even though the least educated
subjects developed a more adverse lifestyle than those with higher educational level,
the inverse association between education and coronary risk was independent from
such factors. The authors suggested that this inverse association may be a result of
psychosocial differences [417].
Based on analyses of data from a statutory health insurance, an advanced risk for acute
myocardial infarction in men with lower educational level was reported for Germany [418],
[419]. Further studies exclusively focusing on Germany could confirm this relation for
West Germany [420] and the former German Democratic Republic [421]. Bormann and
Schroeder (1994) emphasized an increased MI risk of 32.5% for individuals with at least
12 years of education, whereas people with nine years of educational attainment or less
revealed a risk of already 48% [422].
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As concluding remark, the uneven distribution of strains and stresses in different industrial
sectors and job profiles results in raising rates of early retirement due to diseases, like MI,
or accidents in Germany. The current Report on Poverty and Wealth revealed that men
without completed vocational education had a 5.6-fold risk of early retirement compared
to those with higher education received from technical college or university. Low-qualified
females showed a 2.8-fold risk [423].
5.5.2 Marital status
Within the West German population, modifications in gender roles, social and cultural
norms during the post-war era have resulted in an altered weight of marriage or cohabitation
on health and mortality over time [424].
Trials investigating all-cause mortality among AMI survivors stated a protective effect of
marital status or cohabitation, leading to a negative impact of being single, divorced, or
widowed on long-term [425].
The population-based MONICA and KORA (Cooperative Health Research in the Region
of Augsburg) myocardial infarction registry encompasses data from the city of Augsburg
and two adjoining districts situated in southern Bavaria, Germany. In order to investigate
the effects of marital status on long-term mortality after the first acute myocardial infarction,
a total of 3,766 men and women in the age of 28 to 74 years post 28 days were included.
2,854 participants, which is 75.8%, were married. It could be revealed that marital status
had a strong protective effect in patients with diagnosed hyperlipidaemia, decreasing
with advanced age. However, specific treatments or recommended alterations in lifestyle
adjusted to hyperlipidaemia might have been influenced by the social interference and
contribution of an individual’s spouse [314].
A follow-up study aimed to clarify if statin treatments during the last week prior to AMI
might explain this finding [426]. In fact, prior statin therapy seemed to be an underlying
variable for long-term mortality reduction in married survivors after AMI with hypercholesterolemia.
The authors assumed that, in marriage or cohabitation, beneficial effects of treatment
and/or diet might had a larger impact on patients with diagnosed hyperlipidaemia.
The INTER-HEART China case-control study found that being single was significantly
associated with an increased risk for AMI, especially in women (OR, 2.95; 95% CI [1.99-
4.37]) [427]. However, after adjusting for potential risk factors, the protective effect of
marriage did not persist for men.
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In summary, an increasing number of studies found that total and cardiovascular disease
mortality was higher among those individuals who never married [428]. Older age groups
seem to have a smaller relative risk compared to their younger counterparts.
5.5.3 Cohousing
A prospective register study investigated 302,885 Finnish men and women, aged 40 to
60 years over a period from 1995 until 2007 [429]. Men, who were married, had a lower
risk of MI incidence even after adjusting for socioeconomic factors, namely education,
occupation, income, wealth, and employment status. In this line, the effects of living
arrangements on incidence were fully related to the same socioeconomic factors for
females. It clearly has to be stated that these results revealed that living arrangements
were strong determinants for survival after MI independent of other socio-demographic
variables. These findings underline higher fatality associated with living alone in men.
The social support and regulation provided by marital relationship may especially protect
from MI fatality.
Patients living alone have been reported with poorer clinical outcomes after AMI [430].
Living in a one-person household and/or being unmarried increased the risk of experiencing
a heart attack, deteriorating the prognosis. This was observed for both, men and women
regardless of age [431].
In a prospective cohort study in Denmark, it could be revealed that living in a single
household doubled the risk of death. After controlling for potential confounding factors,
living single was an independent predictor of death (HR 2.55; 95% CI [1.52-4.30]).
Additionally, it was confirmed that patients who live alone had higher long-term all-cause
mortality following AMI (HR, 7.60; 95% CI [1.99-29.08]) [432].
5.5.4 Coronary heart disease mortality and socioeconomic position
Further investigations on mortality showed discrepancies in hospital specific 30 day risk-
stratified mortality rates for patients with AMI. The patient’s socioeconomic status profile
was significantly associated with mortality rates [433].
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In the Health Survey for England, both, psychological distress and low SES were associated
with increased mortality from coronary heart disease after adjustment for demographic
and clinical variables [434].
To conclude, individuals in low socioeconomic position were more vulnerable to the
adverse effect of psychological distress. It has been suggested that persons belonging
to higher SES implement more effective management strategies and take advantage
of larger support networks as well as greater material possessions to cope with the
potentially stressful situations [435], leading to decreased mortality rates.
5.6 General implications of socioeconomic position on
the risk of stroke and myocardial infarction
Despite the fact that numerous trials have researched associations between socioeconomic
status and cardiovascular disease, comparatively few studies have investigated socioeconomic
status and stroke specifically. In terms of an association between SEP and AMI, there is
also a lack of conclusive studies for Germany [436]. The gap regarding socioeconomic
survival after stroke and CHD has remained predominantly unchanged during the 2000s.
Socially underprivileged individuals represent a target group for advanced stroke as well
as MI care and support during or after their hospital stay [389]. All those findings lead
to the conclusion that individuals with a low level of education are relatively unprotected
against acute coronary risk [417] and stroke.
This comparative neglect in research may also mirror past assumptions of homogeneity
in the older population to some extend [437]. As measuring the socioeconomic status of
elderly holds specific complications (see chapter 4), this aspect itself may discourage
research and might lead to hampering in some cases [295]. Innovative acute and
long-term stroke care strategies aiming at people with SED are needed. Those should
specifically target older subjects, as in the present study, and female patients [438].
As a result, public health policy-makers should aim to inform this target group about the
consequences of suboptimal lifestyle in enhancing the risk of developing acute coronary
events. There is a persisting need for gathering of carefully designed research that
will enable the development and testing of new conceptual and empirical models of
the causal pathways through which socioeconomic status affects stroke risk and its
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outcomes [335]. In the course of time, this will simplify and speed up the expansion
of suitably targeted interventions [290].
Throughout Germany, a range of initiatives have been launched aiming at implementing
this policy [439]. As there is an association between socioeconomic status and use of
health services [440], administrators and providers of health care services also need
information on social inequalities at national and regional level [295]. At this point, the
INVADE study wants to contribute to a deepened understanding of local necessities and
socioeconomic differences.
Ideally, any system of measuring socioeconomic status should be based on theoretical
assumptions and rely on data that can be collected rather easily and reliably [441].
Consequently, the present study focuses on well-defined and consistently measured
socioeconomic variables as educational level, marital status, occupational group, and
housing conditions in a rural community based cohort in Ebersberg, southern Bavaria,
Germany. Detailed knowledge about differences in risk factors is fundamental in order to
define targeted and effective stroke prevention and management strategies for the area
in question [335]. The reported results from one country cannot identically be applied to
another country or even area [436]. As the population characteristics of the study cohort
are highly individual, an overgeneralization should be handled carefully.
So far, a description of the diseases focused on in the present study was given, namely
ischaemic stroke, ischaemic stroke including TIA, and myocardial infarction. In order to
evaluate the global impact of those conditions, prevalence, incidence, and death rates
were displayed (see chapter 1.3). A current review of literature has emphasized the
broad range of risk factors for stroke (see chapter 2) and MI (see chapter 3) leading to
these rates. Differences and similarities between those variables increasing the risk for
stroke and MI have been provided. This will help to understand the choice of risk factors
used in the present study. The association between the mentioned risk factors and
specific socioeconomic aspects will be investigated in the INVADE cohort. Consequently,
an overview of the general socioeconomic circumstances in life and their impact on
health was underlined (see chapter 4). Subsequently, the specific association of educational
level, occupation, marital status, and cohousing with stroke or MI was discussed in the
present chapter. These findings provide the opportunity to compare the results stated in
this study (see chapter 8) with conclusions drawn from current literature. This will enable
to deduce implementations of the reported findings (see chapter 9).
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6 Motivation
The present chapter will summarize the immense burden of disease and will give an
insight in the complex and various mechanisms which come into force after having
suffered from stroke.
6.1 Burden of stroke
Stroke has a comprehensive tragic personal impact on patients and their families. Moreover,
it shows overwhelming financial strain on the economy [11]. The following chapter will
delve deeper into the facets of the burden of stroke.
6.1.1 Global burden of risk factors for stroke
The Global Burden of Diseases 2010 studies identified three general major risk factors
for disease burden, namely high blood pressure, smoking of tobacco involving second-
hand smoke as well and the consummation of alcohol [183]. Furthermore, these three
risk factors were rated in the top three for numerous low- to middle-income regions,
including Central and Eastern Europe, Central Asia, and Southern Latin America. Nearly
70% of all incident stroke occur in low- to middle-income countries [8]. Additionally,
lifestyle factors, such as poor fruit intake and low physical activity as well as high sodium
intake made 10% of disability-adjusted life years (DALY) in 2010. These risk factors
substantially contribute, along with non-modifiable variables like sex, age, and race/ethnicity,
to the incidence of stroke [188]. Those variables and their impact have been be discussed
in detail in chapter 2.
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6.1.2 Psychological burden in patient
It can be stated that depression is the most frequent psychiatric disorder which exerts an
immense impact on patients with stroke. Depressive symptoms following stroke could
add to post-stroke morbidity and mortality [442]. Based on cohort characteristics and
diagnostic criteria, the prevalence of post-stroke depression varies substantially across
studies. Nevertheless, it can be underlined that it is considerably higher compared to
control populations after having controlled for sex and age [443]. In general, younger
age, poor functional outcome, previous diagnosed depression, and not being able to
fulfil a profession three months after stroke are linked with post-stroke depression at 12
months [444], [443]. The annual incidence of depression post-stroke was estimated from
7% up to 21% [445].
Skolarus et al. (2014) found that depressive and anxiety symptoms were independently
associated with participation restrictions within patient’s family and friends as well as
religious communities. Additionally, aphasia and/or dysarthria can impede social activities.
This clearly emphasizes the serious need of a timely diagnose. Improving physical
capacity, treating depression, and anxiety in addition to focusing on aphasia and dysarthria
has high potential to contribute to the quality of life of stroke survivors and their social
environment [446]. Consequently, systematic evaluation for depression in this patient
population should be integrated into daily clinical routine [447].
6.1.3 Psychological burden in caregivers
Psychosocial distress of caregivers should also be considered as crucial and need to be
addressed adequately in this context [448]. Culminated stress of caregivers is a common
reason for eventual institutionalisation of the stroke survivor. Frequently, this experience
leads to additional psychological and physical health compromise for the caring relative
[449]. Again, critically assessing of and providing for physical, psychosocial, and educational
support requirements of nursing relatives will assist in alleviating the daily burden and
prepare for future challenges [450]. Programmes focusing on training in time management
and coping strategies as well as respite care provision could be advantageous. This
approach might contribute to diminish the burden of caregiving. Additionally, it would
certainly also have a beneficial influence on the stroke patient himself [451], [452].
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6.1.4 The concept of treatment burden in stroke
“Treatment burden” is a rather novel approach describing self-care procedures that patients
with chronic disease must meet to execute management strategies and respond to the
demands of health care systems as well as providers [453], [454]. It involves information
gathering, taking medications, meeting numerous appointments as well as enacting self-
care and financial management to pay for treatments [455].
Individuals rather diverge in their capacity to accommodate and achieve such practices,
which may have a considerable impact on patient functioning and well-being [453], [456]
and on the above mentioned adherence to scheduled management plans [457], [458].
This coping capability is based on environmental variables such as social support and
financial constraints [459]. Additionally, internal factors like health literacy and resilience
play a fundamental role [460].
Current research suggests that treatment burden can overpower patients in exceeding
their coping threshold thus resulting in ineffective treatment and wasted resources [461],
[462]. A recent systematic review of literature revealed that patients with history of stroke
indicated four main areas of treatment burden, namely interacting with other individuals,
making sense of stroke management and planning care, realizing management strategies,
and reflecting on management [454].
Non-adherence to management strategies by patients with chronic disease is a worldwide
health problem [457]. This fundamental issue in chronic disease management is well
acknowledged by the World Health Organization but not fully grasped yet. It has immense
potential to result in negative outcomes for patients in terms of morbidity and dissipated
investment for health care systems [463]. As a result, there is growing concern in the
concept of treatment burden internationally [453], [456].
It is well described that treatment for, and rehabilitation from stroke can be a prolonged,
laborious process, demanding substantial personal input from the affected patient [464].
Gallacher et al. (2013) found that stroke patients spend a significant amount of time and
energy seeking out, cognitively handling, and reflecting information about the management
of stroke [454], as mentioned before. On a global level, it can be stated that the supply
and distribution of this information by health services is presently insufficient. Those
findings match with previous research on treatment burden in heart failure patients [456],
[465].
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A recent Cochrane review on information provision to stroke patients suggested that an
amelioration in patient knowledge would raise patient satisfaction and could also lead to
a small reduction in depression [466].
Similar to patients with heart failure, shifts from intensive care environments or rehabilitation
institutions to self-depended and community-based services can substantially alter the
burden of treatment from professionals to patients and their caregivers. In a recent
investigation, patients and caregiving relatives judge themselves constantly burdened
and described inadequate support from health care services [454].
Understanding restrictions in participation and the role of capacity is fundamental to
improve stroke survivorship [446].
6.1.5 Economic burden
Situation worldwide
To facilitate health policy planning, it is compulsory to comprehend projected future
prevalence and cost of stroke. This approach enables to determine potential actions
that could lead to a reduction of the economic strain.
The long-term direct costs include spending for inpatient stays, outpatient visits, rehabilitation,
prescribed medicines, home health care, and nursing home [467]. In the US, direct
expenses for non–nursing home stroke care comprises more than 10.7% of the so-called
medicare budget, which is a national social insurance program, administered by the US
federal government, and more than 1.7% of overall national health expenditures [52].
The total annual direct costs were estimated at $22.8 billion in 2009 for the United
States [468] and e26.6 billion in 2010 for the European Union plus Iceland, Norway,
and Switzerland [469].
Additionally, there are indirect costs derivable from premature mortality and lost productivity
for stroke survivors [470]. Furthermore, costs of informal caregiving usually provided by
unpaid family members need to be considered in this matter as well.
Heidenreich et al., (2011) predicted that annual indirect costs will raise in the US from
$27 billion in 2010 to $47 billion in 2030 [244]. The attributable one-year cost of post-
stroke aphasia was predicted at $1,703 in South Carolina, US [471].
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In the US, the direct and indirect cost of stroke in 2010 was $36.5 billion [52]. The mean
lifetime costs of ischaemic stroke were estimated at $140,048. This involved inpatient
care, rehabilitation as well as follow-up care necessary for enduring disabilities [472]. In
the period of 2012 to 2030, total direct medical stroke-related expenses are projected to
triple. A range from $71.6 billion to $184.1 billion is expected, with the majority of the
projected raise in costs arising from those patients aged 65 to 79 years [11]. Inpatient
hospital costs for an acute stroke event can be attributed to 70% of first-year post-stroke
costs [472].
It clearly has to be stated that the indirect expenses are greater than all direct costs
combined [470].
Situation in Germany
In Central Europe, a similar development has risen in Germany. As the ongoing aging of
the German population will still increase in coming decades, the potential raise in stroke
costs is fundamental. The combination of an aging population, declining stroke case-
fatality rates, and to some extend limited success in reducing the incidence of stroke led
to this increase in the prevalence of stroke survivors.
In Germany, cardiovascular diseases accounted for the biggest single item of health
expenses with e35 billion per year in 2002. In an international comparison per capita
expenditure, Germany ranked in the upper middle group of western industrialized nations
[30].
The total cost of illness in Germany was aboute223.6 billion in 2002, with cerebrovascular
diseases such as strokes accounting for e7.8 billion and ischaemic heart diseases such
as cardiac infarction for e7 billion (see figure 6.1).
Based on data from the Erlangen Stroke Registry, hospital care during the first quarter
of one year after stroke was the largest component of the costs, accounting for at least
40% [473]. The length of stay in institution care can be described as the main factor
influencing the expenses accrued during the acute stage.
The overall cost per first-year survivor of first ischaemic stroke is predicted to bee18,517.
Rehabilitation procedures attributed with 37% to this amount. In consecutive years,
outpatient care was the major expense factor [474].
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Figure 6.1
Development of health expenditure in Germany [30].
Kolominsky-Rabas et al. (2006) estimated that the overall discounted lifetime costs per
case were e43,129. Additionally, higher expenses in men (e45,549) than in women
(e41,304) were reported.
National projections for the period of 2006 to 2025 identified 1.5 million new cases of
ischaemic stroke in men and 1.9 million in women. Current costs of e51.5 billion for
males and e57.1 billion for females were underlined [474]. As the number of stroke
patients and the healthcare expenses for strokes in Germany will rise steadily until 2025,
stroke prevention and reduction of stroke-related disability should be considered first
concerns in health planning policies [475], [474], [476].
6.2 Burden of coronary heart disease
As already mentioned before, the center of attention in this thesis lays on ischaemic
stroke. For the sake of completeness, the following paragraph describes the global
burden of coronary heart disease, focusing on myocardial infarction.
The burden of CHD is composed of years of life lost from CHD deaths and years of
disability lived with mainly three sequelae of disease which are non-fatal. This includes,
as mentioned before (see 1.2), non-fatal acute myocardial infarction, angina pectoris,
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and ischaemic heart failure.
The Global Burden of Disease 2010 Study analysed projected global and regional estimates
of acute myocardial infarction incidence by sex, age, and global region in 1990 and 2010
[477]. This investigation was based on data from a systematic review and nonlinear
mixed-effects meta-regression methods. It could be revealed that age-standardized
acute myocardial infarction incidence decreased worldwide in the period from 1990 to
2010.
Additionally, the global burden of CHD raised by 29 million DALY in the same timeframe,
which is an increase by 29%.
Approximately 32.4% of the growth in global CHD disability-adjusted life-years was derived
from aging of the world population, while 22.1% was attributable to population growth.
Furthermore, total DALY were attenuated by a 25.3% decrease in per head CHD burden.
Moreover, the amount of individuals living with non-fatal CHD elevated more than the
number of CHD deaths since 1990, but more than 90% of CHD DALY in 2010 were
directly linked with CHD deaths.
In 2006, in-patients costs per discharge for AMI were $14,009. Generally speaking,
the estimated expenses, taking together direct and indirect cost of CVD for 2010, were
$315.4 billion [52]. By 2030, total direct medical costs of CVD are projected to raise
to a level of $918 billion based on methodology described by Heidenreich et al. (2011)
[244].
In summary, it can be stated that decreased age-standardized fatal and non-fatal CHD
were documented in most regions since 1990. Nevertheless, population increase and
general aging resulted overall in a higher global burden of CHD in 2010.
6.3 Research question
As coronary heart disease is known to be the first and stroke the second leading cause of
mortality in the industrialized world and future generations need to balance the complex
burden described above desperately, this study is more relevant than ever. For further
details see figure 1.5 displaying causes of death in high income countries per deceases/100,000
residents.
Bearing all these aspects in mind, the basic objective which drives the present study,
is the investigation of risk factor impact such as age, sex, diabetes mellitus, arterial
hypertension, atrial fibrillation, lack of movement, LDL/HDL levels, adiposity, alcohol
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consumption as well as smoking on the incidence of ischaemic stroke, ischaemic stroke
including TIA, and myocardial infarction in a population-based cohort in a rural area of
Germany, called Ebersberg.
There is an urgent need to understand how socioeconomic factors like education, family
status, occupational level, and living conditions affect the occurrence of stroke and MI
on a local level. This would enable an implementation of these findings in future long-
term health care management programs focusing on prevention and medical education,
adapted to regional demands and on multiple levels in daily life.
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7 Methods
The following investigation is based on data derived from the INVADE study, which was
launched in 2001. The present trial is a prospective and population-based cohort study in
elderly focusing on stroke and myocardial infarction prevention as well as health related
education. The observation period ended on 31th May 2008.
7.1 Project aims
The general purpose of the INVADE project is the recording and investigation of epidemiological
data in a clearly defined geographical area in Ebersberg, south Bavaria, Germany.
This enables the consequent treatment of revealed risk factors based on World Health
Organization and American Heart Association recommendations. Furthermore, particular
health care requirements shall be revealed based on specific socioeconomic circumstances
in the targeted area.
The main objective of this study is the long-term reduction of ischaemic stroke including
TIA and MI incidence based on a systematic registration of vascular events, specific
treatment of modifiable risk factors, and targeted health education on administrative
district level in close cooperation with primary medical care.
7.2 Endpoints
In the present study, the association of ischaemic stroke, ischaemic stroke including
TIA, and MI with educational attainment, cohousing, marital status, and occupational
level was investigated. Accordingly, the following five endpoints were considered in the
present study. The incidence of ischaemic stroke, ischaemic stroke including transient
ischaemic attack, and the occurrence of myocardial infarction. The forth endpoint is
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marked by participant’s death and lastly, the end of the Allgemeine Ortskrankenkasse
(AOK) insurance period. All endpoints are summarized in table 7.1.
Table 7.1
INVADE study endpoints
Five study endpoints
1. Incidence of ischaemic stroke
2. Incidence of ischaemic stroke including transient ischaemic attack
3. Incidence of myocardial infarction
4. Death unrelated to ischaemic stroke, TIA, MI
5. Termination of the AOK insurance period
7.3 Responsible persons in research organisation and
management
Two clinical branches of the University Hospital Klinikum Rechts der Isar, Technical
University Munich were involved conducting the study. PD Dr. D. Sander and Prof.
Dr. B. Conrad managed the study centre at the “Neurologische Klinik der Technischen
Universität München, Klinikum Rechts der Isar“, while Dr. H. Bickel and Prof. H. Förstl
were in charge of the study at the „Psychiatrische Klinik der Technischen Universität
München“.
The local organisational management was administered by Dr. H. Gnahn, supported by
Dr. C. Briesenick from the „Qualitätszirkel für Neurologie und Psychiatrie/Psychotherapie
im Landkreis Ebersberg“.
Immediate patient care and data collection was operated in general practitioners’ (GP)
practices in the administrative district of Ebersberg, in cooperation with the “AOK Bayern”
and the “Stiftung Deutsche Schlaganfallhilfe”. The partnership of INVADE with the health
insurance company AOK is based on the interest in their insured persons’ well-being as
well as decreasing the cost for medical care and rehabilitation following vascular events.
An overview of those immense expenses is given in chapter 6.1.5 on the burden of
disease.
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7.4 Aim of the study
As stroke is known to be the second leading cause of mortality in the industrialized world,
developing and establishing effective prophylaxes and therapies are of high interest
[478]. The global situation as well as the current state in Germany has been discussed
in chapter 1.3.
Before the INVADE study was conducted, epidemiological trials have been operated in
the Federal Republic of Germany as well. On the one hand, the Erlangen stroke project
[32] was originated, on the other hand, there was an epidemiological stroke register
in the former German Democratic Republic within the WHO-MONICA-Projects in east
Germany [479]. Both trials made valuable contributions to the epidemiological research
on stroke in Germany.
Therefore, the aim of the present study is to fill this gap by analyzing the impact of
conclusive socioeconomic variables, namely education, family status, occupational level,
and living conditions on the incidence of ischaemic stroke, ischaemic stroke including
TIA, as well as myocardial infarction in a specific regional area in south Bavaria. As an
individual’s socioeconomic position in life is closely linked to his or her health condition
over the course of life (see chapter 4 and 5 on SEP in general and related to stroke/myocardial
infarction), a deeper insight in social inequalities in this specific area could enable the
development of concrete procedures to compensate this imbalance. A cooperation
between politics, health care providers, and medical support on-site could lead to a
further step in optimization of stroke prevention measurements and management policies.
As stated in the chapters above, socially deprived citizens represent a higher incidence
and greater risk profile of suffering from stroke as well as myocardial infarction, along
with greater disability rates [290]. This leads to a “double suffering” on this social level
[393].
Additionally, this population at risk is in need of expanded care systems and support
during as well as after hospitalization. As a result, forthcoming long-term health care
management concepts aiming at medical education for prevention could enable customized
answers to regional requirements to address the various and often interconnected layers
of continued health and well-being in the addressed population.
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7.5 Study protocol
7.5.1 Time frame
The total duration of the INVADE study was set up for eight years. Patient recruitment
was conducted in the first two years of the investigation. The baseline phase was carried
out from 2001 to 2003.
7.5.2 Design
INVADE is a prospective project on an administrative district level. All potential subjects
were identified in the AOK database and then asked via mail to participate in the INVADE
trial.
7.6 Study population
7.6.1 Inclusion criteria
All subjects had to be inhabitants of the community of Ebersberg, Germany. Ebersberg
consists of 31 municipalities in total. Additional inclusion criteria were the membership in
the health insurance company AOK and birth in or before 1946. Lastly, a signed patient
information and informed consent had to be present.
A total number of 3,908 participants were included in the present analysis based on the
inclusion criteria mentioned above. Table 7.2 displays the study inclusion criteria.
Table 7.2
INVADE inclusion criteria
Four inclusion criteria
1. Residence in Ebersberg
2. Health insurance by AOK
3. Birth ≤1946
4. Signature of patient information and informed consent
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7.6.2 Ethical approval
The research project was approved by the ethics committee of the University Hospital
Klinikum Rechts der Isar, Technical University Munich. An additional submission was
made to the ethics committee of the State Medical Council of Bavaria. All clinical
investigations were conducted according to the principles stated in the Declaration of
Helsinki.
7.6.3 Data privacy protection
The attorney Dr. Baierl was in charge of the data protection. The place of business was
located in Ebersberg. The data security concept was coordinated and agreed with the
state data protection commissioner in Bavaria.
7.6.4 Informed consent and patient information
In the beginning of the study, an informed consent had to be signed and dated by all
participants. Patient information and informed consent were stored in a safe place.
Those documents were added to the patient documentation.
The primary or referring physician informed the patient about requirements and intentions
of the planned project. The right to refuse the participation at any point of time in the
study was underlined. The patient information was handed out in written form. Further
questions could be addressed and have been answered thoroughly at all times of the
trial. Additionally, every patient had to agree with a storage of his or her medical data
and biosamples followed by a data transfer in order to practice data analysis at the
corresponding sites.
7.6.5 Project course
A total number of 65 general practitioners of the district of Ebersberg conducted the
baseline investigations. This was composed of a standardized questionnaire (see appendix)
followed by a physical examination, the evaluation of multiple risk factors as listed below,
the patient’s medical and disease history, and a 12-lead ECG. Moreover, an overnight
105
Methods
fasting venous blood sample was taken for subsequent analysis carried out by a central
laboratory Bieger, Munich, Germany.
Assessment of risk factors
The following risk factors have been evaluated based on questionnaires, physical examinations,
and laboratory measurement: arterial hypertension, ankle-brachial index, atrial fibrillation,
dyslipoproteinaemia, diabetes mellitus, hyperhomocysteinaemia, body mass index, intima
media thickness, cognitive and depressive disorders, current medication, nicotine, and
alcohol consumption besides the amount of physical activity. A detailed overview of all
these factors and their association with ischaemic stroke and myocardial infarction is
provided in chapter 2 and 3.
Going into greater detail, general sociodemographic data was collected by the questionnaire
(see appendix), filled in by patient and doctor. Among other variables, the questionnaire
assessed marital, educational, and occupational status as well as living conditions at
home.
Former episodes of ischaemic stroke and/or TIA and myocardial infarction were recorded
additionally. In cases of indictment of depressive or cognitive disorders, a diagnostic
clarification was recommended.
Entry examination
Additionally, all subjects received a duplex ultrasonographic examination of the carotid
arteries to measure common carotid artery intima-media thickness. This was in accordance
with a standardized protocol in eight local practices, internally qualified as centers of
excellence. Data captured from these eight experienced investigators were stored on
video or digital audiotapes. Subsequently, the data was transferred to the neurovascular
laboratory of the Department of Neurology, and digitalized if needed. The measurements
of mean common carotid artery IMT (intima media thickness) were performed based on
a computer-supported image analysis system, namely Sigmascan-Pro 5.0, SPSS. In this
way, the progression of early carotid atherosclerosis could be monitored.
Based on the available risk profile, the GP initiated specific treatment measures in accordance
with the catalogue of criteria in the INVADE project. The design of these risk profiles
was based on the Framingham risk tables for cardiovascular [480] and cerebrovascular
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events, respectively [481]. Detail regarding the population at risk can be seen in chapter
2 and 3.
Follow-up visits
Following the baseline investigation, patients were continuously monitored for major
events through linkage of the study database with the three-month visit files from the
primary care physicians, the AOK database, and the municipality. If an event was
recorded, additional information was retrieved through hospital reports, autopsy records,
or death certificates.
After the first period of two years, the complete follow-up investigations for this time
period were available for 3,478 participants (98.5%). Intervention measurements were
documented on an ongoing basis. Furthermore, the compliance of the subject, the
efficiency of the treatment, and a re-evaluation of previous findings were assessed.
At intervals of two, four, and six years after baseline, a comprehensive follow-up examination
was scheduled, in which a complete re-assessment of the risk factors, laboratory examinations,
and the self-performed questionnaires (see appendix) were performed after the base-
line examination. Over the period of eight years, this resulted in four cycles of the basic
examination.
Laboratory examinations
Overnight fasting venous blood samples were collected by the according GP. The samples
were sent to a central laboratory to evaluate the following parameters: C-reactive protein,
creatinine, blood sugar, HbA1c, total cholesterol, lipoprotein(a) and homocysteine, and
LDL as well as HDL cholesterol measured in serum. The ankle-brachial index is the ratio
of the SBP measured at the ankle to that measured at the brachial artery. It can serve
as a prognostic marker for cardiovascular events [482].
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7.7 Study variables
7.7.1 Traditional risk factors
According to the International Statistical Classification of Diseases and Related Health
Problems, 10th revision (ICD-10), ischaemic stroke (I63) was defined as a neurological
deficit that persisted longer than 24 hours.
Stroke was only considered after the confirmation of a neurologist. A TIA was characterized
by a neurological deficit that endured less than 24 hours, again assessed by a neurology
specialist (ICD-10 I63, G45). Diagnosing by medical professionals can clearly be seen
as an advantage of this study [483].
Myocardial infarction was defined as ICD I21, namely as disorder characterized by gross
necrosis of the myocardium due to an interruption of blood supply to the area in question
[483]. Analysing patient’s history, no cases of I22 (subsequent ST elevation and non-
ST elevation myocardial infarction) and four cases of I24 (other acute ischemic heart
diseases) were present. Consequently, the last two classifications were excluded in the
present analysis.
A comprehensive and state-of-the-art definition for ischaemic stroke, TIA, and MI are
given in chapter 1.2.
Myocardial infarction and ischaemic stroke were diagnosed according to recent recommendations
by the involved GPs, resulting in carefully standardized and verified cases of ischaemic
stroke [484], TIA and myocardial infarction [485].
To get a better understanding of the chosen variables in this study, refer to chapter 2
regarding risk factors for stroke and TIA as well as chapter 3 focusing on risk factors for
myocardial infarction.
Age and sex
Apart from age and sex, which are well known confounding factors for stroke, TIA [74]
and MI [235], a description of the study variables in terms of risk factors are displayed
in the following section. The careful selection of those specific variables is based on
current research on well-documented modifiable and less well-documented or potentially
modifiable risk factors.
108
Methods
Hypertension
Arterial hypertension was defined as blood pressure above 140 and 90 mmHg measured
in a standardized fashion and/or the use of any antihypertensive medication. The classification
and definition of hypertension in table 7.3 is displayed in the study protocol.
Table 7.3
Thresholds of hypertension
Category Systole Diastole
Optimum <120 <80
Normal <130 <85
High normal 130-139 85-89
Mild hypertension (grade 1) 140-159 90-99
Moderate hypertension (grade 2) 160-179 100-109
Severe hypertension (grade 3) ≥180 ≥110
Isolated systolic hypertension ≥140 < 90
In the results section, it was focused on clinical significant values of SPB ≥140 mmHg
and DBP ≥90 mmHg.
High-density and low-density lipoprotein
Primary dyslipidaemia can be classified in three groups:
Table 7.4
Classification of dyslipidaemia
1. Hypercholesterolaemia (elevated LDL cholesterol)
2. Combined hyperlipidaemia (elevated LDL cholesterol and triglyceride)
3. Isolated hypertriglyceridaemia (elevated triglyceride)
Total HDL and LDL concentrations were measured in mg/dL.
Atrial fibrillation
Atrial fibrillation had to be diagnosed by a GP and documented in the patient’s history.
An ECG was applied additionally to verify the condition.
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Diabetes mellitus
A treatment with anti-diabetic drugs or overnight fasting serum glucose levels ≥126
mg/dL defined diabetes mellitus in this study.
Body mass index
The body mass index was calculated as weight in kilograms divided by height in meters
squared. A BMI >30.0 kg/m2 was defined as obese.
Physical activity
At baseline, physical activity was determined by asking participants the number of days
per week they performed strenuous activities, like walking, hiking, bicycling, swimming,
gardening, or another type of exercise (see appendix).
In this study, the activity performance was divided into two levels, i.e. not active (no
activity) versus moderately active (physical exercise less than three times a week) and
very active (physical exercise at least three times a week) taken together.
Dichotomization was applied to prevent too small cell formation.
Alcohol consumption
A subject’s average alcohol consumption was addressed by the entry questionnaire (see
appendix). Intake of no alcohol in contrast to <7 drinks per week up to ≥21 drinks per
week was chosen. One drink was defined as either one glass of wine (0.2 l) or beer (0.5
l) or one shot of spirit (0.02 l), which is about the same amount of pure alcohol.
Cigarette smoking
In terms of consumption of nicotine, three grades were registered: never having smoked
cigarettes, previous or present smoker. For this analysis patients were stratified in two
groups, namely current or previous smoking versus no smoking experience, again to
gain meaningful data.
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7.7.2 Socioeconomic variables
Educational status
Education was classified as low level (primary school qualification: “Volksschulabschluss”
or secondary school certificate: “Hauptschulabschluss”) or no school leaving qualification
at all versus intermediate/higher education (secondary modern school certificate: “Realschulabschluss“,
polytechnic degree: “Fachhochschulabschluss“, A-level: “allgemeine Hochschulreife“, or
university degree: “Hochschulabschluss”).
Marital status
Married individuals or those living in cohabitation were classified against subjects who
stated to be single, were divorced, or widowed.
Housing conditions
In terms of living conditions at home, a differentiation between individuals living alone
and individuals living in a group of two or more people was chosen.
Occupational group
Regarding a subject’s occupation, never having worked in an employment was compared
with having pursued a career. Additionally, current employment was investigated as
opposed to retirement at baseline.
7.8 Statistical analysis
Multivariate Cox regression was used to calculate hazard ratios and analyse the association
between risk factors, socioeconomic variables, and the incidence of ischaemic stroke,
TIA, or MI.
All multivariate analysis were adjusted for traditional covariates according to the literature
(see chapter 2 for stroke and chapter 3 for myocardial risk factors, respectively). These
were age at baseline, sex, hypertension, high-density lipoprotein as well as low-density
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lipoprotein, atrial fibrillation, diabetes mellitus, BMI, physical activity, alcohol consumption,
and cigarette smoking to give an unbiased estimate for the relation between baseline
status and incident events. Calculations were performed with JMP 5.01 software (SPSS
Inc.). A p-value of <0.05 was considered to be statistically significant. For ischaemic
stroke including TIA, ischaemic stroke, and MI, one model was calculated, respectively.
7.8.1 Time-to-event analysis
In time-to-event analysis or survival analysis, clinical trials usually document the length of
time from the beginning of the study to an endpoint defined by a disease or a treatment
[486]. Generally, these data are displayed in a Kaplan-Meier curve, from which the
median (time at which 50% of cases are resolved) and the mean (average resolution
time) can be read [487], [488].
By making comparisons between the number of survivors in each group at multiple points
in time, this method becomes effective [486].
The alternative approach would be to exclude patients, who are lost to follow-up but this
might lead to considerable bias. The data generated by these patients prior to their exit
of the trial is crucial to the validity and the power of the study [486]. Consequently, this
study aimed at high completion rates in follow-up.
Additionally, time-to-event analysis is able to include information about subjects that may
change over time. Those are called time-dependent covariates. Clinically important
differences in the effect of treatment could be concealed if the proportions of survivors
or recovered individuals in the treatment group are only compared to that of the control
group at a single point in time. For example, this could be the conclusion of the trial
[488]. Consequently, survival analysis can be a potentially more powerful and informative
method of analysis [486].
7.8.2 Censored data
Survival analysis also provides a method to include patients, who fail to complete the
trial or do not reach the study endpoint. This is crucial, as a significant feature of survival
times is that the event of interest is very rarely observed in all subjects. Such survival
times are called “censored”. It indicates that the period of observation was cut off before
the event of interest occurred [489]. Examples for censoring are individuals who do
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not experience the event before the study ends, study subjects who are lost to follow-
up during the study period, and persons withdrawn from the study because of death, if
death is not the event of the interest [490].
Data can be left or right censored. Usually, right censored data is encountered. Additionally,
data is left censored if the patient had been on risk for disease for a period of time prior
to entering the study. Nevertheless, left censoring is usually manageable, as the starting
point is generally defined by a specific event. This could be the entry of the patient in the
trial, his or her randomization or the occurrence of a procedure or treatment [491].
7.8.3 Cox proportional hazards model
There are a number of methods available to analyse time-to-event curves [492]. The
Cox proportional hazards, log-rank, and Wilcoxon two-sample-test are some examples
[490]. Over many years, the Cox proportional hazards model has been the most widely
used procedure in medical research in this field of interest [493], due to its applicability
to a wide range of clinical studies [494], [495]. The Cox model is a semiparametric
regression method for survival data and used to investigate several variables at a time
[494]. It provides an estimate of the hazard ratio and its confidence interval [486].
The procedure regresses the survival times, or more specifically the so-called hazard
function, on several explanatory variables [496], [497]. The Cox regression is also known
as proportional hazards regression analysis [489], [498].
7.8.4 Survival function
The survival function, S(t) describes the probability that a person survives longer than
some specified time t. It gives the probability that the random variable T exceeds the
specified time t. The survival function is elementary to a survival analysis and is often
expressed as a Kaplan-Meier curve as mentioned above [490]. This curve measures the
fraction of subjects living for a certain amount of time after an event.
7.8.5 Hazard function
The hazard function is the probability that an individual will experience an event (e.g.
death) within a small time interval, given that the individual has survived up to the
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beginning of the interval. Consequently, it can be interpreted as the risk of dying at
time t. The hazard function, h(t), can be estimated based on the following equation
[489].
h(t) = number of individuals expecting an event in interval beginning at t
(number of individuals surviving at time t) ∗ (interval width)
7.8.6 Hazard ratio
The hazard ratio is an equivalent to the odds that an individual in the group with the
higher hazard reaches the trial endpoint first [486]. This rate is the probability that if the
event in question has not already occurred, it will take place in the next time interval,
divided by the length of that interval. As the time interval is made very short, the hazard
rate actually shows an instantaneous rate [486].
A fundamental assumption of proportional hazards regression is that the hazard ratio
stays constant over time [499]. Therefore, the hazard ratio indicates the relative likelihood
of disease resolution in treated versus control subjects at any given point in time in clinical
studies which have disease resolution as the endpoint [486].
The hazard ratio deriving from this model serves as a statistical test of treatment efficacy
and an estimate of relative risk of events of interest [486].
7.8.7 Regression coefficient
The interpretation of the Cox model includes examining the coefficients for each explanatory
variable. A positive regression coefficient for an explanatory variable marks a higher
hazard. Consequently, the prognosis is worse. Conversely, a negative regression coefficient
involves a better prognosis for patients with higher values of that variable [489].
7.9 Statistical implementations for this study
The three primary goals of survival analysis are first, to estimate and interpret survival
and/or hazard functions from the survival data. Second, to analyse survival and/or
hazard functions, and lastly, to assess the relationship of explanatory variables to survival
time. Survival analysis provides a valuable tool for analysing the time to an event type
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of data. In this study, these events are death, end of insurance period, ischaemic stroke
ischaemic stroke including TIA, or myocardial infarction (see 7.2). Those endpoints
deliver right censored data.
The Cox proportional hazards model is the method of choice in this study as it is both,
flexible and powerful.
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8 Results
8.1 Population characteristics
After having identified 10,325 potential study subjects in the AOK database, data from a
total of 3,908 participants fulfilling all inclusion criteria (see 7.6.1) were analysed in this
study. 1,600 (40.9%) men and 2,308 (59.1%) women were included with age ranging
from 53.74 to 101.85 years (SD= 7.8). According to the AOK database more than 40%
of all inhabitants of the district of Ebersberg aged >55 years were insured by the AOK.
Following the official population census at the beginning of the study, the district of
Ebersberg was populated by 119,000 inhabitants [500]. The AOK had and still has a
market share of >40% in Bavaria [501].
About half of the cohort had lived in the district of Ebersberg for more than 50 years.
3,674 (94.0%) have been residents in this area for ≥10 years. 867 (22.3%) had seen
their GP less than once quarterly. Additionally, 877 (22.5%) participants had reported an
inpatient treatment in the past year (table 8.1).
Table 8.1
Age of study subjects and characteristics of a general practitioner consultation
Characteristics Men (n=1,600) Women (n=2,308) Total (n=3,908)
Age, mean±SD, y 66.7±7.1 68.5±8.1 67.7±7.8
Duration of residency in
district, mean±SD, y
44.4±20.0 45.5±20.7 45.0±20.1
GP consultation less
than once a quarter
391 (24.5%) 476 (20.7%) 867 (22.3%)
Inpatient treatment in
past 12 months
371 (23.2%) 506 (22.0%) 877 (22.5%)
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8.1.1 Patients lost to follow-up
Patients, who were lost to follow-up are described in the section below. An overview of
in- and exclusion criteria is given under 7.6.1.
3,374 participants were still insured by the AOK until the end of the trial in 2008.
In total 534 cases lost to follow-up were registered. 57 (1.5%) of them were documented
due to a termination of the insurance relationship and 477 (12.2%) due to death during
the trial period. Among other unspecified reasons, those deaths also include the study
endpoints, namely ischaemic stroke including TIA, ischaemic stroke, and MI. The average
age at death was 74.41 years (SD= 8.7).
Two (3.7%) individuals of the 57 drop-outs due to termination of the insurance period
had an ischaemic stroke including TIA and one (1.9%) experienced an ischaemic stroke.
No myocardial infarction was documented.
The category “ischaemic stroke including TIA” was chosen, as both conditions are medically
closely related (see 2) and sometimes difficult to distinguish. In order to investigate, if the
comparable risk factors for ischaemic stroke and TIA show commensurable outcomes,
this classification was applied. In that way, ischaemic stroke alone can be compared to
the overlapping category of ischaemic stroke and TIA. Consequently, data lost due to
unspecific diagnosing is minimized.
38 (70.4%) subjects who dropped out after to the end of the AOK insurance period had no
degree or finished secondary school (“Hauptschule”). Furthermore, 16 (29.6%) finished
secondary modern school (“Realschule”) or had a high school graduation (“Abitur”).
Additionally, 38 (70.4%) patients were married. Seven (13.0%) individuals were living
alone.
8.1.2 Baseline characteristics
The mean systolic blood pressure was 139.4 mmHg (SD= 17.8), while the diastolic blood
pressure was reported with 82.2 mmHg (SD= 9.4).
The most common disease documented by the GP was arterial hypertension with 2,242
(57.6%) individuals. 420 (32.5%) of the participants with diagnosed and treated hypertension
showed blood pressure in the target range of <140/90 mmHg. At baseline, 1,967 (50.3%)
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had a systolic blood pressure ≥140 mmHg and 947 (24.2%) a diastolic blood pressure
≥90 mmHg.
Moreover, in 588 cases (15.0%) high blood pressure was identified at baseline, which
was unknown and untreated to this point.
Furthermore, at baseline 1,694 (43.9%) of all patients had dyslipidaemia, 393 (10.1%)
participants were initially diagnosed. Additionally, 789 (20.2%) of the patients suffered
from diabetes mellitus at baseline. 65 (1.7%) participants were newly diagnosed. 185
(4.7%) subjects suffered from atrial fibrillation at the beginning of the study (table 8.2,
figure 8.1).
Figure 8.1
Top 5 baseline characteristics as reported by a general practitioner
At baseline, 135 (3.5%) patients suffered from ischaemic stroke (which is 67 (4.2%)
men and 68 (3.0%) women), 174 (4.5%) from a TIA (which is 79 (5.0%) men and 95
(4.1%) women) as well as 162 (4.2%) participants from myocardial infarction (which is
115 (7.2%) men and 47 (2.0%) women). For further details please see table 8.2 below.
8.1.3 Laboratory results of cholesterol
The average serum concentration of HDL was 58.0 mg/dL (SD= 16.0) and of LDL 132.5
mg/dL (SD= 34.7). Further details are displayed in table 8.3.
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Table 8.2
Baseline characteristics as reported by a general practitioner
Baseline characteristics as reported by GP
Characteristics Men (n=1,600) Women (n=2,308) Total (n=3,908)
Hypertension 883 (55.4%) 1,359 (59.1%) 2,242 (57.6%)
Systolic blood pressure
≥140 mmHg
795 (49.7%) 1,172 (50.8%) 1,967 (50.3%)
Diastolic blood pressure
≥90 mmHg
405 (25.3%) 542 (23.5%) 947 (24.2%)
Diabetes mellitus 373 (23.4%) 416 (18.0%) 789 (20.2%)
Dyslipidaemia 691 (43.2%) 1,003 (44.0%) 1,694 (43.9%)
Atrial fibrillation 94 (5.9%) 91 (3.9%) 185 (4.7%)
History of ischaemic
stroke
67 (4.2%) 68 (3.0%) 135 (3.5%)
History of TIA 79 (5.0%) 95 (4.1%) 174 (4.5%)
History of myocardial
infarction
115 (7.2%) 47 (2.0%) 162 (4.2%)
Table 8.3
Laboratory results of cholesterol
Physical examination and laboratory results
Characteristics Men (n=1,600) Women (n=2,308) Total (n=3,908)
HDL in mg/dL, mean±SD 51.8±13.9 62.4±15.9 58.0±16.0
LDL in mg/dL, mean±SD 128.8±34.7 135.1±34.5 132.5±34.7
8.1.4 Socioeconomic status
Living conditions
In terms of socioeconomic variables, the following picture emerged. 435 subjects (10.9%)
had an intermediate or higher education level (“Realschulabschluss“ or “Fachhochschulabschluss“,
“allgemeine Hochschulreife” and “Hochschulabschluss”).
To go into detail, 284 (7.3%) individuals finished secondary modern school (“Realschule”,
103 (6.4%) men and 181 (7.8%) women) and 5.6 (1.4%) held a degree from a technical
college (“Fachhochschule”, 32 (2.0%) men and 24 (1.0%) women). Furthermore, 66
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(1.6%) had passed their A-levels (“Abitur”) and went to university (38 (2.4%) men and 28
(1.2%) women).
Aditionally, 3,473 (89.5%) participants never went to school, only finished primary (“Grundschulabschluss”)
or only secondary school (“Hauptschulabschluss”).
In detail, 186 (4.8%) did not have a school leaving qualification (70 (4.4%) men and 116
(5.0%) women) and 3,287 (84.1%) finished primary or secondary school (1,347 men
(84.2%) and 1,940 (84.1%) women).
1,205 (30.8%) subjects described their marital status as widowed, divorced, or single,
while 2,701 individuals were married (69.2%). Living alone was indicated by 893 (22.9%)
of all participants.
Working conditions
Over their life time, 343 (8.8%) were never working in an employment. It clearly has to
be stated that this group consists of four (0.3%) men and 339 (14.7%) women.
3,277 (83.9%) individuals (1,262 (78.9%) men and 2,015 (87.3%) women) indicated that
they currently had no active profession, being retired (see table 8.4).
To go into detail regarding former occupation, 343 (8.8%) subjects did not pursue a
career in their life or worked as housewives. Four (0.3%) of those never having worked
in an employment were males and 339 (14.7%) were females.
Additionally, 1,789 (45.8%) were manual workers, 154 (3.9%) family workers in operating
their own businesses, and 81 (2.1%) self-employed farmers.
Furthermore, 1,219 (31.2%) participants were employees, 267 (6.8%) individuals stated
that they have been self-employed in trade and services, and 55 (1.4%) subjects worked
as civil servants.
Taken together, 2,024 (51.8%) participants were employed in manual-labour occupations,
while 1,541 (39.4%) of all subjects belonged to the skilled-labour group.
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Table 8.4
Socioeconomic variables
Socioeconomic factors
Characteristics Men (n=1,600) Women (n=2,308) Total (n=3,908)
Low educational level 1,417 (89.1%) 2,056 (89.8%) 3,473 (89.5%)
Currently married 1,330 (83.2%) 1,371 (59.4%) 2,701 (69.2%)
Living alone 199 (12.4%) 694 (30.2%) 893 (22.9%)
Never working in
employment
4 (0.3%) 339 (14.7%) 343 (8.8%)
Currently no active
profession
1,262 (78.9%) 2,015 (87.3%) 3,277 (83.9%)
Life style variables
Regarding life style factors, the body mass index was in average 27.7 kg/m2 (SD= 4.4).
1,007 (25.8%) participants had a BMI >30.0 at the baseline examination and are thus
considered as obese according to the WHO standards [502]. 586 (15.0%) stated to be
physically inactive. 2,423 (62.0%) individuals drank seven up to 21 drinks per week and
were thus considered as current drinkers. 1,345 (34.4%) were current or former smokers
(see table 8.5).
Table 8.5
Life style factors
Life style factors
Characteristics Men (n=1,600) Women (n=2,308) Total (n=3,908)
BMI, mean±SD 27.9±3.8 27.6±4.8 27.7±4.4
Obesity (body mass index
>30.0 kg/m2), kg/m2
391 (24.4%) 616 (26.7%) 1,007 (25.8%)
No regular physical activity 191 (12.0%) 395 (17.1%) 586 (15.0%)
Current drinker 1,325 (82.9%) 1,098 (47.6%) 2,423 (62.0%)
Current or former smoker 949 (59.4%) 396 (17.2%) 1,345 (34.4%)
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8.1.5 Follow-up outcome measures
During the study period, 230 (5.9%) patients suffered from ischaemic stroke including
TIA, 161 (4.1%) from ischaemic stroke, and 92 (2.4%) participants from myocardial
infarction, as displayed in table 8.6.
Table 8.6
Incidence of ischaemic stroke including TIA, ischaemic stroke, and MI over study period
Incidence of ischaemic stroke, TIA and MI over study period
Characteristics Men (n=1,600) Women (n=2,308) Total (n=3,908)
Incidence of ischaemic
stroke including TIA
96 (6.0%) 134 (5.8%) 230 (5.9%)
Incidence of ischaemic
stroke
74 (4.6%) 87 (3.8%) 161 (4.1%)
Incidence of myocardial
infarction
61 (3.8%) 31 (1.3%) 92 (2.4%)
Figure 8.2 gives an overview of all pre-defined endpoints it this study. The 477 (12.2%)
deaths mentioned above include deceases from ischaemic stroke including TIA, ischaemic
stroke, or MI over the study period.
Figure 8.3 compares reported ischaemic stroke, ischaemic stroke including TIA, as well
as baseline MI with the development of those diseases in the course of the study.
The following section focuses on the endpoints incidence of ischaemic stroke, ischaemic
stroke including TIA, as well as the occurrence of myocardial infarction. The association
of generally non-modifiable risk factors such as age and gender and modifiable risk
factors like hypertension, LDL, HDL, atrial fibrillation, diabetes mellitus, obesity and
body fat distribution, activity level in addition to consumption of alcoholic beverages,
and smoking of cigarettes were investigated (see 2 and 3). The category of potentially
modifiable risk factors included educational level, living arrangements, marital status,
and occupation in a rather rural demographic structure of elderly (see 4 and 5).
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Figure 8.2
Number of cases by study endpoints
Figure 8.3
Number of cases at baseline compared to follow-up ischaemic stroke including TIA,
ischaemic stroke, and MI
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8.2 Ischaemic stroke including transient ischaemic
attack
8.2.1 Traditional risk factors
Higher age (B= 0.08, SE= 0.01, p= 4.76x10-19) as well as cigarette smoking (B= 0.35,
SE= 0.16, p= 0.03) were associated with an increased hazard to suffer ischaemic stroke
including transient ischaemic attack.
Higher physical activity (B= -0.39, SE= 0.16, p= 0.02) had a significant protective effect.
The results indicate an increased risk of ischaemic stroke including TIA with atrial fibrillation
(B= 0.38, SE= 0.24, p= 0.11), although it did not pass significance level.
Even though considered as risk factors, no association of hypertension (B= 0.17, SE=
0.15, p= 0.27), diabetes mellitus (B= 0.18, SE= 0.16, p= 0.24), low HDL (B= -0.005, SE=
0.005, p= 0.295), high LDL (B= -0.001, SE= 0.002, p= 0.573), alcohol intake (B= -0.09,
SE= 0.15, p= 0.55), and BMI (B= 0.001, SE= 0.016, p= 0.981) with ischaemic stroke
including TIA was observed (table 8.7).
Table 8.7
Ischaemic stroke including TIA adjusted for traditional risk factors
Association of ischaemic stroke including TIA and traditional risk factors
Risk factors Beta SE p-value
Age 0.078 0.009 4.76x10-19
Sex -0.087 0.176 0.622
Hypertension 0.169 0.153 0.269
HDL -0.005 0.005 0.295
LDL -0.001 0.002 0.573
Atrial fibrillation 0.377 0.235 0.109
Diabetes mellitus 0.182 0.156 0.242
BMI 0.001 0.016 0.981
Physical activity -0.389 0.159 0.015
Alcohol consumption -0.090 0.150 0.551
Cigarette smoking 0.353 0.162 0.029
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Figure 8.4 shows the survival curve from entry in the study until end of trial, death,
drop out due to termination of the insurance period, or ischaemic stroke including TIA. A
continuous occurrence of ischaemic stroke events and TIA are displayed.
Figure 8.4
Survival curve ischaemic stroke including TIA
8.2.2 Educational status
A higher education status was significantly associated (B= -0.85, SE= 0.42, p= 0.05)
with ischaemic stroke including TIA after correction for the confounding factors described
above.
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8.2.3 Marital status
Being married was not associated with getting an ischaemic stroke including TIA (B=
-0.22, SE= 0.20, p=0.27).
8.2.4 Housing conditions
No effect of living arrangements and ischaemic stroke including TIA could be observed
(B= 0.24, SE= 0.19, p= 0.21).
8.2.5 Occupation
No association was found between an individual’s former or current occupation and the
incidence of ischaemic stroke including diagnosed TIA (B= 0.13, SE= 0.24, p= 0.58).
8.3 Ischaemic stroke
8.3.1 Traditional risk factors
Advanced age (B= 0.09, SE= 0.01, p= 1.18x10-17), high LDL (B= 0.005, SE= 0.002, p=
0.041), and the consumption of cigarettes (B= 0.559, SE= 0.193, p= 0.004) significantly
increased risk for ischaemic stroke.
Physical activity (B= -0.39, SE= 0.19, p= 0.04) had a significant protective effect.
A slightly increased risk of ischaemic stroke was observed for patients suffering from
atrial fibrillation (B= 0.50, SE= 0.27, p= 0.07).
Apart from that, none of the traditional risk factors was associated with ischaemic stroke
(see table 8.8).
Figure 8.5 presents the survival curve for ischaemic stroke, indicating a linear incidence
over the course of the study.
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Figure 8.5
Survival curve ischaemic stroke
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Table 8.8
Ischaemic stroke adjusted for traditional risk factors
Association of ischaemic stroke and traditional risk factors
Risk factors Beta SE p-value
Age 0.090 0.011 1.18x10-17
Sex -0.286 0.213 0.179
Hypertension 0.168 0.185 0.363
HDL -0.003 0.006 0.557
LDL 0.005 0.002 0.041
Atrial fibrillation 0.499 0.270 0.065
Diabetes mellitus 0.285 0.183 0.121
BMI 0.006 0.020 0.777
Physical activity -0.391 0.189 0.039
Alcohol consumption -0.180 0.182 0.324
Cigarette smoking 0.559 0.193 0.004
8.3.2 Educational status
For ischaemic stroke, a higher educational status showed a significant influence (B=
-1.63, SE= 0.72, p= 0.03).
8.3.3 Marital status
Married life had no effect (B= -0.34, SE= 0.25, p= 0.17) regarding the risk of ischaemic
stroke.
8.3.4 Housing conditions
The type of housing was not associated with ischaemic stroke (B= 0.11, SE= 0.23, p=
0.63).
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8.3.5 Occupation
Never having worked or no current active profession did not show any association (B=
0.06, SE= 0.28, p= 0.83) with ischaemic stroke.
8.4 Myocardial infarction
8.4.1 Traditional risk factors
Lastly, having had a closer look at the incidence of myocardial infarction, higher age
(B= 0.09, SE= 0.01, p= 0.76x10-9), the incidence of hypertension (B= 0.45, SE= 0.26, p=
0.08), and smoking of cigarettes (B= 0.55, SE= 0.25, p= 0.03) were significant risk factors
for MI. Being female (B= -0.946, SE= 0.297, p= 0.001) and high HDL were significantly
protective (B= -0.025, SE= 0.009, p= 0.004). All other traditional risk factors did not show
any effect (see table 8.9).
Table 8.9
Myocardial infarction adjusted for traditional risk factors
Association of myocardial infarction and traditional risk factors
Risk factors Beta SE p-value
Age 0.087 0.014 0.76x10-9
Sex -0.946 0.297 0.001
Hypertension 0.446 0.257 0.083
HDL -0.025 0.009 0.004
LDL 0.002 0.003 0.444
Atrial fibrillation -0.413 0.470 0.379
Diabetes mellitus 0.126 0.246 0.609
BMI -0.014 0.029 0.619
Physical activity 0.123 0.300 0.683
Alcohol consumption -0.189 0.255 0.458
Cigarette smoking 0.551 0.253 0.029
Consequently, figure 8.6 shows the survival curve for myocardial infarction, indicating
a continuum in incidence of MI. As the incidence rates are higher for ischaemic stroke
including TIA as well as ischaemic stroke separately, the survival curve for MI is flatter.
129
Results
Figure 8.6
Survival curve myocardial infarction
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8.4.2 Educational status
Educational level was not associated (B= -12.97, SE= 377.92, p= 0.97) with MI.
8.4.3 Marital status
Marital status had no effect on the incidence of myocardial infarction (B= 0.29, SE= 0.44,
p= 0.51).
8.4.4 Housing conditions
Regarding the incidence of myocardial infarction, sharing a home with one or more
people showed no association (B= -0.01, SE= 0.40, p= 0.98) with MI.
8.4.5 Occupation
Former or current occupational level had no significant association with suffering from MI
(B= -0.43, SE= 0.43, p= 0.32).
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9 Discussion
The following section will discuss the influence of previously published risk factors in
the INVADE cohort. A detailed overview of current literature on modifiable and non-
modifiable risk factors for stroke and MI can be found in chapters 2 and 3.
9.1 Traditional risk factors
9.1.1 Age and sex
1,600 (40.9%) men and 2,308 (59.1%) women were included in this study, showing a
greater proportion of female participants.
An investigation on socioeconomic structures and morbidity by German health insurance
companies on 21,835 subjects revealed that there are large discrepancies of policy
holders by sex [503]. This is based on the fact that women tend to life longer in Germany
[423]. In 2008, the AOK insured 53% females, marked in turquois (see figure 9.1).
A higher proportion of female AOK policy holders was also documented in the INVADE
study. This observation is assumable based on the general gender distribution in Germany,
as the investigated age group (mean age 67.7 years) has a higher proportion of women
[504].
9.1.2 Hypertension
In the INVADE cohort, arterial hypertension was reported in 2,242 (57.6%) patients.
This confirms the high prevalence of hypertension in Germany compared to most other
European and North American countries (see table 2.1). In 2003, the prevalence of
hypertension was estimated at 55.3%, matching the status of the baseline period in this
study [103].
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Figure 9.1
Gender distribution by health insurance in Germany [503].
9.1.3 High-density and low-density lipoprotein
Dyslipidaemia was documented in 1,694 (43.9%) participants in the present study.
Results from the German Health Update 2009, a recent health interview survey conducted
by the Robert-Koch-Institut, confirmed a prevalence of dyslipidaemia of 43.9% in woman.
In lower educational groups, a slightly higher prevalence of 47.1% was reported [505].
Thus, the INVADE cohort represents the average on diagnosed dyslipidaemia compared
to whole Germany.
9.1.4 Atrial fibrillation
In the INVADE population, atrial fibrillation was reported in 185 (4.7%) of all subjects at
baseline.
This is consistent with findings, indicating a prevalence of 4% to 6% of AF in the German
population older than 60 years [506].
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9.1.5 Diabetes mellitus
789 (20.2%) subjects had diagnosed diabetes mellitus in this study. Results from the
German Health Interview and Examination Survey for Adults observed a substantial
increase in prevalence of diabetes mellitus with age. While the prevalence was 5%
amongst those being 50 years old, it increased to 22% in those aged 70 to 79 years.
This was reported for both sexes [507]. These data align with results from the INVADE
study.
9.1.6 Body mass index
A mean BMI of 27.7 was documented in the INVADE population, with an average age
of 67.7 years, as mentioned above. For males, the mean BMI was 27.9 and for females
27.6.
Compared with data from the German Health Interview and Examination Survey for
Adults, a BMI of 28.8 (95% CI [28.4–29.2]) for men and 28.5 (95% CI [28.0–29.0]) for
women was published for those aged 60 to 69 years [508].
The reported BMI in the INVADE cohort is consequently outside of the confidence interval,
indicating a significant difference from the German average. This might be based on the
large proportion of manual workers. 2,024 (51.8%) subjects conducted manual-labour
occupations. These professions are associated with increased levels of physical activity
leading to decreased body weight.
9.1.7 Physical activity
No regular physical activity was reported in only 586 (15.0%) participants (191 men
(12.0%) compared to a slightly higher rate of 395 women (17.1%)) in the present trial.
The German Health Interview and Examination Survey for Adults observed that 15.9%
(95% CI [13.5–18.5]) of those aged 60 to 69 years payed little or no attention to physical
activity [509]. Thus, the INVADE cohort represents the entire German population in
respect to PA.
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9.1.8 Alcohol consumption
In the INVADE cohort, 2,423 (62.0%) participants indicated to consume alcohol regularly.
1,325 (82.9%) of those were males and 1,098 (47.6%) females.
Alcohol intake is hard to capture and questionnaires are error-prone. Thus, there is no
reliable estimation of alcohol intake in Germany. Data based on the WHO Global status
report on alcohol and health 2014 documented the pure alcohol consumption among
persons aged 15 years or older in litres per capita per year [510]. For Germany, a total
consumption of 11.8 l was published, consisting of 53.6% beer, 27.8% wine, and 18.6%
spirits.
Following the statistical yearbook of the German Central Office for Questions Regarding
Addiction, 96.4% of the population aged 18 to 64 drink alcohol [511]. Compared to
the INVADE cohort, this number seems rather high. It might be based on the different
study populations, as a decline in consumption with older aged compared to youth was
underlined in the report. Consequently, a decreased level was expected in the present
study.
In this context, it clearly has to be reported that men consumed about one third more
alcohol than women. This gender distribution was also found in the INVADE study.
9.1.9 Cigarette smoking
1,345 (34.4%) subjects were current or former smokers in this study, these are 949
(59.4%) male and 396 (17.2%) female participants.
According to data from the German Health Interview and Examination Survey for Adults,
29.7% of the population aged 18 to 79 years did smoke in 2013 [512]. This rate is
slightly below the one found in the present study. As mentioned before, manual work
is commonly linked with higher proportions of smokers, especially in men [201], [333],
[513].
9.1.10 Educational status
In the INVADE cohort, 3,473 (89.5%) individuals never went to school, completed primary
school (“Grundschulabschluss”) only, or secondary school (“Hauptschulabschluss”) only.
This trend can also be confirmed in those insured by the AOK outside of Bavaria. The
135
Discussion
AOK holds the highest percentage of individuals with low educational attainment (see
figure 9.2) compared to other health care providers. 48% of its customers finished only
primary or secondary school [503]. Solely 9% passed the general matriculation standard
(A-Level: “allgemeine Hochschulreife”).
Figure 9.2
Educational level by health insurance in Germany [503];
legend to this overview: “Hochschulreife”: matriculation standard; “Fachhochschulreife”:
technical college certificate; “Realschule”: secondary modern school; “Haupt-/Volksschule”:
secondary school/ elementary school; “anderer Abschluss oder noch ohne Abschluss”: other
degree or not yet graduated.
The higher amount of subjects belonging to lower educational levels might be based
on the selected INVADE cohort. It encompasses individuals born in 1946 or before.
Consequently, this study involves individuals, who grew up during war or the time after.
At the time of World War II and in the post-war generation, education was not one of the
first priorities in private and public life. This particularly applied for females [514].
To get a broader picture of how education developed in the administrative district of
Upper Bavaria, Bavaria’s population census from 27th May 1970 will give an overview of
educational attainment [515] as one of the first official publications after World War II.
This census revealed that 69.5% of all inhabitants finished primary school (“Hauptschulabschluss”
or “Volksschulabschluss”) as highest degree (in relation to 77.3% in whole Bavaria).
Having a closer look at the gender difference, in upper Bavaria 66.0% males and 72.6%
females indicated primary school as their highest school leaving qualification.
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In the INVADE cohort, primary or secondary school was finished by 3,287 (84.1%)
subjects, 1,347 men (84.2%), and 1,940 (84.1%) women. These numbers are higher as
reported in the census because two types of school were taken together in the patients’
questionnaires.
For 11.6% secondary modern school (“Realschulabschluss”) was the highest qualification
(in relation to 9.0% in whole Bavaria). This was reported for 8.8% men and 14.1%
woman.
In the present study, 284 (7.3%) participants graduated from secondary modern school,
103 (6.4%) men and 181 (7.8%) women. Those numbers are below the findings documented
in the census, indicating a decreased educational level for the administrative district of
Ebersberg. This might be explained by a more rural infrastructure and less educational-
based interest due to future manual-orientated employments.
In terms of high school graduation (“allgemeine Hochschulreife”), 3.6% in Upper Bavaria
(in relation to 2.1% in whole Bavaria) was documented. This level of education was
passed by 4.8% of all males and 2.6% of all females.
Finally, a university level degree (“Hochschulabschluss”) was obtained by 4.4% of the
population of Upper Bavaria (in relation to 3.0% in whole Bavaria). 4.5% of all men and
1.7% of all woman finished college education.
In the INVADE study, 66 (1.6%) participants went to university, 38 (2.4%) men and 28
(1.2%) women. Those numbers are far below the ones registered for Upper Bavaria,
confirming the low educational level in the district of Ebersberg for the targeted generation.
The census’s calculations were based on 7,788,000 residents of Bavaria having passed
the mandatory age to attend school. To conclude, the statements above have to be kept
in mind when considering the rather low educational standards in the present cohort,
especially observed for woman.
9.1.11 Marital status
69.2% of all participants were married at baseline in the INVADE cohort.
In Germany, a decrease in marriages over the past decades was reported. In 1950,
there have been 11.0 marriages/1,000 inhabitants, in total 750,452 marriages. This
number declined until 2013 to 4.6 marriages/1,000 inhabitants, in total 373,655 newly
wed couples [516]. Figure 9.3 shows the trend in marriages in Germany from 1950 until
today [516].
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In 2013, Bavaria accounted with 47.5 marriages/10,000 inhabitants, in total 59,623 marriages.
This was slightly less than the national average.
Figure 9.3
Trend in marriages in Germany, 1950 to 2015 [516].
Furthermore, 30.8% of all INVADE study participants stated to be divorced, widowed, or
single.
In 1950, 1.9 marriages/1,000 inhabitants got divorced, in total 134,600 divorces. In
contrast to this, in 2012, 2.2 marriages/1,000 inhabitants were ended [516]. In 2013, 21.1
divorces/10,000 inhabitants were registered, in total 169,833 divorces. In Bavaria, 19.7
divorces/10,000 inhabitants, in total 24,797 divorces, were below the federal average.
Moreover, in 2000, the year prior to baseline of the INVADE trial, men aged 60 to 69
years had a ratio of widowhood of 5.0%. For woman, this was 20.1%, which can be
explained by differences in life expectancy [517].
In 1991, 11.6% of all males and 11.0% of all females aged 65 years and older were
single [518].
Taken together, the reported proportions of marriage versus divorce, widowhood, or
being single in the general German population are rather similar to those found in the
present study.
9.1.12 Housing conditions
At baseline, 893 (22.9%) subjects indicated to live alone in the investigated cohort. In
2003, the end of the baseline period in this study, 21.1% single-person households were
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registered in Germany, supporting these findings [519].
9.1.13 Occupation
In Upper Bavaria, the proportion of employees was steadily raising over the last decade
[520]. The employment rate of those aged 55 to 65 years was higher in regards to other
European countries [521]. In 2012, it was 61.5% for Germany compared with 48.8% in
the whole EU. In the post-war generation, as predominant in this cohort, there was a
clear distinction in occupational level by gender. Men tended to go to working as single
earners. Women stayed at home, taking care of house and children [514]. This was also
observed in the INVADE study. As a result, the focus of educational attainment, which
attributes to future employment prospects (see 4.3), was on males rather than females.
This explains the lower rates in educational level and occupation in women in this cohort,
leading to a high number of housewives. On average, the AOK policy holder earned a
net household income of e1.500 to e1.750 in 2008 [503]. As already mentioned, data
regarding income was not collected in the present study.
9.2 Ischaemic stroke including transient ischaemic
attack
In the following, the association of specific established risk factors as well as selected
socioeconomic variables with the incidence of ischaemic stroke including TIA will be
discussed.
The incidence of ischaemic stroke including TIA was 96 (6.0%) for males and 134 (5.8%)
for females, leading to a total of 230 (5.9%) cases in the INVADE population.
9.2.1 Traditional risk factors
In the present investigation, advanced age, cigarette smoking, and atrial fibrillation were
associated with an increased hazard to suffer from ischaemic stroke including transient
ischaemic attack. Higher amounts of physical exercise had a significant protective effect.
The next section will focus on the association of the reported significant risk factors with
ischaemic stroke including TIA.
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Increased age is a major risk factor for ischaemic stroke including TIA, as described in
detail in chapter 2.1.2. At baseline, man had an average age of 66.7 years compared
to 68.5 years for woman. In the course of the study, 161 (4.1%) ischaemic strokes were
registered. 74 (4.6%) men versus 87 (3.8%) woman suffered from ischaemic stroke. This
higher amount of male stroke patients confirms recent publications on higher incidence
rates for stroke in males compared to females [522]. For further details on the incidence
on stroke see chapter 1.3.
Consistent evidence from literature underlines that stroke risk factors progress over time,
leading to an increased risk of ischaemic stroke with advanced age [25], [58], [74] (see
chapter 2). This association was also confirmed in the INVADE study.
Moreover, the present trial underlined a significant association of the risk of ischaemic
stroke including TIA with nicotine.
Literally every multivariable study on stroke risk factors, e.g. Framingham [20], Cardiovascular
Health Study [181], and the Honolulu Heart Study [182], emphasized that smoking leads
to an increased risk of stroke. Current smokers have a 50% higher risk of suffering from
stroke during their course of life compared to persons who never smoked [186], [187].
Recent data stressed a strong associations between education and smoking for Germany,
with higher prevalence rates of smokers in less educated classes [30], as present in this
study.
A beneficial impact of PA was also documented in the INVADE cohort.
Furthermore, a wealth of evidence confirmed a significant association of PA and decreased
risk of stroke [144], [146], [143]. The attractive leisure opportunities in the area of
Ebersberg and frequent ownership of a garden or real estate went along with continuous
activity.
Additionally, the present findings indicated an association of arterial fibrillation with an
increased risk of ischaemic stroke including TIA, even though the results did not reach
significance level.
Recent guidelines identified a relation of AF to a four- to five-fold increased risk of
ischaemic stroke [74], which can also be assumed to highly contribute to the incidence
of TIA.
Despite the fact that hypertension, diabetes mellitus, increased level of LDL, BMI, and
alcohol consumption (see table 8.7) are considered as crucial risk factors for ischaemic
stroke including TIA, no association could be found here. In the following, those results
will be discussed.
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Regarding hypertension, another study in the INVADE population analysed the reduction
of long-term care dependence based eight year primary care prevention for stroke and
dementia [523]. In this trial, the use of antihypertensive medications rose from 57.4% at
baseline to 70.6% at follow-up. Additionally, the intake of statins increased from 16.1%
to 25.9% and anticoagulants combined with antiplatelet drugs from 31.0% to 43.5%.
Patient recognition of stroke risk factors, including BP, had improved continuously. Higher
awareness might lead to a better adherence to recommended health behaviours and an
increased motivation of life-style changes [524]. This modified attitude could have a huge
impact on other listed risk factors, diminishing the negative influence of hypertension.
The same underlying principles might be assumed for a modified adaption by diagnosed
diabetes mellitus as well as increased level of LDL. All these variables can be attributed
to well-documented and modifiable risk factors [74]. Pathways mediating associations
not significant for hypertension could also be connected to diabetes mellitus, because
diabetes is perceptibly linked to hypertension [56].
As hypertension, diabetes mellitus as well as increased levels of LDL were documented
at baseline, an appropriate therapy was initiated by the attending GP. As a result, the
absence of a relationship might also indicate that the applied treatments worked, confirming
the value of the INVADE study. The addressed cohort highly benefits from participating
in the trial through closely and ongoing monitoring of their medical health and well-being.
To further investigate this progress, follow-up treatments would have to be analysed.
Furthermore, the classification of consumption of no alcohol in contrast <7 drinks up
to ≥21 drinks per week was applied. For ischaemic stroke including TIA, a J-shaped
relationship with alcohol intake has been repeatedly reported [203], [202]. Compared to
international standards, Germany ranks as one of the countries with the highest alcohol
consumption for years [30]. Based on data of the German Central Office for Questions
Regarding Addiction, 96.4% individuals in the age of 18 to 64 consume alcohol [511], as
mentioned above. In the INVADE cohort, the majority of participants were not excessive
but rather occasional drinkers. Thus, no significant effect was reported.
In terms of BMI, the absence of an association of BMI with ischaemic stroke including TIA
was documented in the INVADE cohort. A generally high level of physical activity and
increased proportions of manual working groups leading to a decreased body weight,
might explain this finding. There is an ongoing discussion about the accuracy of the
index. In a recent cross-sectional study, BMI misclassified 25% men and 48% women
as not obese, underestimating obesity prevalence, especially in women [525]. The
prevalence of falsely measured BMIs, increased misclassifications in females with advancing
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age, and the reliability of gender-specific revised BMI cut-offs clearly have to be kept in
mind. Consequently, a biased BMI can be assumed in the present trial.
In addition to BMI, measurement of abdominal body fat predicting stroke risk seem more
efficient [176], [177]. Finally, the effect of BMI on stroke risk is to some extend driven
by the influence of adiposity on other stroke risk factors [56], which were accounted for
individually.
9.2.2 Educational status
Beside the risk factor analysis, the focus in the present study was on specific socioeconomic
variables and their association with ischaemic stroke including TIA.
In the INVADE cohort, a higher educational status was significantly protective against
ischaemic stroke including TIA after adjusting for the risk factors discussed above.
This is in agreement with numerous studies confirming an association of low educational
attainment and ischaemic stroke [335], [203], [327], [363]. Generally, this effect can be
attributed to specific health related behaviour, general life style, and the knowledge of
stroke-related connections. A higher prevalence of well-established risk factor for stroke,
such as increased smoking, higher prevalence of hypertension, and more frequent consumption
of alcohol, are more common among groups with low SES and lower educational attainment
[201], [333].
In the INVADE study however, a significantly increased risk for ischaemic stroke after
correcting for these risk factors was documented. This is a clear strength of the present
study. These findings indicate that low educational level is independently associated with
an increased risk of ischaemic stroke.
A detailed overview of risk factors for stroke and the particular influence of lower SEP on
stroke is given in chapters 4 and 5.
As a higher education level is also associated with an increased awareness of warning
signs for stroke and a timely admission to hospital [367], health education is particularly
crucial in areas with lower educational attainment, as in the present study. Health
information programs might have an immense impact on stroke outcome and therefore
quality of life in survivors.
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9.2.3 Marital status
Measuring social isolation is a multiplex effort involving both structural, such as marital
status and living arrangements, and functional aspects, like emotional and perceived
support, of social relationships [526]. The next section will focus on the association of
marital status with ischaemic stroke including TIA.
The implementation of contraceptives, student revolts in the so called “’68 generation”,
and women’s liberation at home as well as on the labor market led to significant changes
of the importance of marriage and its effect on health in Germany [424].
This is also applicable for Upper Bavaria, a region which is still strongly influenced by
catholic faith. As the meaning of marriage diverges across countries and even varies
within Germany, a generalization of the impact of marriage on stroke might be problematic.
In this context, no significant association between marital status and ischaemic stroke
including TIA was found in the administrative district of Ebersberg in an elderly population.
A variety of studies from different regions questioned the protective effect of married life
on risk for stroke.
For instance, the US Health and Retirement Study included participants born in 1947 or
before [382], comparable with the cohort in the present trial. The association of being
unmarried with stroke diminished after controlling for financial property. Unfortunately,
values on income were not collected in the present study.
Moreover, another US community-based study found that patient characteristics of never
married individuals seemed to resemble those of married persons [527]. This was found
particularly for older people, who represent the target group in the INVADE study as
well.
In this line, it was reported that single women older than 75 years did not differ from
married or divorced women in their risk profile for stroke [424]. These findings suggest
an attenuated meaning of marriage in later life. As mentioned above, this was also
reported in the present cohort.
9.2.4 Housing conditions
The following section will discuss an additional aspect of life spent together with another
person, namely cohousing.
To our knowledge, this is the first study investigating the effect of cohousing and the
incidence of stroke including TIA. Most trials so far focused on related aspects, such
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as referral time to the hospital, adherence to medical regimes, and outcome post-stroke
regarding cohabitation (see chapter 5.2.5). No direct impact on the incidence of ischaemic
stroke including TIA were determined. In this study, no significant association between
living together with another individual and ischaemic stroke including TIA could be observed.
In rural structures, as present in the INVADE study, an increased social support in
the neighborhood by societies and clubs can be assumed. Those helping networks
might compensate for the absence of a housemate by some extend. This daily social
bonding could ameliorate the effects of living alone. Close neighborhood communities
and proximity to family members could be decisive for a timely admission to the hospital
and the ongoing stroke rehabilitation process.
Future research is needed to delve deeper into the multilayered interrelationship among
living alone, social isolation, access to acute stroke care [384], and the incidence of
ischaemic stroke including TIA.
9.2.5 Occupation
Former profession or current occupation did not show any association with ischaemic
stroke including TIA. Occupation was highly correlated with age and sex in the present
population, as people only work up to a certain age. Currently, the retirement age for
Germany is 67 years.
In the INVADE cohort, 629 (16.1% regarding the whole study population) individuals
(337 (53.6%) males and 292 (46.4%) females regarding working people) were employed
at baseline. Age ranged from 53.74 to 82.90 years (SD= 3.97), with a mean age of
59.90 years for persons, who were still working at baseline. 14 (2.2%) out of these 629
participants in the working group suffered from ischaemic stroke including TIA during the
trial phase.
In contrast to this, there were 3,277 (83.9% regarding the whole study population) participants
(1,262 males (38.5%) and 2,015 females (61.5%) regarding retired people) not working
at baseline. Age ranged from 53.95 to 101.85 years, with a mean age of 69.23 years in
persons still working. On average, this group of retired persons is ten years older than
the working subjects. Furthermore, it consist of two thirds of woman. The dominating
proportion of females, both, in the retried group and those never having been employed,
go back to historical reasons, as already stated above [514]. In the investigated cohort,
woman working as housewives, raising children, and doing the household were prevalent.
This proportion was consequently expected.
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216 (6.6%) participants of the non-working subjects, composed of 3,277 individuals,
suffered from ischaemic stroke including TIA during the trial phase. These higher rates
in incidence of stroke in pensioners are supposedly mainly driven by advanced age and
the resulting impact on risk factors for ischaemic stroke including TIA as discussed in
chapter 2.
In general, occupational classification schemes can be rather diverse and pose a challenge
to extract specific effects of individual indicators (see chapter 4).
In the Survey on Health and Ageing in Europe, 11,462 participants aged 50 to 64 years
were investigated [528]. It could be revealed that stroke was strongly associated with
early retirement and other types of non-participation in the labour force. This involved
being a housewife or not having paid employment.
As in this study, no association of being housewife/unemployment with ischaemic stroke
including TIA could be observed, the number of ischaemic stroke and TIA events might
have been too small to get significant results.
Today, retirees are more than ever able to make the most of their free time after employment
due to a comparable economical wealth, general improvements in the health care system,
and broad life style modifications. A social rethinking process applies for the investigated
cohort. An example for this would be the former omnipresence of smoking in politics,
cinema, and daily life [232] in addition to increased consumption of traditional meals
containing larger amounts of fat [505].
The termination of daily obligation, both, for men at work and for woman at home, might
lead to a benefit and enjoyment of retirement. The observed generation still receives
a comparatively secure pension. Living in the district of Ebersberg, Upper Bavaria, a
Germany-wide economical strong area, facilitates deserved sunset years.
9.3 Ischaemic stroke
The following section contextualises the findings for ischaemic stroke separately.
Traditional risk factors and socioeconomic variables
In this cohort, the incidence of ischaemic stroke was 74 (4.6%) for males and 87 (3.8%)
for females, leading to a total of 161 (4.1%) cases in the observed population.
The same pattern and trends as described above for ischaemic stroke including transient
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ischaemic attack were reported for ischaemic stroke considered separately. This underlines
the described distinct similarities (see 2) between ischaemic stroke and TIA [43], confirming
the medically close connection. By considering both, ischaemic stroke including TIA and
ischaemic stroke as individual groups, the strong association of the two diseases was
confirmed.
Similar tends were also found regarding the selected socioeconomic variables. Again,
there was a significant association of lower educational status with the incidence of
ischaemic stroke.
9.4 Myocardial infarction
Furthermore, the next section will discuss the observations made for myocardial infarction.
In this study, the incidence of myocardial infarction was 61 (3.8%) for males and 31
(1.3%) for females, resulting in a total of 92 (2.4%) cases in the INVADE population.
9.4.1 Traditional risk factors
Having had a closer look at the incidence of MI, higher age, the incidence of hypertension,
and nicotine consume were significantly associated with an increased risk of myocardial
infarction while high levels of HDL were significantly protective against MI. The risk to
suffer from MI was found to be significantly lower for women.
In agreement with numerous other studies [101], [235], [468], [226], [5], age and hypertension
were also major risk factors for MI in the present study.
In general, smoking rates declined over the past decades, especially in old age [324],
[30]. Nevertheless, the high prevalence of current smokers, particularly in males, induced
an increased risk of myocardial infarction in this cohort.
Even though considered as traditional risk factors, no association of higher concentration
of LDL, was found in this study. Furthermore, diagnosed diabetes mellitus, increased
alcohol consumption, higher BMI, and physical inactivity did also not show any association.
In contrast to several other studies [247], [5], [246] we could not observed an increased
risk of MI in diabetes patients. However, due to the design of the INVADE study, all
cases of diabetes were treated instantly after diagnosis, as described above. Again, no
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relation might be based on the effective treatment applied in the cohort, closely medically
monitoring its patients.
This might also be applicable for LDL concentrations, as no association was found
between LDL level and incidence of MI in the present cohort. A large number of trials
reported treatments targeting lower LDL in dyslipidaemic patients were highly efficient
in preventing MI [249], [235], [226]. At baseline, 1,694 (43.9%) of all participants had
dyslipidaemia, 393 (10.1%) subjects were initially diagnosed. The immediate initiation
of an appropriate therapy might have helped to control the disease, weakening the
association with the risk of MI.
As mentioned earlier, the strength of the association between alcohol consumption and
risk of MI decreases with advanced age [529]. Thus, this might have weakened a
potential relation.
Additionally, the measure of BMI could lead to misclassifications of overweight and
obesity [530]. On the one hand, some people are overweight according to BMI but
nevertheless live healthy and move a lot and on the other hand, others are not overweight
based on BMI but do not move regularly. As a result, the latter group has for instance a
high proportion of body fat, which is unhealthier than actual overweight. This potentially
hidden effect could also be present in this cohort, including individuals with higher BMI
but good general fitness.
In terms of physical activity, the actual level of physical exercise might have easily been
underestimated, as a large number of individuals live in and/or possess larger estates
in and around Ebersberg. Employees in jobs with a high proportion of physical activity,
such as craftsman or farmers, might not do any regular sport after work, but are moving
a lot all day long.
9.4.2 Educational status
In the present study, no significant association of MI and educational level could be
observed. A number of trials reported no significant or only a weak association of
lower educational attainment and mortality after myocardial infarction [531], [532]. In
opposition to this, other researchers observed a significant inverse association of low
educational level and MI mortality [436].
The majority of investigations analysed mortality rates rather than incidence, which was
investigated in the INVADE cohort. Kirchberger et al. (2014) emphasized that additional
studies on the association between education and long-term mortality after first AMI in
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Germany are required. The present study however underlines the importance of further
studies on MI incidence in association with educational attainment as well.
In this context, it can be argued that individuals with different educational levels diverge
in unobservable ways. This might involve different preferences regarding long term
investment in their future [294].
Instead of assuming that good health is induced by education, underlying hidden variables
could cause both, good health and better education. In the present study, this is corrected
for risk factors like high BMI, raised BP, and high lipid concentration. It might be that the
lack of an association between MI and education is not due to a better general health of
those, who have a higher educational attainment.
Furthermore, education might spring into action through improving health related knowledge,
enabling the choice of healthier lifestyles, which decreases mortality risk. Again, education
leads to advantageous employment situations with higher salary, improving living conditions
throughout adulthood.
9.4.3 Marital status
In the INVADE cohort, marital status had no protective effect on the incidence of myocardial
infarction.
There are some studies, which have reported commensurable findings. After controlling
for socioeconomic and lifestyle factors, women, who were married or living with a partner,
had a similar risk of developing CHD in comparison with women, who were not married
or living with a partner [533].
Additionally, after adjusting for potential risk factors, a protective effect of marriage on
incidence of MI could not be documented among men [427].
On the other hand, other investigations reported a protective effect of marital status on
incidence of MI [425], [314]. Populations of studies that found this effect were comparatively
younger.
Consequently, it is not fully understood, if an association between marriage and AMI
is independent of other psychosocial factors including social support and living alone
[425]. In this line, a Swedish study investigated the impact on psychosocial factors for
prognosis after myocardial infarction. It could be revealed that marital status, marital
strain, and dissatisfaction with family life were not significantly associated with mortality
after first infarction having controlled for social support [534].
A decreased protective effect of marriage with advanced age compared to younger age
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groups was observed [428], [314]. This might also apply for the present study. The
beneficial effects attributed to marriage, such as dietary patters, physical activation, and
adherence to heath care variables, could already be incorporated into daily life in the
elderly INVADE population, becoming independent of the mediation by the social support
of spouses.
This aspect of accumulation of positive effects of marriage over long periods of time was
specifically reported for Germany [424]. The wealth of experience older people obtained
during the course of their lives might lead to a prolongation of it.
9.4.4 Housing conditions
The impact of cohousing on MI is controversial. The majority of studies was focusing on
mortality after MI rather than on incidence of MI. Further research is needed to fill this
gap. While some studies found a positive association between living alone and mortality
after MI [535], other trials did not reveal any impact [536].
After multivariable adjustment for patients’ demographic, medical history, clinical treatment,
and baseline health status, subjects living alone had a comparable risk of mortality
and readmission to hospital (HR, 0.99, 95% CI [0.76-1.28]) compared to individuals in
cohousing [425].
In the present study, no association between cohousing and the risk of AMI could be
found. As already discussed before (see 9.2.4), a potential negative impact of living
alone might be mediated through intensified interpersonal relationships in this specific
cohort. Social network measures collect the number of different domains in which an
individual cultivates social contacts. These were strong predictors of mortality risk, but
weak to predict incident disease [537]. It might also be true in the present study. Marital
status alone does not always incorporate a protective effect against the incidence of MI.
The true impact of living together correlates with the outcome of the disease, which was
not measured in this study.
9.4.5 Occupation
In the INVADE cohort, no association was found regarding former or current occupation
and MI. As stated above (see 9.2.5), 629 (16.1%) subjects (337 (53.6%) of those males
and 292 (46.4%) females) were in employment at baseline. Eight (1.3%) participants of
the working group, composed of 629 subjects, suffered from myocardial infarction over
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the course of the trial.
Opposed to this, 3,277 (83.9%) individuals (1,262 of those males (38.5%) and 2,015
females (61.5%) regarding retired people) had no active profession at baseline.
84 (2.6%) out of these 3,277 participants of the non-working subjects suffered from MI
during the trial phase. These higher rates in incidence of myocardial infarction in retired
persons were assumedly mediated by advanced age and the resulting effects on risk
factors of MI, as discussed in chapter 3.
Even if occupational class is largely considered as an exceedingly comprehensive indicator
of an individual’s socioeconomic status [287], substantial differences within occupational
classes might not have been registered in this study. Collecting additional information,
such as income or ownership structures, might be helpful in future studies. However, in
Germany, especially in rural areas as applicable for the investigated cohort, disclosure
of wealth is considered as taboo. Therefore, it is questionable if information about the
individual financial situation can be reliably collected. Particularly, if this information had
to be handed over to the GP, a widely honored but exceedingly public figure within the
community.
Educational attainment might reflect gradual alterations in factors like health behaviour
and access to health information, influencing mortality differentials over a long period of
time. Contrarily, trends in occupational diversity may mirror modifications in variables,
such as the physical and psychosocial ranges of work [538].
As a result, the informative value and the validity of the education level as applied
measurement regarding occupation was emphasized.
To conclude this section, not all studies confirmed an association of socioeconomic
position and MI [539], [540], [541]. Other investigations reported an inverse association
of low SES with increased risk of MI [415], [414].
In this context, it clearly has to be mentioned that a direct comparison of the reported
findings might be challenging as these studies differ significantly regarding country of
origin, follow-up time, and indicators used for measuring SES [436]. As a result, the
impact of socioeconomic variables on the incidence of MI is an ongoing debate to which
INVADE contributes in the present study.
9.5 Strengths and limitations
In the following, strength and limitations of the INVADE study will be considered.
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9.5.1 Strengths
Approximately half of the study population had lived in the district of Ebersberg for more
than 50 years. 94.0% of all participants have been residents in this area for more than ten
years. This leads to a stable group of study subjects without considerable confounding
due to moves or frequent changes of GP, as it can be expected in larger cities in the
same area, such as Munich, Upper Bavaria, Germany.
80.5% of all subjects have seen their GP more than once quarterly. This ensured a
timely and ongoing monitoring of changes in the patient’s health status. Furthermore,
it enables an individually tailored treatment approach, which is highly beneficial for the
included patients. Examples for this connection were given above. Germany-wide, the
AOK ranks on first place in terms of number of doctor appointments compared with other
health insurance companies, reporting five consultations on average in the last 12 month.
This number clearly confirms the observations made in the INVADE trial.
In this line, the long and rather complete follow-up of all patients initially included in the
study is a fundamental strength of the present investigation.
Figure 9.4
Number of doctor’s consultations per year by health insurance in Germany [503].
Most importantly, a large number of reviewed studies showed the essentiality of adjusting
for relevant risk factors for stroke and MI. The majority of trials reported a significant
crude association between SES and mortality of MI, which generally weakens significantly
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after controlling for confounders such as diabetes or smoking [541]. In contrast to
this, the present study adjusted for numerous traditional risk factors based on current
literature review for both, ischaemic stroke including TIA (see chapter 2) and MI (see
chapter 3).
9.5.2 Limitations
All potential subjects were identified in the AOK database and then asked via mail to
participate in the INVADE trial. This can be considered as a study limitation as subjects
were selected based on only one insurances company. More than 40% of all inhabitants
of the district of Ebersberg older than 55 years were insured by the AOK. The AOK has
a market share of more than 40% in Bavaria [501] and covers about one third of the
German population.
Generally, different insurance companies tend to represent special patient clienteles
[503]. With 51%, the AOK shows the highest percentage of policyholders in lower social
classes. Only 2% can be attributed to the upper class (see figure 9.5). In this context,
it clearly has to be underlined that the present cohort in the administrative district of
Ebersberg is a very selective sample based on rural structures. In addition to this, there
is a disproportionately high number of individuals, who have only attended secondary
school in the observed age group. Consequently, this might not always allow a direct
comparison with current findings published within the Anglo-American area. Educational
attainment might act as an intervening variable in this case.
Furthermore, to be able to further decode potential interconnections of incidence of
ischaemic stroke, TIA, and MI, psychosocial measures, including social isolation, social
assistance, or psychosocial loneliness, were not directly included in the present analysis.
Associations might exist in the present cohort, but could not be revealed.
Additionally, previous publications investigating the INVADE population have focused
on dementia [542], [543], [544], aspects of long-term care dependence [523], chronic
kidney disease [545], [546] as well as atherosclerosis [547], [548]. Consequently, not
only the endpoints differ substantially from those selected in the present study, but also
variables diverged substantially. Beside the traditional risk factors of which some of the
selected variables have also been addressed in prior studies [478], [549], the inclusion
of socioeconomic variables is so far a new and singular approach. The collected data
during baseline and follow-up examinations were not primarily designed for the research
issue addressed here. If focused from the start, more sensitive and concise approaches
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Figure 9.5
Socioeconomic position by health insurance in Germany [503];
legend to this overview: “Oberschicht”: upper class; “obere Mittelschicht”: upper middle
class, “Mittelschicht”: middle class; “untere Mittelschicht”: lower middle class; “untere
Schicht”: lower class.
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might have been included in the methods and design of the questionnaires.
Moreover, a long-term investigation on mortality after ischaemic stroke, TIA, and MI
would have been highly interesting. Most of the reviewed trials took stroke or MI mortality
as study endpoint. As the INVADE trial is still actively running, a follow-up study to
compare alterations in the influence of the discussed socioeconomic variables with the
status stated here, might be highly interesting.
9.6 Implementations
9.6.1 Value of health care education for health economics
Regarding the described raising prevalence of stroke and DALYs lost due to stroke and
MI (see chapter 1.3), health resources worldwide are already overburdened [8].
As a result, health-care providers should focus on the provision of stroke and MI chronic
care, involving the prevention of secondary cases [550]. In this course, the integration of
community rehabilitation, including self-managed rehabilitation procedures are recommended.
Stroke and MI share a large number risk factors. At the same time, socioeconomic
differences in stroke mortality remained relatively stable, while disparities in CHD mortality
widened over time in most European countries [324]. Educational disparities in stroke
mortality remained of comparable magnitude, while increasing in ischemic heart disease
mortality.
Even though research on older age groups in developed countries with old age structures
is increasing [551], it persist to be rather sporadic compared to the number of trials
conducted in younger or middle aged subjects [552], [553].
In the population of elderly, recommended stroke therapies are often underused. In
addition to this, several studies underlined that subjects with a poor education were
more likely to discontinue medication after MI. The effect of advanced age on medication
therapy cessation was more pronounced in women than men [554].
Those aspects relating compliance and age clearly have to be considered when designing
health care campaigns. More efficient strategies are required to appropriately educate
the general as well as high-risk population regarding stroke [11] and MI in terms of
warning signs and an immediate response enabling a timely hospitalisation. In order
to increase awareness of warnings signs and symptoms regarding stroke, the INVADE
network actively contributed to a recent information event in Ebersberg [555]. The main
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aim of this campaign was to call the emergency ambulance immediately, as every single
minutes of delay in hospitalization may result in significantly wore prognosis. More
initiatives like this should be launched to ensure public attention.
Health care education can be based on a variety of different efficient approaches. Policies
should include improved access to heathy, affordable, and labelled foods within the
community. More frequent physical education in schools and also at worksites, increased
access to recreational spaces, higher taxes on tobacco and alcohol, promotion of public
funding for heart disease, stroke intervention programs, and CVD preventive benefits in
health insurances should be addressed.
To deliver this crucial message, mass media has a huge impact on distributing information
about prevention of CVD. As the source of information varies according to patient characteristics
[556], health education programs should be adapted accordingly. For instance, a recent
study suggested a “stroke riskometer app”, individually indicating the absolute risk of
suffering from stroke in the upcoming years [557].
To summarize, well directed health care education in lower socioeconomic classes can
contribute to decreased incidence rates in stroke and MI, lowering overall costs in the
German health care system [505]. Direct and indirect effects based on those strategies
might not be seen immediately, but future generations will feel their impact.
9.6.2 Perspectives
The Global Burden of Diseases, Injuries, and Risk Factors Study revealed a substantial
geographical difference in stroke burden by regions and country income level. This is
presumably attributed to the diversity in the national income per person [8]. Within highly
industrialized countries, like Germany, good health services and strategies for stroke
prevention and care are the most likely elucidations for the decrease in stroke and MI
incidence, mortality, and DALYs lost. Development and monitoring of the effectiveness
of preventive programs focusing on risk factors for stroke and myocardial infarction, such
as control of blood pressure, smoking cessation, effective preventive strategies [8], and
optimisation of acute stroke and chest pain units, could fulfil a most effective contribution.
These approaches should be culturally acceptable, economical, and aimed at both, high-
risk individuals and the general population.
Research plays an essential role in lowering the burden of stroke [11], [558] and MI by
improving quality standards in medical care, disseminating interdisciplinary knowledge,
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and providing data on comparative effectiveness. In all sectors and on all levels of
health care, including not only governmental committees, but also health care providers,
patient groups, and non-governmental agencies, combined effort should be directed on
the decrease of projected incidence rates for stroke and MI (see chapter 1.3).
In January 2009, the existing German risk structure compensation scheme between
sickness funds from 1994, called “Risikostrukturausgleich” (RSA), has been extended
in order to involve morbidity-oriented factors as well [559]. This led to the term “morbi-
RSA”, aiming at preventing risk selection, improving the medical care for patients with
chronic diseases, and equalizing starting positions for competition between sickness
funds. The morbi-RSA implicated a fundamental reorganization of finance flows which
is highly controversial. Diagnostics are profitable for the health insurance companies,
creating economic costs. In the present study, educational attainment was reported as
an independent and significant risk factor for ischaemic stroke and TIA. This variable is
currently not included in the morbi-RSA, indicating a disadvantage for the AOK. In the
future, a potential involvement of educational level might lead to intense socio-political
discussions.
There is an urgent need for ongoing well-designed, easy to compare, community-based
stroke epidemiology and surveillance trials. Implementation of preventive strategies have
proven highly effective at community level [557]. A deepened health care education
focusing on the revealed discrepancies in the INVADE cohort might lower incidence rates
and the burden of disease in the administrative district of Ebersberg.
Furthermore, the generated results from future research will ameliorate our knowledge
of stroke as well as MI determinants and burden worldwide. Moreover, an in-dept
understanding of assumed causes of discrepancies and alterations in trends in disease
burden will be enabled by this approach. Delving deeper into the question why lower
educational level was significantly and independently associated with the incidence of
ischaemic stroke and TIA in this study, but not with MI, would be exceedingly enlightening.
As stroke including TIA are diseases directly affecting the brain, a closer connection
between knowledge and brain compared to diseases aiming at the heart could be assumed.
Qureshi et al. (2003) reported that the effect of educational attainment on myocardial
infarction was more prominent in persons aged 50 years or less [328]. This finding
might lead to the conclusion that the adverse consequences of low educational level are
more likely to manifest in younger individuals. In older age groups, as in the present
study, traditional risk factors might have a higher impact than educational attainment in
determining an individual’s risk for MI, as opposed to stroke and the closely linked TIA.
156
Discussion
To conclude, the third Report on Poverty and Wealth in Germany clearly states that
prevention and participation services should aim at diminishing the effects of illness and
disability to achieve the longest re(integration) in life [423]. According to the coalition
agreement of November 2005, prevention and health promotion are to be highly promoted
in order to increase life expectancy and quality of life in Germany.
The present study attributed to this goal with a further step on a long way ahead.
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Figure A.1
INVADE questionnaire admission examination for patient.
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Figure A.2
INVADE questionnaire admission examination for general practitioner.
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Figure A.3
INVADE questionnaire follow-up examination for patient.
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Figure A.4
INVADE questionnaire follow-up examination for general practitioner.
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